10-Q

__________________________________________________________________________________________________________

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

☑    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

For the transition period from _____ to ______

Commission File Number: 1-31923

 UNIVERSAL TECHNICAL INSTITUTE, INC.

(Exact name of registrant as specified in its charter)

Delaware	86-0226984
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

4225 East Windrose Drive, Suite 200

Phoenix, Arizona 85032

(Address of principal executive offices, including zip code)

(623) 445-9500

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, $0.0001 par value	UTI	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes þ    No  ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes   þ    No ¨  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨	Accelerated filer þ
Non-accelerated filer ¨	Smaller reporting company ☐
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  þ

At May 1, 2024, there were 53,801,456 shares outstanding of the registrant's common stock.

UNIVERSAL TECHNICAL INSTITUTE, INC.

INDEX TO FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2024

 

		Page
		Number
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS		ii
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements
	Condensed Consolidated Balance Sheets at March 31, 2024 and September 30, 2023 (Unaudited)	1
	Condensed Consolidated Statements of Operations for the Three and Six Months Ended March 31, 2024 and 2023 (Unaudited)	2
	Condensed Consolidated Statements of Other Comprehensive Income for the Three and Six Months Ended March 31, 2024 and 2023 (Unaudited)	3
	Condensed Consolidated Statements of Shareholders’ Equity as of March 31, 2024 and 2023 (Unaudited)	4
	Condensed Consolidated Statements of Cash Flows for the Six Months Ended March 31, 2024 and 2023 (Unaudited)	6
	Notes to Condensed Consolidated Financial Statements (Unaudited)	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	26
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	41
Item 4.	Controls and Procedures	41
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	42
Item 1A.	Risk Factors	42
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	42
Item 3.	Defaults upon Senior Securities	42
Item 4.	Mine Safety Disclosures	42
Item 5.	Other Information	42
Item 6.	Exhibits	43
SIGNATURES		44

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q and the documents incorporated by reference herein contain forward-looking statements within the meaning of the safe harbor from civil liability provided for such statements by the Private Securities Litigation Reform Act of 1995 (set forth in Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”) and Section 27A of the Securities Act of 1933, as amended (“Securities Act”), which include information relating to future events, future financial performance, strategies, expectations, competitive environment, regulation and availability of resources and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. From time to time, we also provide forward-looking statements in other materials we release to the public as well as verbal forward-looking statements.

In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “could,” “would,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “projects,” “predicts,” “potential” and similar expressions (including the negative form of such expressions) intended to identify forward-looking statements, although not all forward looking statements contain these identifying words. Forward-looking statements are based on our current expectations and assumptions, do not strictly relate to historical or current facts, any of which may not prove to be accurate. Many factors could cause actual results to differ materially and adversely from these forward-looking statements. Important factors that could cause actual results to differ from those in our forward-looking statements include, without limitation:

•failure of our schools to comply with the extensive regulatory requirements for school operations;

•our failure to maintain eligibility for federal student financial assistance funds;

•the effect of current and future Title IV Program regulations arising out of negotiated rulemakings, including any potential reductions in funding or restrictions on the use of funds received through Title IV Programs;

•the effect of future legislative or regulatory initiatives related to veterans’ benefit programs;

•continued Congressional examination of the for-profit education sector;

•our failure to maintain eligibility for or the ability to process federal student financial assistance;

•regulatory investigations of, or actions commenced against, us or other companies in our industry;

•changes in the state regulatory environment or budgetary constraints;

•our failure to execute on our growth and diversification strategy, including effectively identifying, establishing and operating additional schools, programs or campuses;

•our failure to realize the expected benefits of our acquisitions, or our failure to successfully integrate our acquisitions;

•our failure to improve underutilized capacity at certain of our campuses;

•enrollment declines or challenges in our students’ ability to find employment as a result of macroeconomic conditions;

•our failure to maintain and expand existing industry relationships and develop new industry relationships;

•our ability to update and expand the content of existing programs and develop and integrate new programs in a timely and cost-effective manner while maintaining positive student outcomes;

•a loss of our senior management or other key employees;

•failure to comply with the restrictive covenants and our ability to pay the amounts when due under the Credit Agreement;

•the effect of our principal stockholder owning a significant percentage of our capital stock, and thus being able to influence certain corporate matters and the potential in the future to gain substantial control over our company;

•the effect of public health pandemics, epidemics or outbreak, including COVID-19; and

•risks related to other factors discussed in our 2023 Annual Report on Form 10-K filed with the SEC on December 1, 2023 (the “2023 Annual Report on Form 10-K”).

The factors above are not exhaustive, and new factors may emerge or changes to the foregoing factors may occur that could impact our business. We cannot guarantee that any forward-looking statement will be realized. Achievement of future results is subject to risks, uncertainties and potentially inaccurate assumptions. Many events beyond our control may determine whether results we anticipate will be achieved. Should known or unknown risks or uncertainties materialize, or should

ii

underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected. Among the factors that could cause actual results to differ materially are the factors discussed under Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” You should bear this in mind as you consider forward-looking statements.

Also, these forward-looking statements represent our estimates and assumptions only as of the date of the document containing the applicable statement. Except as required by law, we undertake no obligation to update or revise forward looking statements, whether as a result of new information, future events or otherwise. Thus, you should not assume that our silence over time means that actual events are bearing out as expressed or implied in such forward-looking statements. We qualify all of the forward-looking statements in this Quarterly Report on Form 10-Q, including the documents that we incorporate by reference herein, by these cautionary statements. You are advised, however, to consult any further disclosures we make on related subjects in our reports and filings with the Securities and Exchange Commission (“SEC”).

iii

PART I. FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value and per share amounts)

(Unaudited)

	March 31, 2024		September 30, 2023
Assets
Cash and cash equivalents	$	116,099	$	151,547
Restricted cash	4,446		5,377
Receivables, net	24,294		25,161
Notes receivable, current portion	6,163		5,991
Prepaid expenses	12,200		9,412
Other current assets	7,032		7,497
Total current assets	170,234		204,985
Property and equipment, net	263,538		266,346
Goodwill	28,459		28,459
Intangible assets, net	18,627		18,975
Notes receivable, less current portion	34,909		30,672
Right-of-use assets for operating leases	169,626		176,657
Deferred tax asset, net	4,556		3,768
Other assets	12,139		10,823
Total assets	$	702,088	$	740,685
Liabilities and Shareholders’ Equity
Accounts payable and accrued expenses	$	70,079	$	69,941
Deferred revenue	67,599		85,738
Operating lease liability, current portion	22,841		22,481
Long-term debt, current portion	2,600		2,517
Other current liabilities	3,323		4,023
Total current liabilities	166,442		184,700
Deferred tax liabilities, net	663		663
Operating lease liability	158,448		165,026
Long-term debt	139,317		159,600
Other liabilities	4,605		4,729
Total liabilities	469,475		514,718
Commitments and contingencies (Note 16)
Shareholders’ equity:
Common stock, $0.0001 par value, 100,000 shares authorized, 53,884 and 34,157 shares issued	5		3
Preferred stock, $0.0001 par value, 10,000 shares authorized; 0 and 676 shares of Series A Convertible Preferred Stock issued and outstanding, liquidation preference of $100 per share	—		—
Paid-in capital - common	216,359		151,439
Paid-in capital - preferred	—		66,481
Treasury stock, at cost, 82 shares	(365)		(365)
Retained earnings	14,684		5,946
Accumulated other comprehensive income	1,930		2,463
Total shareholders’ equity	232,613		225,967
Total liabilities and shareholders’ equity	$	702,088	$	740,685

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

1

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2024		2023		2024		2023
Revenues	$	184,176	$	163,820	$	358,871	$	283,824
Operating expenses:
Educational services and facilities	97,488		86,930		189,897		148,338
Selling, general and administrative	75,496		70,941		143,551		125,089
Total operating expenses	172,984		157,871		333,448		273,427
Income from operations	11,192		5,949		25,423		10,397
Other (expense) income:
Interest income	1,427		1,805		3,402		2,628
Interest expense	(2,184)		(2,637)		(5,055)		(4,060)
Other income (expense), net	119		126		333		451
Total other expense, net	(638)		(706)		(1,320)		(981)
Income before income taxes	10,554		5,243		24,103		9,416
Income tax expense (Note 14)	(2,767)		(1,763)		(5,927)		(3,288)
Net income	$	7,787	$	3,480	$	18,176	$	6,128
Preferred stock dividends	—		(1,251)		(1,097)		(2,528)
Income available for distribution	$	7,787	$	2,229	$	17,079	$	3,600
Income allocated to participating securities	—		(833)		(2,855)		(1,348)
Net income available to common shareholders	$	7,787	$	1,396	$	14,224	$	2,252
Earnings per share (Note 18):
Net income per share - basic	$	0.14	$	0.04	$	0.32	$	0.07
Net income per share - diluted	$	0.14	$	0.04	$	0.31	$	0.07
Weighted average number of shares outstanding (Note 18):
Basic	53,757		33,999		45,048		33,901
Diluted	54,770		34,553		46,050		34,477

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

2

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE INCOME

(In thousands)

(Unaudited)

	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2024		2023		2024		2023
Net income	$	7,787	$	3,480	$	18,176	$	6,128
Other comprehensive income (loss):
Unrealized gain (loss) on interest rate swaps, net of taxes	353		(538)		(533)		(664)
Comprehensive income	$	8,140	$	2,942	$	17,643	$	5,464

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(In thousands)

(Unaudited)

	Common Stock			Preferred Stock			Paid-in Capital - Common		Paid-in Capital - Preferred		Treasury Stock			Retained Earnings		Accumulated Other Comprehensive Income		Total Shareholders’ Equity
	Shares	Amount		Shares	Amount						Shares	Amount
Balance as of September 30, 2023	34,157	$	3	676	$	—	$	151,439	$	66,481	(82)	$	(365)	$	5,946	$	2,463	$	225,967
Net income	—	—		—	—		—		—		—	—		10,389		—		10,389
Issuance of common stock under stock-based compensation plans	538	—		—	—		—		—		—	—		—		—		—
Shares withheld for payroll taxes	(178)	—		—	—		(2,054)		—		—	—		—		—		(2,054)
Stock-based compensation	—	—		—	—		1,482		—		—	—		—		—		1,482
Preferred stock dividends	—	—		—	—		—		—		—	—		(1,097)		—		(1,097)
Preferred share repurchase	—	—		(33)	—		—		(3,275)		—	—		(8,341)		—		(11,616)
Preferred stock conversion	19,297	2		(643)	—		63,204		(63,206)		—	—		—		—		—
Unrealized loss on interest rate swaps, net of taxes	—	—		—	—		—		—		—	—		—		(886)		(886)
Balance as of December 31, 2023	53,814	$	5	—	$	—	$	214,071	$	—	(82)	$	(365)	$	6,897	$	1,577	$	222,185
Net income	—	—		—	—		—		—		—	—		7,787		—		7,787
Issuance of common stock under stock-based compensation plans	74	—		—	—		—		—		—	—		—		—		—
Shares withheld for payroll taxes	(4)	—		—	—		(65)		—		—	—		—		—		(65)
Stock-based compensation	—	—		—	—		2,353		—		—	—		—		—		2,353
Unrealized gain on interest rate swaps, net of taxes	—	—		—	—		—		—		—	—		—		353		353
Balance as of March 31, 2024	53,884	$	5	—	$	—	$	216,359	$	—	(82)	$	(365)	$	14,684	$	1,930	$	232,613

4

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (CONTINUED)

(In thousands)

(Unaudited)

	Common Stock			Preferred Stock			Paid-in Capital - Common		Paid-in Capital - Preferred		Treasury Stock			Retained (Deficit) Earnings		Accumulated Other Comprehensive Income		Total Shareholders’ Equity
	Shares	Amount		Shares	Amount						Shares	Amount
Balance as of September 30, 2022	33,857	$	3	676	$	—	$	148,372	$	66,481	(82)	$	(365)	$	(1,307)	$	2,213	$	215,397
Net income	—	—		—	—		—		—		—	—		2,648		—		2,648
Issuance of common stock under stock-based compensation plans	223	—		—	—		—		—		—	—		—		—		—
Shares withheld for payroll taxes	(73)	—		—	—		(525)		—		—	—		—		—		(525)
Stock-based compensation	—	—		—	—		1,169		—		—	—		—		—		1,169
Preferred stock dividends	—	—		—	—		—		—		—	—		(1,277)		—		(1,277)
Unrealized loss on interest rate swap, net of taxes	—	—		—	—		—		—		—	—		—		(126)		(126)
Balance as of December 31, 2022	34,007	$	3	676	$	—	$	149,016	$	66,481	(82)	$	(365)	$	64	$	2,087	$	217,286
Net Income	—	—		—	—		—		—		—	—		3,480		—		3,480
Issuance of common stock under stock-based compensation plans	175	—		—	—		—		—		—	—		—		—		—
Shares withheld for payroll taxes	(33)	—		—	—		(223)		—		—	—		—		—		(223)
Stock-based compensation	—	—		—	—		2,113		—		—	—		—		—		2,113
Preferred stock dividends	—	—		—	—		—		—		—	—		(1,251)		—		(1,251)
Unrealized loss on interest rate swap, net of taxes	—	—		—	—		—		—		—	—		—		(538)		(538)
Balance as of March 31, 2023	34,149	$	3	676	$	—	$	150,906	$	66,481	(82)	$	(365)	$	2,293	$	1,549	$	220,867

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Six Months Ended March 31,
	2024		2023
Cash flows from operating activities:
Net income	$	18,176	$	6,128
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	14,186		11,994
Amortization of right-of-use assets for operating leases	10,952		10,073
Bad debt expense	3,189		2,071
Stock-based compensation	3,835		3,282
Deferred income taxes	(314)		2,479
Training equipment credits earned, net	962		47
Unrealized loss on interest rate swap	(533)		(664)
Other losses (gains), net	83		(196)
Changes in assets and liabilities:
Receivables	(1,533)		(3,895)
Prepaid expenses	(4,469)		(898)
Other assets	(1,088)		2,709
Notes receivable	(4,409)		(579)
Accounts payable, accrued expenses and other current liabilities	(2,140)		(16,446)
Deferred revenue	(18,139)		(9,554)
Operating lease liability	(10,139)		(10,745)
Other liabilities	(274)		(121)
Net cash provided by (used in) operating activities	8,345		(4,315)
Cash flows from investing activities:
Cash paid for acquisition, net of cash acquired	—		(16,973)
Purchase of property and equipment	(9,759)		(38,641)
Proceeds from maturities of held-to-maturity securities	—		29,000
Net cash used in investing activities	(9,759)		(26,614)
Cash flows from financing activities:
Proceeds from revolving credit facility	20,000		90,000
Payments on revolving credit facility	(39,000)		—
Debt issuance costs related to the revolving credit facility	—		(484)
Payments on term loans and finance leases	(1,246)		(715)
Payment of preferred stock cash dividend	(1,097)		(2,528)
Preferred share repurchase	(11,503)		—
Payment of payroll taxes on stock-based compensation through shares withheld	(2,119)		(748)
Net cash (used in) provided by financing activities	(34,965)		85,525
Change in cash, cash equivalents and restricted cash	(36,379)		54,596
Cash and cash equivalents, beginning of period	151,547		66,452
Restricted cash, beginning of period	5,377		3,544
Cash, cash equivalents and restricted cash, beginning of period	156,924		69,996
Cash and cash equivalents, end of period	116,099		120,579
Restricted cash, end of period	4,446		4,013
Cash, cash equivalents and restricted cash, end of period	$	120,545	$	124,592

6

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(In thousands)

(Unaudited)

	Six Months Ended March 31,
	2024		2023
Supplemental disclosure of cash flow information:
Income taxes paid, net of refunds	$	6,185	$	306
Interest paid	5,476		3,496
Supplemental schedule of noncash investing and financing activities:
Training equipment obtained in exchange for services	$	302	$	343
Depreciation of training equipment obtained in exchange for services	270		394
Change in accrued capital expenditures during the period	(1,768)		1,964
Conversion of Series A Preferred Stock	63,206		—

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

7

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 1 - Nature of the Business

Universal Technical Institute, Inc., which together with its subsidiaries is referred to as the “Company,” “we,” “us” or “our,” was founded in 1965 and is a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, whose mission is to serve students, partners, and communities by providing quality education and support services for in-demand careers across a number of highly-skilled fields. We offer the majority of our programs in a blended learning model that combines instructor-facilitated online teaching and demonstrations with hands-on labs. We have two reportable segments as follows:

Universal Technical Institute (“UTI”): UTI operates 16 campuses located in nine states and offers a wide range of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute and Marine Mechanics Institute (“MMI”), NASCAR Technical Institute, and MIAT College of Technology (“MIAT”). UTI also offers manufacturer specific advanced training programs, which include student-paid electives, at our campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Lastly, UTI provides dealer technician training or instructor staffing services to manufacturers. UTI works closely with multiple original equipment manufacturers and industry brand partners to understand their needs for qualified service professionals.

Concorde Career Colleges (“Concorde”): Concorde operates across 17 campuses in eight states and online, offering degree, non-degree, and continuing education programs in the allied health, dental, nursing, patient care and diagnostic fields. The Company has designated campuses that offer degree granting programs “Concorde Career College;” where allowed by state regulation. The remaining campuses are designated as “Concorde Career Institute.” Concorde believes in preparing students for their healthcare careers with practical, hands-on experiences including opportunities to learn while providing care to real patients. Prior to graduation, students will complete a number of hours in a clinical setting or externship, depending upon their program of study. We acquired Concorde on December 1, 2022. See Note 4 on “Acquisitions” for additional information.

“Corporate” includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments. Additional information about our reportable segments is presented in Note 19.

Our primary source of revenues is currently tuition and fees paid by students. To pay for a substantial portion of their tuition, the majority of students rely on funds received from federal financial aid programs under Title IV Programs of the Higher Education Act of 1965, as amended (“HEA”), as well as from various veterans’ benefits programs. For further discussion, see Note 2 on “Summary of Significant Accounting Policies - Concentration of Risk” and Note 19 on “Government Regulation and Financial Aid” included in our 2023 Annual Report on Form 10-K.

Note 2 - Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, our condensed consolidated financial statements do not include all the information and footnotes required by GAAP for complete financial statements. Normal and recurring adjustments considered necessary for a fair statement of the results for the interim periods have been included. Operating results for the six months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending September 30, 2024. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our 2023 Annual Report on Form 10-K.

The unaudited condensed consolidated financial statements include the accounts of Universal Technical Institute, Inc. and our wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates.

8

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Other than described below, there have been no material changes or developments in our significant accounting policies or evaluation of accounting estimates and underlying assumptions or methodologies from those disclosed in Note 2 of our 2023 Annual Report on Form 10-K.

Segment Recast

During fiscal 2023, in coordination with the integration of Concorde, we began to reassess our operating model to determine the optimal structure to achieve future growth goals and support the business. In furtherance of the foregoing, we executed an internal reorganization of our operations to fully transition our operating and reporting model to support a multi-divisional business. Each of the reportable segments now has dedicated accounting, finance, information technology, and human resources teams. Additionally, certain human resources and information technology costs that benefit the entire organization are now allocated across the UTI, Concorde and Corporate segments each period based upon relative headcount. As a result, additional costs have moved from the Corporate segment into the UTI segment and to a lesser extent the Concorde segment, as resources were redirected to support each segment’s objectives. Due to these changes in allocation methodology, the segment disclosures in Note 19 for the three and six months ended March 31, 2023 have been recast from the prior year presentation for comparability to the current year presentation.

Note 3 - Recent Accounting Pronouncements

The Financial Accounting Standards Board (“FASB”) and the SEC periodically issue new accounting standards or disclosure requirements in a continuing effort to improve standards of financial accounting and reporting. We have reviewed the recently issued pronouncements and concluded the following new accounting standard updates (“ASU”) or SEC rules apply to us.

Effective in Fiscal 2025

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses and increased interim disclosure requirements, among others. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, and the amendments should be applied retrospectively. This ASU will be effective for our Form 10-K for fiscal 2025 and our Form 10-Q for the first quarter of fiscal 2026. We are currently evaluating the impact this ASU may have on our financial statement disclosures.

Effective in Fiscal 2026

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, among others, in order to enhance the transparency of income tax disclosures, including consistent categories and greater disaggregation of information in the rate reconciliation and disaggregation by jurisdiction of income taxes paid. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied prospectively; however, retrospective application is also permitted. This ASU will be effective for our Form 10-K for fiscal 2026. We are currently evaluating the impact this ASU may have on our financial statement disclosures.

Effective in Fiscal 2027

In March 2024, the SEC issued final rules to enhance public company disclosures related to the risks and impacts of climate-related matters. In April 2024, the SEC voluntarily stayed the new rules as a result of pending legal challenges. The new rules, if adopted, include requirements to disclose Scope 1 and Scope 2 greenhouse gas emissions and other climate-related topics in annual reports and registration statements, when material. Disclosure requirements will begin phasing in for our Form 10-K for fiscal 2027. We are currently evaluating the impact this rule may have on our financial statement disclosures.

9

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 4 - Acquisitions

Concorde Career Colleges

On December 1, 2022, we completed the acquisition of Concorde. Concorde operates 17 campuses across eight states with approximately 7,600 students, and offers its programs via in-person, hybrid and online formats. Concorde offers more than 20 programs across the allied health, dental, nursing, patient care, and diagnostic fields. The acquisition expands our portfolio of offerings into the higher-growth healthcare arena and creates the opportunity to bring workforce educational solutions to a broader array of students and employers.

Under the terms of the Stock Purchase Agreement (the “Purchase Agreement”), dated May 3, 2022, by and among the Company, Concorde, Liberty Partners Holdings 28, L.L.C., a Delaware limited liability company, and Liberty Investment IIC, LLC, a Delaware limited liability company (each a “Seller,” and collectively, the “Sellers”); and Liberty Partners L.P., a Delaware limited partnership, in its capacity as a representative of the Sellers, we acquired all of the issued and outstanding shares of capital stock of Concorde for a base purchase price of $50.0 million, less $1.9 million of net adjustments including the post-closing working capital adjustment, for total cash consideration paid of $48.1 million. As a result of the transactions contemplated by the Purchase Agreement, Concorde is now a wholly-owned subsidiary of the Company. We funded the consideration paid for Concorde by the Credit Facility entered into on November 18, 2022. See Note 12 for further details on the Credit Facility.

In connection with the acquisition, we incurred total transaction costs of $5.3 million, of which $3.0 million was incurred during the year ended September 30, 2022 and $2.3 million was incurred during the year ended September 30, 2023. These costs are included in “Selling, general and administrative” expenses in the condensed consolidated statements of operations for the applicable period.

Allocation of the purchase price

Under the acquisition method of accounting, the total purchase price was allocated to the identifiable assets acquired and the liabilities assumed based on our valuation estimates of the fair values as of the acquisition date. As of December 1, 2023, the fair value and purchase price allocation are considered final.

The final allocation of the purchase price at December 1, 2022 is summarized as follows:

Assets acquired:
Cash and cash equivalents	$	30,064
Restricted cash	1,689
Accounts receivable, net	6,800
Prepaid expenses	2,957
Other current assets	827
Property and equipment	23,238
Right-of-use assets for operating leases	71,153
Goodwill	11,600
Intangible assets	5,400
Deferred tax assets	5,112
Other assets	4,997
Total assets acquired	$	163,837

10

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Less: Liabilities assumed
Accounts payable and accrued expenses	$	15,482
Deferred revenue	20,145
Operating lease liability, current portion	10,011
Long-term debt, current portion (1)	807
Other current liabilities	208
Long-term debt (1)	5,468
Operating lease liability	63,582
Total liabilities assumed	115,703
Net assets acquired	$	48,134

(1)    Long-term debt consists of one lease classified as a finance lease under ASC 842.

Since September 30, 2023, we further adjusted the purchase price allocation by approximately $0.1 million for income taxes receivable and approximately $0.6 million for deferred income taxes due to completing and filing the final stub period income tax return for Concorde, which resulted in a $0.7 million adjustment to property and equipment. These adjustments did not have a material impact on the financial statements since the date of acquisition.

The amount allocated to goodwill of $11.6 million represents the acquired assembled workforce. None of the goodwill is expected to be deductible for tax purposes. Factors that contributed to a purchase price resulting in the recognition of goodwill include Concorde’s strategic fit into our growth and diversification strategy, which is focused on offering a broader array of high-quality, in-demand workforce education solutions which both prepare students for a variety of careers in fast-growing fields and help close the country's skills gap by leveraging key industry partnerships.

The purchase price allocation requires subjective estimates that, if incorrectly estimated, could be material to our condensed consolidated financial statements including the amount of depreciation and amortization expense. The fair value of the property and equipment was estimated using the cost and market approaches as of the valuation date. The fair value of the leases were estimated using the income and market approaches to determine if there was any favorable or unfavorable terms in place.

The intangible assets acquired, which primarily consist of the accreditations and regulatory approvals, trademarks and trade names, and curriculum, were valued using different valuation techniques depending upon the nature of the intangible asset acquired, all of which are considered level 3 as defined in Note 6. The accreditations and regulatory approvals were valued using the multi-period excess earnings method (“MPEEM”) under the income approach. The MPEEM is a variation of discounted cash-flow analysis. Rather than focusing on the whole entity, the MPEEM isolates the cash flows that can be associated with a single intangible asset and measures fair value by discounting them to present value. The trademarks and trade names were valued using the relief from royalty method. The value of the trade name encompasses all items necessary to generate revenue utilizing the trade name. The curriculum was valued using the cost approach.

The table below presents the final summary of the intangible assets acquired and the useful lives of these assets:

Intangible Asset	Useful life	Amount
Accreditations and regulatory approvals	Indefinite	$	3,500
Trademarks and trade names	10 years	500
Curriculum	5 years	1,400
Total		$	5,400

See Note 8 and Note 9 and for additional details on goodwill and intangible assets.

11

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Student receivables

When financial assets are acquired in connection with a business combination, we evaluate whether those acquired financial assets have experienced a more-than-insignificant deterioration in credit quality since origination. Financial assets acquired with evidence of such credit deterioration are referred to as purchased credit deteriorated (“PCD”) assets and reflect the acquirer’s assessment at the acquisition date. The student receivables acquired in the Concorde acquisition were reviewed to determine if any had experienced a more-than-insignificant deterioration in credit quality since origination. Student receivables of approximately $2.3 million met the established criteria to indicate a more-than insignificant deterioration in credit quality and were identified as PCD assets. Using our best estimate of projected losses over the term of the contracts, we calculated an allowance for credit losses on these PCD assets of approximately $1.0 million.

Pro forma financial information

The following unaudited pro forma financial information summarizes our results of operations as though the acquisition occurred on October 1, 2022:

	Six Months Ended
	March 31, 2023
Revenue	$	319,845
Net income	5,919

The unaudited pro forma financial information includes adjustments to reflect the additional amortization that would have been charged assuming the fair value adjustments to intangible assets and the finance lease asset had been applied from October 1, 2022, with the related tax effects. The unaudited pro forma financial information also includes adjustments to reflect the additional interest expense on the new Credit Facility issued to fund the acquisition (see Note 12 for further details on the Credit Facility). Lastly, the unaudited pro forma financial information includes adjustments to reflect the reduction in depreciation expense assuming the fair value adjustments to property and equipment assets had been applied from October 1, 2022.

This unaudited pro forma financial information is for informational purposes only. It does not reflect the integration of the business or any synergies or incremental costs that may result from the acquisition. As such, it is not indicative of the results of operations that would have been achieved had the acquisition been consummated on October 1, 2022. In addition, the unaudited pro forma financial information amounts are not indicative of future operating results.

Note 5 - Revenue from Contracts with Customers

Nature of Goods and Services

Revenues across the UTI and Concorde segments consist primarily of student tuition and fees derived from the programs we provide after reductions are made for discounts and scholarships that we sponsor and for refunds for students who withdraw from our programs prior to specified dates. We apply the five-step model outlined in Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts from Customers. Tuition and fee revenue is recognized ratably over the term of the course or program offered.

In addition to revenue from tuition and fees, UTI and Concorde derive supplemental revenues from sales of textbooks and program supplies and other revenues, which includes revenues from dealer technician training and staffing services to manufacturers. All of these revenues are recognized as the transfer of goods or services occurs. Deferred revenue represents the excess of tuition and fee payments received as compared to tuition and fees earned and is reflected as a current liability in our condensed consolidated balance sheets because it is expected to be earned within the next 12 months.

All of our revenues are generated within the United States. The impact of economic factors on the nature, amount, timing and uncertainty of revenue and cash flows is consistent across our various programs for both the UTI and Concorde segments. See Note 19 for disaggregated segment revenue information.

12

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

The following table provides information about receivables and deferred revenue resulting from our enrollment agreements with students:

	March 31, 2024		September 30, 2023
Receivables (1)	$	64,559	$	59,863
Deferred revenue	67,599		85,738

(1)     Receivables includes tuition receivables, retail installment contract receivables and notes receivable, both current and long term.

During the six months ended March 31, 2024, the deferred revenue balance included decreases for revenues recognized during the period and increases related to new students who started their training programs during the period.

Note 6 - Fair Value Measurements

The accounting framework for determining fair value includes a hierarchy for ranking the quality and reliability of the information used to measure fair value, which enables the reader of the financial statements to assess the inputs used to develop those measurements. The fair value hierarchy consists of three tiers:

Level 1:    Defined as quoted market prices in active markets for identical assets or liabilities.

Level 2:    Defined as inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, model-based valuation techniques for which all significant assumptions are observable in the market or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3:    Defined as unobservable inputs that are not corroborated by market data.

Any transfers of investments between levels occurs at the end of the reporting period. Assets measured or disclosed at fair value on a recurring basis consisted of the following:

			Fair Value Measurements Using
	March 31, 2024		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds(1)	$	24,563	$	24,563	$	—	$	—
Notes receivable(2)	41,072		—		—		41,072
Total assets at fair value on a recurring basis	$	65,635	$	24,563	$	—	$	41,072
Revolving credit facility and term loans(3)	137,155		—		137,155		—
Total liabilities at fair value on a recurring basis	$	137,155	$	—	$	137,155	$	—

13

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

			Fair Value Measurements Using
	September 30, 2023		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds(1)	$	29,687	$	29,687	$	—	$	—
Notes receivable(2)	36,663		—		—		36,663
Total assets at fair value on a recurring basis	$	66,350	$	29,687	$	—	$	36,663
Revolving credit facility and term loans(3)	156,991		—		156,991		—
Total liabilities at fair value on a recurring basis	$	156,991	$	—	$	156,991	$	—

(1) Money market funds and other highly liquid investments with maturity dates less than 90 days are reflected as “Cash and cash equivalents” in our condensed consolidated balance sheets as of March 31, 2024 and September 30, 2023.

(2) Notes receivable relate to UTI’s proprietary loan program and are reflected as “Notes receivable, current portion” and “Notes receivable, less current portion” in our condensed consolidated balance sheets as of March 31, 2024 and September 30, 2023.

(3) The Credit Facility and Term Loans bear interest at rates commensurate with market rates, and therefore, the respective carrying values approximate fair value (Level 2).

Note 7 - Property and Equipment, net

Property and equipment, net consisted of the following:

	March 31, 2024		September 30, 2023
Land	$	25,601	$	25,601
Buildings and building improvements	164,325		160,920
Leasehold improvements	89,462		87,525
Training equipment	112,448		110,292
Office and computer equipment	37,472		37,251
Curriculum development	3,570		2,478
Software developed for internal use	13,103		12,573
Vehicles	1,406		1,406
Right-of-use assets for finance leases	5,603		5,603
Construction in progress	7,246		9,061
	460,236		452,710
Less: Accumulated depreciation and amortization	(196,698)		(186,364)
Total	$	263,538	$	266,346

Depreciation expense related to property and equipment was $7.0 million and $13.8 million for the three and six months ended March 31, 2024, and $6.6 million and $11.7 million for the three and six months ended March 31, 2023, respectively.

14

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 8 - Goodwill

Our goodwill balance of $28.5 million as of March 31, 2024 and September 30, 2023, respectively, represents the acquired assembled workforce and the excess of the cost of an acquired business over the estimated fair values of the assets acquired and liabilities assumed.

The goodwill balance by reportable segment as of March 31, 2024 and September 30, 2023 was:

UTI	$	16,859
Concorde	11,600
Total	$	28,459

Goodwill is reviewed at least annually for impairment, which may result from the deterioration in the operating performance of the acquired businesses, adverse market conditions, adverse changes in applicable laws or regulations and a variety of other circumstances. Our goodwill is tested annually for impairment as of August 1 and more frequently if events or circumstances lead to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There were no indicators of goodwill impairment as of March 31, 2024.

Note 9 - Intangible Assets

The following table provides the gross carrying value, accumulated amortization, net book value and remaining useful life for those intangible assets that are subject to amortization as of March 31, 2024:

	Gross Carrying Value		Accumulated Amortization		Net Book Value		Weighted Average Remaining Useful Life (Years)
Accreditations and regulatory approvals	$	16,300	$	—	$	16,300	Indefinite
Trademarks, trade names and other	1,942		(848)		1,094		4.89
Curriculum	1,800		(567)		1,233		3.49
Total	$	20,042	$	(1,415)	$	18,627	4.15

The following table provides the gross carrying value, accumulated amortization, net book value and remaining useful life for those intangible assets that are subject to amortization as of March 31, 2023:

	Gross Carrying Value		Accumulated Amortization		Net Book Value		Weighted Average Remaining Useful Life (Years)
Accreditations and regulatory approvals	$	16,300	$	—	$	16,300	Indefinite
Trademarks, trade names and other	1,942		(513)		1,429		5.51
Curriculum	1,800		(207)		1,593		4.47
Total	$	20,042	$	(720)	$	19,322	4.96

Amortization expense was $0.2 million and $0.3 million for the three and six months ended March 31, 2024, and $0.2 million and $0.3 million for the three and six months ended March 31, 2023, respectively.

15

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Future intangible asset amortization expense is expected to be as follows:

Fiscal Year
Remainder of 2024	$	348
2025	677
2026	660
2027	337
2028	97
Thereafter	208
Total	$	2,327

The remaining weighted average useful lives shown are calculated based on the net book value and remaining amortization period of each respective intangible asset. Amortization is computed using the straight-line method based on estimated useful lives of the related assets. Our indefinite-lived intangible assets are reviewed at least annually for impairment as of August 1, or more frequently if there are indicators of impairment. There were no indicators of impairment for our indefinite-lived intangible assets as of March 31, 2024.

Note 10 - Leases

As of March 31, 2024, we have facility leases at 29 of our 33 campuses and three non-campus locations under non-cancelable operating or finance leases, some of which contain escalation clauses and requirements to pay other fees associated with the leases. The facility leases have original lease terms ranging from 5 to 20 years and expire at various dates through 2036. In addition, the leases commonly include lease incentives in the form of rent abatements and tenant improvement allowances. We sublease certain portions of unused building space to third parties, which as of March 31, 2024, resulted in minimal income. All of the leases, other than those that may qualify for the short-term scope exception of 12 months or less, are recorded on our condensed consolidated balance sheets.

Some of the facility leases are subject to annual changes in the Consumer Price Index (“CPI”). While lease liabilities are not remeasured as a result of changes to the CPI, changes to the CPI are treated as variable lease payments and recognized in the period in which the obligation for those payments was incurred. Many of our lease agreements include options to extend the lease, which we do not include in our minimum lease terms unless they are reasonably certain to be exercised. There are no early termination with penalties, residual value guarantees, restrictions or covenants imposed by our facility leases. The components of lease expense are included in “Educational services and facilities” and “Selling, general and administrative” on the condensed consolidated statement of operations, with the exception of interest on lease liabilities, which is included in “Interest expense.”

The components of lease expense during the three and six months ended March 31, 2024 and 2023 were as follows:

	Three Months Ended March 31,				Six Months Ended March 31,
Lease Expense	2024		2023		2024		2023
Operating lease expense(1)	$	7,597	$	8,273	$	15,259	$	13,977
Finance lease expense:
Amortization of leased assets	227		127		454		325
Interest on lease liabilities	79		35		161		122
Variable lease expense	2,476		2,307		4,837		4,257
Sublease income	(33)		(25)		(65)		(57)
Total net lease expense	$	10,346	$	10,717	$	20,646	$	18,624

(1)    Excludes the expense for short-term leases not accounted for under ASC 842, which was not significant for the three and six months ended March 31, 2024 and 2023.

16

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Supplemental balance sheet, cash flow and other information related to our leases was as follows (in thousands, except lease term and discount rate):

Leases	Classification	March 31, 2024		September 30, 2023
Assets:
Operating lease assets	Right-of-use assets for operating leases	$	169,626	$	176,657
Finance lease assets	Property and equipment, net(1)	4,391		4,846
Total leased assets		$	174,017	$	181,503
Liabilities:
Current
Operating lease liabilities	Operating lease liability, current portion	$	22,841	$	22,481
Finance lease liabilities	Long-term debt, current portion(1)	887		844
Noncurrent
Operating lease liabilities	Operating lease liability	158,448		165,026
Finance lease liabilities	Long-term debt	4,304		4,757
Total lease liabilities		$	186,480	$	193,108

(1)     The finance lease assets and liabilities as of March 31, 2024 and September 30, 2023 consisted of one facility lease. Finance lease assets are recorded net of accumulated amortization of $1.2 million and $0.8 million as of March 31, 2024 and September 30, 2023, respectively.

Lease Term and Discount Rate	March 31, 2024		September 30, 2023
Weighted-average remaining lease term (in years):
Operating leases	7.57		7.91
Finance lease	4.83		5.33
Weighted average discount rate:
Operating leases	4.86	%	4.76	%
Finance lease	6.02	%	6.02	%

	Six Months Ended March 31,
Supplemental Disclosure of Cash Flow and Other Information	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	10,139	$	10,745
Financing cash flows from finance leases	410		304
Non-cash activity related to lease liabilities:
Lease assets obtained in exchange for new operating lease liabilities (1)	$	3,921	$	149

(1) During the six months ended March 31, 2024, Concorde renewed the campus lease for the San Antonio, Texas campus.

17

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Maturities of lease liabilities were as follows:

	As of March 31, 2024
Years ending September 30,	Operating Leases		Finance Lease
Remainder of 2024	$	14,312	$	585
2025	30,148		1,193
2026	30,509		1,229
2027	28,874		1,266
2028	26,747		1,304
2029 and thereafter	85,892		439
Total lease payments	216,482		6,016
Less: interest	(35,193)		(825)
Present value of lease liabilities	181,289		5,191
Less: current lease liabilities	(22,841)		(887)
Long-term lease liabilities	$	158,448	$	4,304

Note 11 - Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following:

	March 31, 2024		September 30, 2023
Accounts payable	$	17,658	$	14,438
Accrued compensation and benefits	28,971		36,332
Accrued tool sets	4,743		4,096
Other accrued expenses	18,707		15,075
Total accounts payable and accrued expenses	$	70,079	$	69,941

Note 12 - Debt

	March 31, 2024					September 30, 2023
	Interest Rate		Maturity Date	Carrying Value of Debt(6)		Carrying Value of Debt(6)
Revolving Credit Facility(1)	7.78	%	Nov 2025	$	71,000	$	90,000
Avondale Term Loan(2)	7.37	%	May 2028	28,825		29,251
Lisle Term Loan(3)	7.33	%	Apr 2029	37,330		37,740
Finance lease(4)	6.02	%	Various	5,191		5,601
Total debt				142,346		162,592
Debt issuance costs presented with debt (5)				(429)		(475)
Total debt, net				141,917		162,117
Less: current portion of long-term debt				(2,600)		(2,517)
Long-term debt				$	139,317	$	159,600

(1)     Interest on the Revolving Credit Facility (as defined below) accrues at a rate equal to one-month Term SOFR plus a margin of 2.0% and a lender specific spread of 0.10-0.15% or a Prime Rate as set by the lender.

(2)    Interest on the Avondale Term Loan (as defined below) accrues at a rate equal to one-month Term SOFR plus 2.0% and a tranche adjustment of 0.046%.

(3)    Interest on the Lisle Term Loan (as defined below) accrues at a rate equal to one-month Term SOFR plus 2.0%.

18

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

(4)    The finance lease is related to a facility lease with an annual interest rate of 6.02% that matures in 2029. See Note 10 for additional details on our finance lease.

(5)    The unamortized debt issuance costs as of March 31, 2024 relate to the Avondale Term Loan and the Lisle Term Loan.

(6)    The Credit Facility, Term Loans and finance leases bear interest at rates commensurate with market rates, and therefore, the respective carrying values approximate fair value (Level 2).

Revolving Credit Facility

On November 18, 2022, we entered into a $100.0 million senior secured revolving credit facility with Fifth Third Bank, a national banking association (the “Credit Facility” or “Revolving Credit Facility”), which includes a $20.0 million sub facility that is available for letters of credit. The Credit Facility has a term of three years, unless earlier terminated pursuant to the terms and conditions set forth in the credit agreement.

This agreement provides that borrowings under the Credit Facility will amortize on an interest-only basis during its term with principal able to be borrowed, re-paid and re-borrowed throughout the term of the Credit Facility and with the outstanding principal due and payable at maturity. In executing the Credit Facility, we incurred $0.5 million in debt issuance costs which are included in “Other assets” on the condensed consolidated balance sheets as of March 31, 2024. On November 28, 2022, we drew $90.0 million from the Credit Facility in support of the closing of the Concorde acquisition at an interest rate of 6.54%. In December 2022, a $1.8 million letter of credit was issued on the Credit Facility.

During the three months ended March 31, 2024, we made payments on the Credit Facility of $39.0 million and we received proceeds of $20.0 million at a fixed base interest rate of 8.5%. During the three months ended March 31, 2024, our $1.8 million letter of credit expired, resulting in $29.0 million in availability under the Credit Facility at period end.

In April 2024, we used cash on hand to pay $20.0 million on the Credit Facility, which increased the availability under the Credit Facility to $49.0 million. It is likely that we will borrow from the Credit Facility in future periods based on future working capital or other needs.

Avondale Term Loan

In connection with the Avondale, Arizona building purchase in December 2020, we entered into a credit agreement with Fifth Third Bank, national banking association (the “Avondale Lender”) on May 12, 2021 in the maximum principal amount of $31.2 million with a maturity of seven years (the “Avondale Term Loan”). Originally, the Avondale Term Loan bore interest at the rate of LIBOR plus 2.0%. On April 3, 2023, we executed an amendment for our Avondale Term Loan to convert the stated rate from LIBOR to SOFR. The Avondale Term Loan bears interest at the rate of Term SOFR plus 2.0% and a tranche rate adjustment of 0.046%.

Principal and interest payments are due monthly. The Avondale Term Loan is secured by a first priority lien on our Avondale, Arizona property, including all land and improvements. Additionally, we entered into an interest rate swap agreement with the Avondale Lender. See Note 13 for further discussion on the interest rate swap.

Lisle Term Loan

On April 14, 2022, our consolidated subsidiary, 2611 Corporate West Drive Venture LLC (the “Borrower”), entered into a new Loan Agreement (“Lisle Loan Agreement”) with Valley National Bank (the “Lisle Lender”), to fund the acquisition and retire the prior loan agreement with Western Alliance bank, via a term loan in the original principal amount of $38.0 million with a maturity of seven years (the “Lisle Term Loan” and together with the Avondale Term Loan, the “Term Loans”). The Lisle Term Loan bears interest at a rate of one-month Term SOFR plus 2.0%. The Lisle Term Loan is secured by a mortgage on the Lisle, Illinois campus and is guaranteed by the Company. In connection with the Lisle Term Loan, we entered into an interest rate swap agreement. See Note 13 for further discussion on the interest rate swap.

Debt Covenants for our Credit Facility and Term Loans

We are subject to certain customary affirmative and negative covenants in connection with our Credit Facility and Term Loans, including, without limitation, certain reporting obligations, certain limitations on restricted payments, limitations on

19

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

liens, encumbrances and indebtedness and a debt service coverage ratio covenant. Events of default under the Credit Facility, Avondale Term Loan and the Lisle Term Loan include, among others, the failure to make payments when due, breach of covenants, and breach of representations or warranties. For further discussion of our debt covenants, see Note 14 on “Debt” included in our 2023 Annual Report on Form 10-K. As of March 31, 2024, we were in compliance with all Credit Facility and term loan debt covenants.

Debt Maturities

Scheduled principal payments due on our debt for the remainder of 2024 and for each year through the period ended September 30, 2028, and thereafter were as follows at March 31, 2024:

Maturity	Revolving Credit Facility & Term Loans		Finance Lease		Total
Remainder of 2024	$	837	$	434	$	1,271
2025	1,763		932		2,695
2026	72,836		1,027		73,863
2027	1,909		1,128		3,037
2028	26,610		1,237		27,847
Thereafter	33,200		433		33,633
Subtotal	137,155		5,191		142,346
Debt issuance costs presented with debt	(429)		—		(429)
Total	$	136,726	$	5,191	$	141,917

Note 13 - Derivative Financial Instruments

In the normal course of business, our operations are exposed to market risks, including the effect of changes in interest rates. We may enter into derivative financial instruments to offset these underlying market risks.

On March 31, 2023, we entered into a new interest rate swap agreement, effective April 3, 2023, with the Avondale Lender that effectively fixes the interest rate we pay on 50% of the principal amount of the Avondale Term Loan at 1.45% for the entire loan term (the “Avondale Swap”). The Avondale Swap was designated as an effective cash flow hedge for accounting and tax purposes.

On April 14, 2022, in connection with the Lisle Term Loan, we entered into an interest rate swap agreement with the Lisle Lender that effectively fixes the interest rate on 50% of the principal amount of the Lisle Term Loan at 4.69% for the entire loan term, or seven years (the “Lisle Swap”). The Lisle Swap was designated as an effective cash flow hedge for accounting and tax purposes.

Changes in the fair value of derivatives that are designated and qualify as cash flow hedges are recorded in “Accumulated other comprehensive income” on the condensed consolidated balance sheets. For cash flow hedges, we report the effective portion of the gain or loss as a component of “Accumulated other comprehensive income” and reclassify it to “Interest expense” in the condensed consolidated statements of operations over the corresponding period of the underlying hedged item. The ineffective portion of the change in fair value of a derivative financial instrument is recognized in “Interest expense” at the time the ineffectiveness occurs. To the extent the hedged forecasted interest payments on debt related to our interest rate swap is paid off, the remaining balance in “Accumulated other comprehensive income” is recognized in “Interest expense” in the condensed consolidated statements of operations. Of the net amount of the existing gains that are reported in “Accumulated other comprehensive income” as of March 31, 2024, we estimate that $0.9 million will be reclassified to “Interest expense” within the next twelve months. As of March 31, 2024, the notional amount of the Avondale Swap and Lisle Swap was approximately $14.4 million and $18.7 million, respectively.

20

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Fair Value of Derivative Instruments

The following table presents the fair value of our Avondale Swap and Lisle Swap (Level 2) which are designated as cash flow hedges and the related classification on the condensed consolidated balance sheets as of March 31, 2024 and September 30, 2023:

Interest Rate Swaps	March 31, 2024		September 30, 2023
Other current assets	$	833	$	957
Other assets	1,488		2,075
Total fair value of assets designated as hedging instruments	$	2,321	$	3,032

Effect of Cash Flow Hedge Accounting on the Consolidated Statements of Operations and Accumulated Other Comprehensive Income

The table below presents the effect of cash flow hedge accounting for our Avondale Swap and Lisle Swap on the condensed consolidated statement of operations and “Accumulated other comprehensive income” for the three and six months ended March 31, 2024 and 2023:

	Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative, net of taxes		Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income
	Three Months Ended March 31, 2024
Avondale Swap and Lisle Swap	$	(738)	$	(267)
	Six Months Ended March 31, 2024
Avondale Swap and Lisle Swap	$	174	$	(538)
	Three Months Ended March 31, 2023
Avondale Swap and Lisle Swap	$	518	$	(199)
	Six Months Ended March 31, 2023
Avondale Swap and Lisle Swap	$	559	$	(327)

Note 14 - Income Taxes

Our income tax expense for the three months ended March 31, 2024 was $2.8 million, or 26.2% of pre-tax income, compared to $1.8 million, or 33.6% of pre-tax income, for the three months ended March 31, 2023. For the six months ended March 31, 2024, our income tax expense was $5.9 million, or 24.6% of pre-tax income, compared to an income tax expense of $3.3 million, or 34.9% of pre-tax income, for the six months ended March 31, 2023. The effective income tax rate for the three and six months ended March 31, 2024 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, federal research and development tax credits and state and local income and franchise taxes. The effective income tax rate for the three and six months ended March 31, 2023 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, transaction costs and state and local income and franchise taxes.

As of each reporting date, management considers new evidence, both positive and negative, that could affect its view of the future realization of deferred tax assets. As of March 31, 2024, we continued to maintain a valuation allowance related to certain federal and state attributes, which are not expected to be utilized prior to expiration.

21

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

Note 15 - Restructuring Costs

On December 5, 2023, UTI announced plans to consolidate the two Houston, Texas campus locations to align the curriculum, student facing systems, and support services to better serve students seeking careers in in-demand fields. As part of the transition, the MIAT Houston campus, acquired in November 2021, will begin operating under the UTI brand and implement a phased teach-out agreement starting in May 2024. Both facilities will remain in use post-consolidation.

The total costs of the restructuring plan are estimated to be approximately $1.4 million and relate to the UTI segment. Approximately $45 thousand of tool related costs were expensed during the three months ended March 31, 2024, and approximately $88 thousand of employee termination and tool related costs were expensed during the six months ended March 31, 2024, all of which are reported in “Selling, general and administrative” on the condensed consolidated statements of operations. Additional estimated costs of $0.5 million are expected to be recorded during the remainder of fiscal 2024 as incurred, and $0.8 million in additional estimated costs are expected to be recorded during fiscal 2025 as incurred.

Note 16 - Commitments and Contingencies

Legal

In the ordinary conduct of our business, we are periodically subject to lawsuits, demands in arbitration, investigations, regulatory proceedings or other claims, including, but not limited to, claims involving current or former students, routine employment matters, business disputes and regulatory demands. When we are aware of a claim or potential claim, we assess the likelihood of any loss or exposure. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, we accrue a liability for the loss. When a loss is not both probable and estimable, we do not accrue a liability.

Where a loss is not probable but is reasonably possible, including if a loss in excess of an accrued liability is reasonably possible, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claims. We are not currently a party to any material legal proceedings, but note that legal proceedings could, generally, have a material adverse effect on our business, cash flows, results of operations or financial condition.

Note 17 - Shareholders’ Equity

Common Stock

Holders of our common stock are entitled to receive dividends when and as declared by our Board of Directors and have the right to one vote per share on all matters requiring shareholder approval. On June 9, 2016, our Board of Directors voted to eliminate the quarterly cash dividend on our common stock.

Preferred Stock

As of March 31, 2024, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated.

Under the terms of the Certificate of Designations for the Series A Preferred Stock (the “CoD”), we had the right to convert the outstanding shares of Series A Preferred Stock to common stock when our common stock achieved a stated volume weighted average price per share for a period of 20 consecutive trading days. On December 18, 2023, upon satisfying the stock price condition, we entered into a preferred stock repurchase agreement with Coliseum Capital Partners, L.P. and Blackwell Partners LLC – Series A (collectively the “Selling Stockholders”), pursuant to which we repurchased, directly from the Selling Stockholders, 33,300 shares of Series A Preferred Stock for an aggregate purchase price of $11.3 million. Additionally, we incurred approximately $0.3 million in fees related to excise taxes and other professional services related to the repurchase, which are recorded in equity. Following the repurchase of those shares of Series A Preferred Stock, and in accordance with the terms of the CoD, we issued a notice of conversion causing all remaining outstanding shares of Series A Preferred Stock to be converted into Common Stock. In connection with the conversion, each share of Series A Preferred Stock was cancelled and converted into the right to receive 30.03003 shares of our Common Stock, no par value per share, and we made a final dividend payment of $1.1 million to the Series A Preferred Stock holders of record as of December 18, 2023. As a result of the conversion, the aggregate 642,585 remaining shares of Series A Preferred Stock outstanding were

22

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

converted into 19,296,843 shares of Common Stock. No shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date. Following the repurchase and subsequent conversion, the Selling Stockholders held less than 25% of our outstanding shares of common stock (a threshold above which we would have been required to seek regulatory approval for the conversion).

As of September 30, 2023, 675,885 shares of Series A Convertible Preferred Stock with a $0.0001 par value each (“Series A Preferred Stock”) were issued and outstanding, respectively. The liquidation preference associated with the Series A Preferred Stock was $100 per share at September 30, 2023.

Share Repurchase Program

On December 10, 2020, our Board of Directors authorized a share repurchase plan that would allow for the repurchase of up to $35.0 million of our common stock in the open market or through privately negotiated transactions. This share repurchase plan replaced the previously authorized plan from fiscal 2012. We have not repurchased any shares under the $35.0 million share repurchase program, including during the six months ended March 31, 2024 or 2023.

Note 18 - Earnings per Share

We calculate basic earnings per common share (“EPS”) pursuant to the two-class method as a result of the issuance of the Series A Preferred Stock on June 24, 2016. The two-class method is an earnings allocation formula that determines EPS for common stock and participating securities according to dividend and participation rights in undistributed earnings. Under this method, all earnings, distributed and undistributed, are allocated to common shares and participating securities based on their respective rights to receive dividends.

Diluted EPS is calculated using the more dilutive of the two-class method or as-converted method. The two-class method uses net income available to common shareholders and assumes conversion of all potential shares other than the participating securities. The as-converted method uses net income and assumes conversion of all potential shares including the participating securities. Dilutive potential common shares include outstanding stock options, unvested restricted share units and convertible preferred stock. As noted above in Note 17, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date.

The following table summarizes the computation of basic and diluted EPS under the two-class or as-converted method, as well as the anti-dilutive shares excluded:

	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2024		2023		2024		2023
Basic earnings per common share:
Net income	$	7,787	$	3,480	$	18,176	$	6,128
Less: Preferred stock dividend declared	—		(1,251)		(1,097)		(2,528)
Net income available for distribution	7,787		2,229		17,079		3,600
Income allocated to participating securities	—		(833)		(2,855)		(1,348)
Net income available to common shareholders	$	7,787	$	1,396	$	14,224	$	2,252
Weighted average basic shares outstanding	53,757		33,999		45,048		33,901
Basic income per common share	$	0.14	$	0.04	$	0.32	$	0.07

23

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2024		2023		2024		2023
Diluted earnings per common share:
Method used:	Two-class		Two-class		Two-class		Two-class
Net income available to common shareholders	$	7,787	$	1,396	$	14,224	$	2,252
Weighted average basic shares outstanding	53,757		33,999		45,048		33,901
Dilutive effect related to employee stock plans	1,013		554		1,002		576
Weighted average diluted shares outstanding	54,770		34,553		46,050		34,477
Diluted income per common share	$	0.14	$	0.04	$	0.31	$	0.07
Anti-dilutive shares excluded:
Outstanding stock-based grants	—		239		17		515
Convertible preferred stock	—		20,297		—		20,297
Total anti-dilutive shares excluded	—		20,536		17		20,812

Note 19 - Segment Information

We operate our business in two reportable segments: (i) the UTI segment; and (ii) the Concorde segment. These segments are organized by key market segments to enhance operational alignment within each segment to more effectively execute our strategic plan. Each reportable segment represents a group of post-secondary education providers that offer a variety of degree and non-degree academic programs. “Corporate” includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments and is included to reconcile segment results to the condensed consolidated financial statements.

As previously discussed in Note 2, the segment disclosures for the three and six months ended March 31, 2023 have been recast from the prior year presentation for comparability to the current year presentation.

Summary information by reportable segment is as follows:

	UTI		Concorde		Corporate		Consolidated
Three Months Ended March 31, 2024
Revenues	$	123,323	$	60,853	$	—	$	184,176
Income (loss) from operations	18,086		3,246		(10,140)		11,192
Depreciation and amortization	5,684		1,217		301		7,202
Net income (loss)	16,616		3,320		(12,149)		7,787
Three Months Ended March 31, 2023
Revenues	$	107,560	$	56,260	$	—	$	163,820
Income (loss) from operations	9,788		6,189		(10,028)		5,949
Depreciation and amortization	5,094		1,649		3		6,746
Net income (loss)	8,821		6,237		(11,578)		3,480

24

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(In thousands, except per share amounts)

(Unaudited)

	UTI		Concorde		Corporate		Consolidated
Six Months Ended March 31, 2024
Revenues	$	238,697	$	120,174	$	—	$	358,871
Income (loss) from operations	33,177		10,373		(18,127)		25,423
Depreciation and amortization	11,178		2,371		637		14,186
Net income (loss)	30,213		10,493		(22,530)		18,176
Six Months Ended March 31, 2023
Revenues	$	213,133	$	70,691	$	—	$	283,824
Income (loss) from operations	23,210		5,463		(18,276)		10,397
Depreciation and amortization	9,869		2,106		19		11,994
Net income (loss)	21,553		5,503		(20,928)		6,128
As of March 31, 2024
Total assets	$	446,337	$	134,849	$	120,902	$	702,088
As of September 30, 2023
Total assets	$	442,507	$	130,813	$	167,365	$	740,685

Note 20 - Government Regulation and Financial Aid

As discussed at length in our 2023 Annual Report on Form 10-K, our institutions participate in a range of government-sponsored student assistance programs. The most significant of these is the federal student aid programs administered by the U.S. Department of Education (“ED”) pursuant to Title IV of the HEA, commonly referred to as the Title IV Programs. Generally, to participate in the Title IV Programs, an institution must be licensed or otherwise legally authorized to operate in the state where it is physically located, be accredited by an accreditor recognized by ED, be certified as an eligible institution by ED, offer at least one eligible program of education, and comply with other statutory and regulatory requirements.

Each of our institutions holds the state or other authorizations required to operate and offer postsecondary education programs, and to recruit in the states in which it engages in recruiting activities. In addition, our institutions are accredited by ED-recognized accreditors: all of the UTI institutions and 14 of the Concorde institutions are accredited by the Accrediting Commission of Career Schools and Colleges, while the remaining two Concorde institutions are accredited by the Council on Occupational Education. ED will certify an institution to participate in the Title IV programs only after the institution has demonstrated compliance with the Higher Education Act and ED’s extensive regulations regarding institutional eligibility. An institution must also demonstrate its compliance to ED on an ongoing basis. As of December 31, 2023, management believes the Company and its institutions are in compliance with the applicable regulations in all material respects. See “Part I, Item 1. Regulatory Environment” and “Part I, Item 1. State and Accreditor Approvals” in our 2023 Annual Report on Form 10-K for a detailed discussion of the regulatory environment in which the Company operates.

Because the Company operates in a highly regulated industry, it, like other industry participants, may be subject from time to time to investigations, claims of non-compliance, or lawsuits by governmental agencies or third parties, which allege statutory violations, regulatory infractions, or common law causes of action. There can be no assurance that regulatory agencies or third parties will not undertake investigations or make claims against the Company, or that such claims, if made, will not have a material adverse effect on the Company’s business, results of operations or financial condition.

25

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and those in our 2023 Annual Report on Form 10-K. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated in such forward-looking statements as a result of certain factors, including but not limited to those described under “Risk Factors” in our 2023 Annual Report on Form 10-K and included in Part II, Item 1A of this Quarterly Report on Form 10-Q. See also “Cautionary Note Regarding Forward-Looking Statements” on page ii of this Quarterly Report on Form 10-Q.

Company Overview

Universal Technical Institute, Inc., which together with its subsidiaries is referred to as the “Company,” “we,” “us” or “our,” was founded in 1965 and is a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, whose mission is to serve students, partners, and communities by providing quality education and support services for in-demand careers across a number of highly-skilled fields. We offer the majority of our programs in a blended learning model that combines instructor-facilitated online teaching and demonstrations with hands-on labs.

Universal Technical Institute (“UTI”): UTI operates 16 campuses located in nine states and offers a wide range of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute, Marine Mechanics Institute, NASCAR Technical Institute, and MIAT College of Technology (“MIAT”). UTI also offers manufacturer specific advanced training programs, which include student-paid electives, at our campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Lastly, UTI provides dealer technician training or instructor staffing services to manufacturers. UTI works closely with multiple original equipment manufacturers and industry brand partners to understand their needs for qualified service professionals.

Concorde Career Colleges (“Concorde”): Concorde operates across 17 campuses in eight states, offering degree, non-degree, and continuing education programs in the allied health, dental, nursing, patient care and diagnostic fields. Concorde believes in preparing students for their health care careers with practical, hands-on experiences including opportunities to learn while providing care to real patients. Prior to graduation, students will complete a number of hours in a clinical setting or externship, depending upon their program of study.

“Corporate” includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments. See Note 19 of the notes to the condensed consolidated financial statements herein for additional details on our segments.

All of our campuses are accredited and are eligible for federal student financial assistance funds under the Higher Education Act of 1965, as amended, commonly referred to as Title IV Programs, which are administered by the U.S. Department of Education. Our programs are also eligible for financial aid from federal sources other than Title IV Programs, such as the programs administered by the U.S. Department of Veterans Affairs and under the Workforce Innovation and Opportunity Act.

We believe that our industry-focused educational model and national presence has enabled us to develop valuable industry relationships, which provide us with significant competitive advantages and supports our market leadership, along with enabling us to provide highly specialized education to our students, resulting in enhanced employment opportunities and the potential for higher wages for our graduates.

26

Overview of the Three and Six Months Ended March 31, 2024

Student Metrics

	Three Months Ended				Six Months Ended
	March 31,		%		March 31,		%
	2024	2023	Change		2024	2023(1)	Change
UTI
Total new student starts	2,840	2,374	19.6	%	5,154	4,348	18.5	%
Average undergraduate full-time active students	13,810	12,516	10.3	%	14,065	13,014	8.1	%
End of period undergraduate full-time active students	13,590	12,104	12.3	%	13,590	12,104	12.3	%
Concorde
Total new student starts	2,640	2,252	17.2	%	4,672	2,573	81.6	%
Average undergraduate full-time active students	8,506	7,808	8.9	%	8,375	7,773	7.7	%
End of period undergraduate full-time active students	8,487	7,708	10.1	%	8,487	7,708	10.1	%
Consolidated
Total new student starts	5,480	4,626	18.5	%	9,826	6,921	42.0	%
Average undergraduate full-time active students	22,316	20,324	9.8	%	22,440	20,787	8.0	%
End of period undergraduate full-time active students	22,077	19,812	11.4	%	22,077	19,812	11.4	%

(1)    New student starts and average student data for Concorde presented in the six months ended March 31, 2023 column represents the period of UTI’s ownership, or December 1, 2022 through March 31, 2023.

For three and six months ended March 31, 2024, the increase in UTI new student starts, average undergraduate full-time active students and end of period students was primarily due to the successful rollout of 14 new programs across nine campuses during the fiscal 2023 fourth quarter and fiscal 2024 first quarter, and increased student demand at a majority of the remaining UTI campuses. Concorde rolled out four new programs at three campuses during the same time period, and also rolled out new cash pay “short courses” at a number of campuses. These program rollouts, along with high demand for its existing programs resulted in increases in new student starts, average undergraduate full-time active students and end of period students compared to the prior year.

Our ability to start new students can be influenced by various factors including: impacts of the state of the general macro-economic environment and its impact on price sensitivity and the ability and willingness of students and their families to incur debt to fund their education; unemployment rates; competition; adverse media coverage, legislative, or regulatory actions and investigations by attorneys general and various agencies related to allegations of wrongdoing on the part of other companies within the education and training services industry, which can cast the aggregate “for-profit” education industry in a negative light; and pandemics and or other national, state or local emergencies as declared by various government authorities.

Operations

Revenues for the three months ended March 31, 2024 were $184.2 million, an increase of $20.4 million, or 12.4%, from the comparable period in the prior year. UTI revenues increased by approximately $15.8 million, or 14.7%, and Concorde revenues increased by approximately $4.6 million, or 8.2%. Both segment increases were driven by the higher student starts and average undergraduate full-time active students as previously noted.

Revenues for the six months ended March 31, 2024 were $358.9 million, an increase of $75.0 million, or 26.4%, from the comparable period in the prior year. UTI revenues increased by approximately $25.6 million, or 12.0%, driven primarily by the higher student starts and average undergraduate full-time active students compared to the prior year. Concorde revenues increased by approximately $49.5 million, or 70.0%, primarily due to the inclusion of two extra months of revenue compared to the prior year period, along with higher student starts and average undergraduate full time active students.

Total income from operations was $11.2 million and $25.4 million during the three and six months ended March 31, 2024, respectively, compared to $5.9 million and $10.4 million for the three and six months ended March 31, 2023, respectively.

27

The increase for the three-month period was primarily driven by the increased revenues from the larger student population. The increase for the six-month period was due to the inclusion of two additional months of revenue for Concorde as compared to the prior year period. Additionally, productivity improvements and proactive cost actions have been a key part of our operating model for the past several years, and we continue to identify and execute on optimization opportunities throughout our operations in both segments.

Business Strategy

Our business strategy has three key tenets: (i) to grow the business by more deeply penetrating existing target markets and adding new markets; (ii) to diversify the business by adding new locations, programs, and offerings that maximize the lifetime value of our students; and (iii) to continually optimize the business by constantly enhancing operational efficiency.

During the six months ended March 31, 2024, we executed the following as part of our business strategy:

•Concorde announced the launch of additional program offerings in dental hygiene in Jacksonville, Florida and sonography in Orlando, Florida and San Bernardino, California. Two additional dental hygiene programs are planned to launch later in 2024, pending final regulatory approval.

•UTI announced additional program expansions of Heating Ventilation Air Conditioning and Refrigeration in Avondale, Arizona, Bloomfield, New Jersey, Long Beach, California and Sacramento, California. The programs are expected to launch in late fiscal 2024 and early fiscal 2025.

•UTI announced plans to consolidate our two Houston, Texas campuses to align the curriculum, student facing systems, and support services to better serve students seeking careers in in-demand fields. As part of the transition, the MIAT Houston campus, acquired in November 2021, will begin operating under the UTI brand and implement a phased teach-out agreement starting in May 2024. Both facilities will remain in use post-consolidation. See Note 15 of the notes to our condensed consolidated financial statements herein for further details on the restructuring.

•UTI obtained Federal Aviation Administration approval for the Airframe and Powerplant Technician program at the Miramar, Florida campus and started the first cohort of students during the first quarter of 2024, which completed the rollout of the 14 new programs announced in fiscal 2023.

•UTI announced new partnerships with United Service Organization, Hawaiian Airlines, iRacing, and several other companies for early employment programs. These partnerships will provide additional career transition and placement opportunities for UTI students.

In addition, we continue to pursue other opportunities that align with our business strategy.

Regulatory Environment

See Note 20 of the notes to our condensed consolidated financial statements herein for a discussion of our regulatory environment.

28

Results of Operations: Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023

The following table sets forth selected statements of operations data as a percentage of revenues for each of the periods indicated. 

	Three Months Ended March 31,
	2024		2023
Revenues	100.0	%	100.0	%
Operating expenses:
Educational services and facilities	52.9	%	53.1	%
Selling, general and administrative	41.0	%	43.3	%
Total operating expenses	93.9	%	96.4	%
Income from operations	6.1	%	3.6	%
Interest income	0.8	%	1.1	%
Interest expense	(1.2)	%	(1.6)	%
Other income (expense), net	0.1	%	0.1	%
Total other expense, net	(0.3)	%	(0.4)	%
Income before income taxes	5.7	%	3.2	%
Income tax expense	(1.5)	%	(1.1)	%
Net income	4.2	%	2.2	%
Preferred stock dividends	—	%	(0.8)	%
Income available for distribution	4.2	%	1.4	%
Income allocated to participating securities	—	%	(0.5)	%
Net income available to common shareholders	4.2	%	0.9	%

Revenues

The following table presents revenue by segment (in thousands):

	Three Months Ended March 31, 2024									Three months ended March 31, 2023
	UTI			Concorde			Consolidated			UTI		Concorde		Consolidated
Revenue	$	123,323		$	60,853		$	184,176		$	107,560	$	56,260	$	163,820
Year over Year % Change	14.7		%	8.2		%	12.4		%

Revenues for the three months ended March 31, 2024 were $184.2 million, an increase of $20.4 million, or 12.4%, as compared to revenues of $163.8 million for the three months ended March 31, 2023.

UTI

Revenues for UTI for the three months ended March 31, 2024 were $123.3 million compared to $107.6 million in the prior period. Revenue increased primarily due to a 10.3% increase in average undergraduate full-time active students during the quarter and 19.6% increase in new student starts from the prior year.

Concorde

Revenues for Concorde for the three months ended March 31, 2024 were $60.9 million compared to $56.3 million in the prior period. Revenues increased primarily due to an 8.9% increase in average undergraduate full-time active students during the quarter and 17.2% increase in new student starts from the prior year.

29

Educational services and facilities expenses

Educational services and facilities expenses were $97.5 million for the three months ended March 31, 2024, as compared to $86.9 million for the three months ended March 31, 2023. This increase was primarily due to the increased student volumes during the period and costs associated with our business strategies.

The following tables set forth the significant components of our educational services and facilities expenses by segment (in thousands):

	Three Months Ended March 31, 2024
	UTI		Concorde		Consolidated
Salaries, employee benefits and tax expense	$	30,655	$	23,768	$	54,423
Bonus expense	746		333		1,079
Stock-based compensation	104		—		104
Compensation and related costs	31,505		24,101		55,606
Occupancy costs	7,586		5,424		13,010
Supplies, maintenance and student expense	8,102		4,351		12,453
Depreciation and amortization expense	5,585		754		6,339
Contract services expense	1,151		526		1,677
Other educational services and facilities expense	6,171		2,232		8,403
Total educational services and facilities expense	$	60,100	$	37,388	$	97,488

	Three months ended March 31, 2023
	UTI		Concorde		Consolidated
Salaries, employee benefits and tax expense	$	29,129	$	19,696	$	48,825
Bonus expense	652		—		652
Stock-based compensation	99		—		99
Compensation and related costs	29,880		19,696		49,576
Occupancy costs	7,944		5,592		13,536
Supplies, maintenance and student expense	5,062		4,104		9,166
Depreciation and amortization expense	4,763		1,530		6,293
Contract services expense	1,012		119		1,131
Other educational services and facilities expense	4,660		2,568		7,228
Total educational services and facilities expense	$	53,321	$	33,609	$	86,930

UTI

Compensation and related costs increased by $1.6 million for the three months ended March 31, 2024, primarily due to instructors and other personnel hired to support the additional programs added at the end of fiscal 2023 and in early fiscal 2024.

Supplies, maintenance and student expense increased by $3.0 million primarily due to the increased cost of student housing in support of relocating students.

Other educational services and facilities expense increased by $1.5 million consistent with the increased average undergraduate full-time active students.

30

Concorde

Compensation and related costs increased by $4.4 million for the three months ended March 31, 2024, primarily due to instructors and other personnel hired to support overall student growth and the launch of additional programs during the current year.

Depreciation expense decreased $0.8 million due to the final adjustments to the purchase price allocation for our acquisition of Concorde as of December 1, 2023, which decreased the depreciable base value of the acquired property and equipment, thereby lowering future depreciation expense.

Selling, general and administrative expenses

Selling, general and administrative expenses for the three months ended March 31, 2024 were $75.5 million, as compared to $70.9 million for the three months ended March 31, 2023. This increase was primarily due to costs associated with our business strategies.

During fiscal 2023, in coordination with the integration of Concorde, we began to reassess our operating model to determine the organizational structure that would best help the Company achieve future growth goals and optimally support the business. Beginning in fiscal 2024, we have executed an internal reorganization to fully transition our operating and reporting model to support a multi-divisional business. As part of the internal reorganization, each of the reportable segments now have dedicated accounting, finance, information technology, and human resources teams. Additionally, human resources and information technology costs that benefit the entire organization are now allocated across UTI, Concorde and Corporate each period based upon relative headcount. As a result, additional costs have moved from Corporate into the UTI segment and to a lesser extent the Concorde segment as resources were redirected to support the segment’s objectives. Due to these changes in allocation methodology, the prior year amounts for selling, general and administrative expenses have been recast for comparability to the current year presentation.

The following tables set forth the significant components of our selling, general and administrative expenses by segment (in thousands):

	Three Months Ended March 31, 2024
	UTI		Concorde		Corporate		Consolidated
Salaries, employee benefits and tax expense	$	20,105	$	7,173	$	3,862	$	31,140
Bonus expense	2,677		496		1,128		4,301
Stock-based compensation	209		69		1,972		2,250
Compensation and related costs	22,991		7,738		6,962		37,691
Advertising and marketing expense	13,900		7,040		211		21,151
Professional and contract services expense	1,620		2,232		3,014		6,866
Other selling, general and administrative expenses	6,626		3,209		(47)		9,788
Total selling, general and administrative expenses	$	45,137	$	20,219	$	10,140	$	75,496

	Three months ended March 31, 2023
	UTI		Concorde		Corporate		Consolidated
Salaries, employee benefits and tax expense	$	18,259	$	6,807	$	3,841	$	28,907
Bonus expense	3,339		480		984		4,803
Stock-based compensation	545		—		1,469		2,014
Compensation and related costs	22,143		7,287		6,294		35,724
Advertising and marketing expense	14,179		6,502		—		20,681
Professional and contract services expense	1,906		1,327		3,051		6,284
Other selling, general and administrative expenses	6,223		1,346		683		8,252
Total selling, general and administrative expenses	$	44,451	$	16,462	$	10,028	$	70,941

31

UTI

Compensation and related costs increased by $0.8 million for the three months ended March 31, 2024 primarily due to additional headcount hired to support the UTI segment and our business strategies.

Advertising and marketing expense remained relatively flat year over year. UTI continues to target cost-efficient marketing with an increased focus on digital media. UTI advertising and marketing expense as a percentage of revenues decreased to 11.3% for the three months ended March 31, 2024 as compared to 13.2% in the prior year.

Concorde

Compensation and related costs increased by $0.5 million for the three months ended March 31, 2024 primarily due to additional headcount hired to support the Concorde segment and our business strategies.

Concorde advertising and marketing increased year over year by $0.5 million. Concorde advertising and marketing expense as a percentage of revenues for the three months ended March 31, 2024 and 2023 remained consistent at 11.6%.

Concorde professional and contract services expenses increased by $0.9 million for the three months ended March 31, 2024 primarily related to the continuing integration activities.

Concorde other selling, general and administrative expenses increased by $1.9 million for the three months ended March 31, 2024 primarily due to an increase of $1.3 million in bad debt expense. The prior year benefited from a favorable adjustment due to aligning accounting policies post acquisition. The allowance for doubtful accounts as a percent of accounts receivable has improved since acquisition.

Corporate

Selling, general and administrative expenses for Corporate increased slightly for the three months ended March 31, 2024 primarily due to a $0.7 million increase in compensation related costs, largely offset by a decrease in other selling, general and administrative expenses.

Income taxes

Income tax expense for the three months ended March 31, 2024 was $2.8 million, or 26.2% of pre-tax income, compared to $1.8 million, or 33.6% of pre-tax income, for the three months ended March 31, 2023. The effective income tax rate for the three months ended March 31, 2024 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, federal research and development tax credits and state and local income and franchise taxes. The effective income tax rate for the three months ended March 31, 2023 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, transaction costs and state and local income and franchise taxes. See Note 14 of the notes to the condensed consolidated financial statements herein for additional details.

Preferred stock dividends

As of March 31, 2024, no shares of Series A Convertible Preferred Stock, the (“Series A Preferred Stock”) remain outstanding and all rights of the holders to receive future dividends have been terminated due to the combination of the repurchase and conversion of all outstanding preferred shares as of December 18, 2023. See Note 17 of the notes to the condensed consolidated financial statements herein for additional details on the conversion of our Series A Preferred Stock.

Pursuant to the Certificate of Designations of the Series A Preferred Stock (the “CoD”), we recorded a preferred stock cash dividend of $1.3 million for the three months ended March 31, 2023.

Income available for distribution

Income available for distribution refers to net income reduced by dividends on our Series A Preferred Stock. As a result of the foregoing, we reported income available for distribution of $7.8 million and $2.2 million for the three months ended March 31, 2024 and 2023, respectively.

Income allocated to participating securities

Series A Preferred Stock is considered a participating security because, in the event that we pay a dividend or make a distribution on the outstanding common stock, we shall also pay each holder of the Series A Preferred Stock a dividend on an

32

as-converted basis. The two-class method is an earnings allocation formula that determines earnings per share for common stock and participating securities according to dividend and participation rights in undistributed earnings. Under this method, all earnings, distributed and undistributed, are allocated to common shares and participating securities based on their respective rights to receive dividends.

As noted above, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date. As such, there is no income allocated to participating securities for the three months ended March 31, 2024. The income allocated to participating securities for the three months ended March 31, 2023 was $0.8 million.

Net income available to common shareholders

We had $7.8 million and $1.4 million of net income available to common shareholders for the three months ended March 31, 2024 and 2023, respectively.

Results of Operations: Six Months Ended March 31, 2024 Compared to Six Months Ended March 31, 2023

The following table sets forth selected statements of operations data as a percentage of revenues for each of the periods indicated. 

	Six Months Ended March 31,
	2024		2023
Revenues	100.0	%	100.0	%
Operating expenses:
Educational services and facilities	52.9	%	52.3	%
Selling, general and administrative	40.0	%	44.1	%
Total operating expenses	92.9	%	96.4	%
Income from operations	7.1	%	3.6	%
Interest income	0.9	%	0.9	%
Interest expense	(1.4)	%	(1.4)	%
Other income (expense), net	0.1	%	0.2	%
Total other (expense), net	(0.4)	%	(0.3)	%
Income before income taxes	6.7	%	3.3	%
Income tax expense	(1.7)	%	(1.2)	%
Net income	5.1	%	2.1	%
Preferred stock dividends	(0.3)	%	(0.9)	%
Income available for distribution	4.8	%	1.3	%
Income allocated to participating securities	(0.8)	%	(0.5)	%
Net income available to common shareholders	4.0	%	0.8	%

33

Revenues

The following table presents revenue by segment (in thousands):

	Six Months Ended March 31, 2024									Six Months Ended March 31, 2023
	UTI			Concorde			Consolidated			UTI		Concorde		Consolidated
Revenue	$	238,697		$	120,174		$	358,871		$	213,133	$	70,691	$	283,824
Year over Year % Change	12.0		%	70.0		%	26.4		%

Revenues for the six months ended March 31, 2024 were $358.9 million, an increase of $75.0 million, or 26.4%, as compared to revenues of $283.8 million for the six months ended March 31, 2023.

UTI

Revenues for UTI for the six months ended March 31, 2024 were $238.7 million compared to $213.1 million in the prior year period. Revenue increased primarily due to an overall increase in average revenue per student and an 8.1% increase in overall average undergraduate full-time active students.

Concorde

Revenues for Concorde for the six months ended March 31, 2024 were $120.2 million compared to $70.7 million in the prior year period. The primary drivers of the increase for Concorde were the inclusion of two additional months of revenue during the current year and an increase in overall average undergraduate full-time active students. Concorde programs are offered year-round, however, there can be fluctuations in the student population due to the timing and size of class starts which are dictated by the accrediting bodies governing the clinical and core programs.

Educational services and facilities expenses

Educational services and facilities expenses were $189.9 million for the six months ended March 31, 2024, as compared to $148.3 million for the six months ended March 31, 2023, which is primarily due to the increase in student volumes during the current period and the inclusion of Concorde results for two additional months in the current year.

34

The following table sets forth the significant components of our educational services and facilities expenses by segment (in thousands):

	Six Months Ended March 31, 2024
	UTI		Concorde		Consolidated
Salaries, employee benefit and tax expenses	$	57,558	$	45,594	$	103,152
Bonus expense	1,399		470		1,869
Stock-based compensation	191		—		191
Compensation and related costs	59,148		46,064		105,212
Occupancy costs	15,044		10,987		26,031
Depreciation and amortization expense	10,977		2,012		12,989
Supplies and maintenance and student expense	18,515		8,212		26,727
Contract services expense	2,035		1,029		3,064
Other educational services and facilities expense	11,749		4,125		15,874
Total educational services and facilities expense	$	117,468	$	72,429	$	189,897

	Six Months Ended March 31, 2023
	UTI		Concorde		Consolidated
Salaries, employee benefit and tax expenses	$	55,981	$	26,255	$	82,236
Bonus expense	1,308		—		1,308
Stock-based compensation	180		—		180
Compensation and related costs	57,469		26,255		83,724
Occupancy costs	15,626		7,356		22,982
Depreciation and amortization expense	9,180		1,950		11,130
Supplies, maintenance and student expense	9,647		5,015		14,662
Contract services expense	2,077		175		2,252
Other educational services and facilities expense	10,199		3,389		13,588
Total educational services and facilities expense	$	104,198	$	44,140	$	148,338

UTI

Compensation and related costs increased by $1.7 million for the six months ended March 31, 2024 primarily due to instructors and other personnel hired to support the additional programs added at the end of fiscal 2023 and in early fiscal 2024.

Occupancy costs decreased by $0.6 million for the six months ended March 31, 2024 due to the purchase of the three primary buildings at the Orlando, Florida campus in March 2023.

Depreciation and amortization expense increased by $1.8 million for the six months ended March 31, 2024 primarily due to the purchase of the three primary buildings at the Orlando, Florida campus in March 2023 and increased capital expenditures related to the new program launches.

Supplies, maintenance and student expense increased by $8.9 million primarily due to the increased cost of student housing in support of relocating students.

Concorde

Compensation and related costs increased by $19.8 million for the six months ended March 31, 2024 primarily due to the inclusion of two additional months of expenses in the current year in addition to increased instructors and other personnel hired to support the new program expansions.

The other expense increases for the six months ended March 31, 2024 were all primarily driven by the additional two months of activity included in the current year.

35

Selling, general and administrative expenses

Selling, general and administrative expenses for the six months ended March 31, 2024 were $143.6 million. This represents an increase of $18.5 million, as compared to $125.1 million for the six months ended March 31, 2023, which is primarily due to the inclusion of two additional months of results for Concorde in the current year and costs associated with our growth and diversification strategy.

As previously noted in the results of operations for the comparable three-month periods, the prior year amounts for selling, general and administrative expenses have been recast for comparability to the current year presentation.

The following table sets forth the significant components of our selling, general and administrative expenses by segment (in thousands):

	Six Months Ended March 31, 2024
	UTI		Concorde		Corporate		Consolidated
Salaries, employee benefit and tax expense	$	38,571	$	13,539	$	7,425	$	59,535
Bonus expense	5,518		1,216		2,150		8,884
Stock-based compensation	592		77		2,975		3,644
Compensation and related costs	44,681		14,832		12,550		72,063
Advertising and marketing expense	27,253		13,132		211		40,596
Professional and Contract services expense	3,323		3,599		5,521		12,443
Other selling, general and administrative expenses	12,796		5,808		(155)		18,449
Total selling, general and administrative expenses	$	88,053	$	37,371	$	18,127	$	143,551

	Six Months Ended March 31, 2023
	UTI		Concorde		Corporate		Consolidated
Salaries, employee benefit and tax expense	$	34,890	$	8,724	$	7,715	$	51,329
Bonus expense	6,226		668		2,118		9,012
Stock-based compensation	716		—		2,386		3,102
Compensation and related costs	41,832		9,392		12,219		63,443
Advertising and marketing expense	27,528		7,782		—		35,310
Professional and Contract services expense	3,906		1,845		5,226		10,977
Other selling, general and administrative expenses	12,459		2,069		831		15,359
Total selling, general and administrative expenses	$	85,725	$	21,088	$	18,276	$	125,089

UTI

Compensation and related costs increased by $2.8 million for the six months ended March 31, 2024 primarily due to an increase in headcount to support the UTI segment and our growth and diversification initiatives as compared to the prior year.

Advertising and marketing expense decreased by $0.3 million for the six months ended March 31, 2024, primarily due to timing of spend along with incremental investment to support our growth objectives. We continue to target cost-efficient marketing with an increased focus on digital media. Advertising and marketing expense as a percentage of revenues decreased to 11.4% for the six months ended March 31, 2024 as compared to 12.9% in the prior year.

Concorde

Concorde compensation and related costs increased by $5.4 million for the six months ended March 31, 2024 primarily due to the inclusion of two additional months of expense in the current year and an increase in headcount to support the Concorde segment and our growth and diversification initiatives as compared to the prior year period.

Advertising and marketing expense as a percentage of revenues remained consistent at 10.9% for the six months ended March 31, 2024 as compared to 11.0% in the prior year period.

36

Selling, general and administrative expenses for Concorde for the six months ended March 31, 2024 increased across all line items as the current year period includes two additional months of expenses compared to the prior year. This increase is also partially due to our continuing integration efforts.

Corporate

Selling, general and administrative expenses for Corporate remained consistent, decreasing by $0.1 million for the six months ended March 31, 2024, with both periods including one-time integration costs related to the Concorde acquisition and costs associated with our growth and diversification strategy.

Income taxes

Our income tax expense for the six months ended March 31, 2024 was $5.9 million, or 24.6% of pre-tax income, compared to income tax expense of $3.3 million, or 34.9% of pre-tax income, for the six months ended March 31, 2023. The effective income tax rate for the six months ended March 31, 2024 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, federal research and development tax credits and state and local income and franchise taxes. The effective income tax rate for the six months ended March 31, 2023 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, transaction costs and state and local income and franchise taxes. See Note 14 of the notes to the condensed consolidated financial statements herein for additional details.

Preferred stock dividends

As of March 31, 2024, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated due to the combination of the repurchase and conversion of all outstanding preferred shares as of December 18, 2023. See Note 17 of the notes to the condensed consolidated financial statements herein for additional details on the conversion of our Series A Preferred Stock.

Pursuant to the CoD, we recorded a preferred stock cash dividend of $1.1 million and $2.5 million for the six months ended March 31, 2024 and 2023, respectively.

Income available for distribution

Income available for distribution refers to net income reduced by dividends on our Series A Preferred Stock. As a result of the foregoing, we reported income available for distribution of $17.1 million and $3.6 million for the six months ended March 31, 2024 and 2023, respectively.

Income allocated to participating securities

Series A Preferred Stock is considered a participating security because, in the event that we pay a dividend or make a distribution on the outstanding common stock, we shall also pay each holder of the Series A Preferred Stock a dividend on an as-converted basis. The two-class method is an earnings allocation formula that determines earnings per share for common stock and participating securities according to dividend and participation rights in undistributed earnings. Under this method, all earnings, distributed and undistributed, are allocated to common shares and participating securities based on their respective rights to receive dividends.

As noted above, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date. The amount of income allocated to the participating securities for the six months ended March 31, 2024 and 2023 was $2.9 million and $1.3 million, respectively.

Net income available to common shareholders

After allocating the income to the participating securities, we had $14.2 million and $2.3 million of net income available to common shareholders for the six months ended March 31, 2024 and 2023, respectively.

Non-GAAP Financial Measures

Our earnings before interest income, income taxes, depreciation and amortization (“EBITDA”) for the three and six months ended March 31, 2024 were $18.5 million and $39.9 million, respectively, compared to $12.8 million and $22.8 million for the three and six months ended March 31, 2023, respectively. We define EBITDA as net income, before interest (income) expense, income tax expense (benefit), and depreciation and amortization.

37

EBITDA is a non-GAAP financial measure which is provided to supplement, but not substitute for, the most directly comparable GAAP measure. We choose to disclose this non-GAAP financial measure because it provides an additional analytical tool to clarify our results from operations and helps to identify underlying trends. Additionally, this measure helps compare our performance on a consistent basis across time periods. Management also utilizes EBITDA as a performance measure internally. To obtain a complete understanding of our performance, this measure should be examined in connection with net income determined in accordance with GAAP. Since the items excluded from this measure should be examined in connection with net income in determining financial performance under GAAP, this measure should not be considered an alternative to net income as a measure of our operating performance or profitability. Exclusion of items in our non-GAAP presentation should not be construed as an inference that these items are unusual, infrequent or non-recurring. Other companies, including other companies in the education industry, may calculate EBITDA differently than we do, limiting its usefulness as a comparative measure across companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

EBITDA reconciles to net income, as follows (in thousands):

	Three Months Ended March 31,				Six Months Ended March 31,
	2024		2023		2024		2023
Net income	$	7,787	$	3,480	$	18,176	$	6,128
Interest income	(1,427)		(1,805)		(3,402)		(2,628)
Interest expense	2,184		2,637		5,055		4,060
Income tax expense	2,767		1,763		5,927		3,288
Depreciation and amortization	7,202		6,746		14,186		11,994
EBITDA	$	18,513	$	12,821	$	39,942	$	22,842

Liquidity and Capital Resources

Overview of Liquidity

Based on past performance and current expectations, we believe that our cash flows from operations, cash on hand and investments, and revolving credit facility will satisfy our working capital needs, capital expenditures, commitments and other liquidity requirements associated with our existing operations, as well as announced program expansions over the next 12 months and beyond. Our cash position is available to fund strategic long-term growth initiatives, including opening additional campuses in new markets and the creation and expansion of new programs in existing markets where we continue to optimize utilization of our campus facilities.

Our aggregate cash and cash equivalents were $116.1 million as of March 31, 2024, a decrease of $35.4 million from September 30, 2023 due primarily to net repayments of $19.0 million to the revolving credit facility and the $11.3 million used to repurchase our Series A preferred shares. We also had available liquidity under our revolving credit facility of $29.0 million as of March 31, 2024.

Strategic Uses of Cash

We believe that additional strategic uses of our cash resources may include consideration of additional strategic acquisitions and organic growth initiatives, the purchase of real estate assets, subsidizing funding alternatives for our students, and the repurchase of common stock, among others. To the extent that potential acquisitions are large enough to require financing beyond cash from operations, cash and cash equivalents, and short-term investments, or we need capital to fund operations, new campus openings or expansion of programs at existing campuses, we may enter into additional credit facilities, issue debt or issue additional equity.

Long-term Debt

As of March 31, 2024, we had $142.3 million of long-term debt outstanding, which is comprised of two term loans, a finance lease and a revolving credit facility. Of the $142.3 million outstanding, $28.8 million relates to a term loan that bears interest at the rate of Term SOFR plus 2.0% and a tranche rate adjustment of 0.046% over the seven-year term secured in connection with the Avondale, Arizona campus property purchased in December 2020. Approximately $37.3 million relates to a term loan that bears interest at the rate of Term SOFR plus 2.0% over the seven-year term, secured in connection with the Lisle, Illinois campus property. For each of the term loans, a derivative interest rate swap is in place that fixes the interest rate on

38

50% of the loan at a market rate at the time the derivative was initiated. Approximately $5.2 million relates to a finance lease for a campus within our Concorde segment. The remaining $71.0 million relates to funds drawn from the $100.0 million revolving credit facility that was secured in connection with the Concorde acquisition. See Note 12 of the notes to the condensed consolidated financial statements herein for additional details on the term loans and the revolving credit facility.

Dividends

We currently do not pay a cash dividend on our common stock. A final cash dividend payment of $1.1 million was paid to Series A Preferred Stock holders of record as of December 18, 2023 during the three months ended December 31, 2023 as a result of the conversion of the Series A Preferred Stock. See Note 17 of the notes to the condensed consolidated financial statements herein for additional details on the conversion of our preferred stock.

Principal Sources of Liquidity

Our principal source of liquidity is operating cash flows and existing cash and cash equivalents. A majority of our revenues are derived from Title IV Programs and various veterans’ benefits programs. Federal regulations dictate the timing of disbursements of funds under Title IV Programs. Students must apply for new funding for each academic year consisting of 30-week periods. Loan funds are generally provided in two disbursements for each academic year. The first disbursement for first-time borrowers is usually received 30 days after the start of a student’s academic year, and the second disbursement is typically received at the beginning of the 16th week from the start of the student’s academic year. Under our UTI proprietary loan program, we bear all credit and collection risk and students are not required to begin repayment until six months after the student completes or withdraws from his or her program. Similarly, we bear all credit and collection risk for students paying through UTI cash payment plans and those under a retail installment contract at Concorde. These factors, together with the timing of when our students begin their programs, affect the timing and seasonality of our operating cash flow.

Operating Activities

Our net cash provided by operating activities was $8.3 million for the six months ended March 31, 2024, compared to net cash used of $4.3 million for the six months ended March 31, 2023.

Net income, after adjustments for non-cash items, for the six months ended March 31, 2024 provided cash of $50.5 million. The non-cash items included $14.2 million for depreciation and amortization expense, $11.0 million for amortization of right-of-use assets for operating leases, $3.8 million for stock-based compensation expense, and $3.2 million for bad debt expense.

Changes in operating assets and liabilities used cash of $42.2 million primarily due to the following:

•The change in deferred revenue used cash of $18.1 million and was primarily attributable to the timing of student starts, the number of students in school and where they were at period end in relation to completion of their program at March 31, 2024 as compared to September 30, 2023.

•Changes in our operating lease liability, primarily as a result of rent payments, used cash of $10.1 million.

•The increase in prepaid expenses used cash of $4.5 million primarily due to the timing of payments.

•The increase in notes receivable used cash of $4.4 million primarily due to higher utilization of the Tuition Loan Program.

Net income, after adjustments for non-cash items, for the six months ended March 31, 2023 provided cash of $35.2 million. The non-cash items included $12.0 million for depreciation and amortization expense, $10.1 million for amortization of right-of-use assets for operating leases, $3.3 million for stock-based compensation expense, $2.5 million related to changes in deferred tax assets, and $2.1 million for bad debt expense.

Changes in operating assets and liabilities used cash of $39.5 million primarily due to the following:

•The decrease in accounts payable and accrued expenses used cash of $16.4 million primarily related to the timing of payments to vendors and for payroll and bonus accruals.

•Changes in our operating lease liability, primarily as a result of rent payments, used cash of $10.7 million.

39

•The change in deferred revenue when excluding the initial purchase price allocation for Concorde used cash of $9.6 million and was primarily attributable to the timing of student starts, the number of students in school and where they were at period end in relation to completion of their program at March 31, 2023 as compared to September 30, 2022.

•The change in receivables when excluding the initial purchase price allocation for Concorde used cash of $3.9 million and was primarily due to the timing of Title IV disbursements and other cash receipts on behalf of our students.

•The change in other assets provided cash of $2.7 million primarily due to activity related to the long-term portion of Concorde’s retail installment contracts.

Investing Activities

During the six months ended March 31, 2024, cash used in investing activities was $9.8 million for the purchase of property and equipment to support new program expansion at both UTI and Concorde.

During the six months ended March 31, 2023, cash used in investing activities was $26.6 million. The cash outflow was primarily related to the purchase of property and equipment of $38.6 million. During the six months ended March 31, 2023, we purchased three buildings and the associated land at our Orlando, Florida campus for $26.2 million, including closing costs and other fees. Additionally, we had continued capital expenditures for further construction at the UTI Austin, Texas and Miramar, Florida campuses, in addition to program expansion costs for both UTI and Concorde. Further, on December 1, 2022, we completed the acquisition of Concorde which resulted in $17.0 million of cash paid for acquisitions, net of cash acquired. Partially offsetting the cash outflows, is the $29.0 million in proceeds from maturities of held-to-maturity securities.

Financing Activities

During the six months ended March 31, 2024, cash used in financing activities was $35.0 million which was primarily related to $19.0 million in net payments on the revolving credit facility, or $39.0 million in payments offset by $20.0 million in proceeds. Additionally, $11.5 million was used to repurchase of Series A Preferred Stock. See Note 17 of the notes to the condensed consolidated financial statements herein for additional details on the repurchase. Other uses of cash included payroll taxes paid for stock-based compensation through shares withheld of $2.1 million, the payment of long-term debt of $1.2 million, and the payment of preferred dividends of $1.1 million.

During the six months ended March 31, 2023, cash provided by financing activities was $85.5 million which was primarily related to proceeds from our revolving credit facility of $90.0 million, partially offset by the semi-annual payment of preferred stock dividends of $2.5 million, $0.7 million in payroll taxes paid for stock-based compensation through shares withheld, payment of long-term debt of $0.7 million, and debt issuance costs related to the revolving credit facility of $0.5 million

Seasonality and Trends

Our operating results normally fluctuate as a result of seasonal variations in our business, principally due to changes in total student population and costs associated with opening or expanding our campuses. Our student population varies as a result of new student enrollments, graduations and student attrition. Historically, UTI has had lower student populations in the third quarter than in the remainder of the year because fewer students are enrolled during the summer months. Additionally, UTI has had higher student populations in the fourth quarter than in the remainder of the year because more students enroll during this period. Concorde typically has higher student populations in January and August through October for its core programs and in February for its clinical programs. UTI and Concorde core program expenses do not vary significantly with changes in student population and revenues. Concorde clinical program expenses fluctuate based on the academic calendar and season due to the timing of clinical starts. We expect quarterly fluctuations in operating results to continue as a result of seasonal enrollment patterns. However, such patterns may change as a result of new school openings, new program introductions, increased enrollments of adult students or acquisitions.

Critical Accounting Policies and Estimates

The preparation of financial statements and related disclosures in conformity with GAAP and management’s discussion and analysis of our financial condition and operating results require management to make judgments, assumptions and estimates that affect the amounts reported. There were no significant changes in our critical accounting policies and estimates in the six months ended March 31, 2024 from those previously disclosed in Part II, Item 7 of our 2023 Annual Report on Form 10-K.

40

Recent Accounting Pronouncements

For information regarding recent accounting pronouncements, see Note 3 of the notes to the condensed consolidated financial statements herein.

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no other material changes in our market risk exposure during the six months ended March 31, 2024. For a discussion of our exposure to market risk, refer to Part II Item 7A. “Quantitative and Qualitative Disclosures About Market Risk” contained in our 2023 Annual Report on Form 10-K.

Item 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act), pursuant to Exchange Act Rule 13a-15 as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2024 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Exchange Act Rule 13a-15(d) or 15d-15(d) that occurred during the three months ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls over financial reporting will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, misstatements, errors and instances of fraud, if any, within our company have been or will be prevented or detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls also can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks that internal controls may become inadequate as a result of changes in conditions, or through the deterioration of the degree of compliance with policies or procedures.

41

PART II. OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

In the ordinary conduct of our business, we are periodically subject to lawsuits, demands in arbitrations, investigations, regulatory proceedings or other claims, including, but not limited to, claims involving current and former students, routine employment matters, business disputes and regulatory demands. When we are aware of a claim or potential claim, we assess the likelihood of any loss or exposure. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, we would accrue a liability for the loss. When a loss is not both probable and estimable, we do not accrue a liability. Where a loss is not probable but is reasonably possible, including if a loss in excess of an accrued liability is reasonably possible, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claim. Because we cannot predict with certainty the ultimate resolution of the legal proceedings (including lawsuits, investigations, regulatory proceedings or claims) asserted against us, it is not currently possible to provide such an estimate. The ultimate outcome of pending legal proceedings to which we are a party may have a material adverse effect on our business, cash flows, results of operations or financial condition.

Item 1A. RISK FACTORS

In addition to the other information set forth in this Quarterly Report on Form 10-Q, including the information contained in Part I, Item 3, you should carefully consider the factors discussed in Part I, Item IA of our 2023 Annual Report on Form 10-K, which could materially affect our business, financial condition or operating results. The risks described in this Quarterly Report on Form 10-Q and in our 2023 Annual Report on Form 10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

Item 3. DEFAULTS UPON SENIOR SECURITIES

None.

Item 4. MINE SAFETY DISCLOSURES

Not applicable.

Item 5. OTHER INFORMATION

(a)     None.

(b)     None.

(c)     During the three months ended March 31, 2024, no director or officer (as defined in Rule 16a-1(f) of the Exchange Act) of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

42

Item 6. EXHIBITS

The following exhibits required by Item 601 of Regulation S-K are filed or furnished with this report, as applicable:

Exhibit Number	Description
10.1	Universal Technical Institute, Inc., Amended and Restated 2021 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 12, 2024).
10.2	Form of Restricted Stock Unit Agreement under Amended and Restated 2021 Equity Incentive Plan effective as of March 7, 2024 (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 12, 2024).
10.3	Form of Performance Unit Award Agreement under Amended and Restated 2021 Equity Incentive Plan effective as of March 7, 2024 (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 12, 2024).
31.1*	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1+	Certification of Chief Executive Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2+	Certification of Chief Financial Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*	XBRL Instance Document.
101.SCH*	XBRL Taxonomy Extension Schema Document.
101.CAL*	XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*	XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document.
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

__________________

*     Filed herewith.

+     Furnished herewith.

43

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		UNIVERSAL TECHNICAL INSTITUTE, INC.
Date:	May 9, 2024	By:	/s/ Troy R. Anderson
		Name:	Troy R. Anderson
		Title:	Executive Vice President and Chief Financial Officer
			(Principal Financial Officer)
Date:	May 9, 2024	By:	/s/ Christine Kline
		Name:	Christine Kline
		Title:	Vice President and Chief Accounting Officer
			(Principal Accounting Officer)

44

EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Jerome A. Grant, certify that:

1.I have reviewed this Report on Form 10-Q of Universal Technical Institute, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 9, 2024

/s/ Jerome A. Grant

Jerome A. Grant

Chief Executive Officer

(Principal Executive Officer)

EX-31.2

Exhibit 31.2

Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Troy R. Anderson, certify that:

1.I have reviewed this Report on Form 10-Q of Universal Technical Institute, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: May 9, 2024

/s/ Troy R. Anderson

Troy R. Anderson

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

EX-32.1

Exhibit 32.1

Certification of CEO Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of Universal Technical Institute, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jerome A. Grant, Chief Executive Officer of the Company, certify, to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	May 9, 2024
		/s/ Jerome A. Grant
		Jerome A. Grant
		Chief Executive Officer
		(Principal Executive Officer)

This certification accompanies the Quarterly Report on Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Universal Technical Institute, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Quarterly Report on Form 10-Q), irrespective of any general incorporation language contained in such filing.

EX-32.2

Exhibit 32.2

Certification of CFO Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of Universal Technical Institute, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Troy R. Anderson, Chief Financial Officer of the Company, certify, to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	May 9, 2024
		/s/ Troy R. Anderson
		Troy R. Anderson
		Executive Vice President and Chief Financial Officer
		(Principal Financial Officer)

This certification accompanies the Quarterly Report on Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Universal Technical Institute, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Quarterly Report on Form 10-Q), irrespective of any general incorporation language contained in such filing.

XML

Cover - shares	6 Months Ended
	Mar. 31, 2024	May 01, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	1-31923
Entity Registrant Name	UNIVERSAL TECHNICAL INSTITUTE, INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	86-0226984
Entity Address, Address Line One	4225 East Windrose Drive
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Phoenix
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85032
City Area Code	623
Local Phone Number	445-9500
Title of 12(b) Security	Common Stock, $0.0001 par value
Trading Symbol	UTI
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		53,801,456
Entity Central Index Key	0001261654
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Assets
Cash and cash equivalents	$ 116,099	$ 151,547
Restricted cash	4,446	5,377
Receivables, net	24,294	25,161
Notes receivable, current portion	6,163	5,991
Prepaid expenses	12,200	9,412
Other current assets	7,032	7,497
Total current assets	170,234	204,985
Property and equipment, net	263,538	266,346
Goodwill	28,459	28,459
Intangible assets, net	18,627	18,975
Notes receivable, less current portion	34,909	30,672
Right-of-use assets for operating leases	169,626	176,657
Deferred tax asset, net	4,556	3,768
Other assets	12,139	10,823
Total assets	702,088	740,685
Current
Accounts payable and accrued expenses	70,079	69,941
Deferred revenue	67,599	85,738
Operating lease liability, current portion	22,841	22,481
Long-term debt, current portion	2,600	2,517
Other current liabilities	3,323	4,023
Total current liabilities	166,442	184,700
Deferred tax liabilities, net	663	663
Operating lease liability	158,448	165,026
Long-term debt	139,317	159,600
Other liabilities	4,605	4,729
Total liabilities	469,475	514,718
Commitments and contingencies (Note 16)
Shareholders’ equity:
Common stock, $0.0001 par value, 100,000 shares authorized, 53,884 and 34,157 shares issued	5	3
Preferred stock, $0.0001 par value, 10,000 shares authorized; 0 and 676 shares of Series A Convertible Preferred Stock issued and outstanding, liquidation preference of $100 per share	0	0
Paid-in capital - common	216,359	151,439
Paid-in capital - preferred	0	66,481
Treasury stock, at cost, 82 shares	(365)	(365)
Retained earnings	14,684	5,946
Accumulated other comprehensive income	1,930	2,463
Total shareholders’ equity	232,613	225,967
Total liabilities and shareholders’ equity	$ 702,088	$ 740,685

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2024	Sep. 30, 2023
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	53,884,000	34,157,000
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	676,000
Preferred stock, shares outstanding (in shares)	0	676,000
Preferred stock, liquidation preference (in dollars per share)	$ 100	$ 100
Treasury stock (in shares)	82,000	82,000

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues	$ 184,176	$ 163,820	$ 358,871	$ 283,824
Operating expenses:
Educational services and facilities	97,488	86,930	189,897	148,338
Selling, general and administrative	75,496	70,941	143,551	125,089
Total operating expenses	172,984	157,871	333,448	273,427
Income from operations	11,192	5,949	25,423	10,397
Other (expense) income:
Interest income	1,427	1,805	3,402	2,628
Interest expense	(2,184)	(2,637)	(5,055)	(4,060)
Other income (expense), net	119	126	333	451
Total other expense, net	(638)	(706)	(1,320)	(981)
Income before income taxes	10,554	5,243	24,103	9,416
Income tax expense (Note 14)	(2,767)	(1,763)	(5,927)	(3,288)
Net income	7,787	3,480	18,176	6,128
Preferred stock dividends	0	(1,251)	(1,097)	(2,528)
Income available for distribution	7,787	2,229	17,079	3,600
Income allocated to participating securities	0	(833)	(2,855)	(1,348)
Net income available to common shareholders	$ 7,787	$ 1,396	$ 14,224	$ 2,252
Earnings per share (Note 18):
Net income per share - basic (in dollars per share)	$ 0.14	$ 0.04	$ 0.32	$ 0.07
Net income per share - diluted (in dollars per share)	$ 0.14	$ 0.04	$ 0.31	$ 0.07
Weighted average number of shares outstanding (Note 18):
Basic (in shares)	53,757	33,999	45,048	33,901
Diluted (in shares)	54,770	34,553	46,050	34,477

XML

CONDENSED CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 7,787	$ 3,480	$ 18,176	$ 6,128
Unrealized gain (loss) on interest rate swaps, net of taxes	353	(538)	(533)	(664)
Comprehensive income	$ 8,140	$ 2,942	$ 17,643	$ 5,464

XML

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Preferred Stock	Paid-in Capital Common Stock	Paid-in Capital Preferred Stock	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income
Common Stock, Beginning Balance (in shares) at Sep. 30, 2022		33,857,000
Beginning Balance at Sep. 30, 2022	$ 215,397	$ 3	$ 0	$ 148,372	$ 66,481	$ (365)	$ (1,307)	$ 2,213
Preferred Stock, Beginning Balance (in shares) at Sep. 30, 2022			676,000
Treasury Stock, Beginning Balance (in shares) at Sep. 30, 2022						(82,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,648						2,648
Issuance of common stock under stock-based compensation plans (in shares)		223,000
Shares withheld for payroll taxes (in shares)		(73,000)
Shares withheld for payroll taxes	(525)			(525)
Stock-based compensation	1,169			1,169
Preferred stock dividends	(1,277)						(1,277)
Unrealized (loss) gain on interest rate swap, net of taxes	(126)							(126)
Common Stock, Ending Balance (in shares) at Dec. 31, 2022		34,007,000
Ending Balance at Dec. 31, 2022	217,286	$ 3	$ 0	149,016	66,481	$ (365)	64	2,087
Preferred Stock, Ending Balance (in shares) at Dec. 31, 2022			676,000
Treasury Stock, Ending Balance (in shares) at Dec. 31, 2022						(82,000)
Common Stock, Beginning Balance (in shares) at Sep. 30, 2022		33,857,000
Beginning Balance at Sep. 30, 2022	215,397	$ 3	$ 0	148,372	66,481	$ (365)	(1,307)	2,213
Preferred Stock, Beginning Balance (in shares) at Sep. 30, 2022			676,000
Treasury Stock, Beginning Balance (in shares) at Sep. 30, 2022						(82,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 6,128
Preferred share repurchase (in shares)	0
Unrealized (loss) gain on interest rate swap, net of taxes	$ (664)
Common Stock, Ending Balance (in shares) at Mar. 31, 2023		34,149,000
Ending Balance at Mar. 31, 2023	220,867	$ 3	$ 0	150,906	66,481	$ (365)	2,293	1,549
Preferred Stock, Ending Balance (in shares) at Mar. 31, 2023			676,000
Treasury Stock, Ending Balance (in shares) at Mar. 31, 2023						(82,000)
Common Stock, Beginning Balance (in shares) at Dec. 31, 2022		34,007,000
Beginning Balance at Dec. 31, 2022	217,286	$ 3	$ 0	149,016	66,481	$ (365)	64	2,087
Preferred Stock, Beginning Balance (in shares) at Dec. 31, 2022			676,000
Treasury Stock, Beginning Balance (in shares) at Dec. 31, 2022						(82,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3,480						3,480
Issuance of common stock under stock-based compensation plans (in shares)		175,000
Shares withheld for payroll taxes (in shares)		(33,000)
Shares withheld for payroll taxes	(223)			(223)
Stock-based compensation	2,113			2,113
Preferred stock dividends	(1,251)						(1,251)
Unrealized (loss) gain on interest rate swap, net of taxes	(538)							(538)
Common Stock, Ending Balance (in shares) at Mar. 31, 2023		34,149,000
Ending Balance at Mar. 31, 2023	220,867	$ 3	$ 0	150,906	66,481	$ (365)	2,293	1,549
Preferred Stock, Ending Balance (in shares) at Mar. 31, 2023			676,000
Treasury Stock, Ending Balance (in shares) at Mar. 31, 2023						(82,000)
Common Stock, Beginning Balance (in shares) at Sep. 30, 2023		34,157,000
Beginning Balance at Sep. 30, 2023	$ 225,967	$ 3	$ 0	151,439	66,481	$ (365)	5,946	2,463
Preferred Stock, Beginning Balance (in shares) at Sep. 30, 2023	676,000		676,000
Treasury Stock, Beginning Balance (in shares) at Sep. 30, 2023	(82,000)					(82,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 10,389						10,389
Issuance of common stock under stock-based compensation plans (in shares)		538,000
Shares withheld for payroll taxes (in shares)		(178,000)
Shares withheld for payroll taxes	(2,054)			(2,054)
Stock-based compensation	1,482			1,482
Preferred stock dividends	(1,097)						(1,097)
Preferred share repurchase (in shares)			(33,000)
Preferred share repurchase	(11,616)				(3,275)		(8,341)
Preferred Stock Conversion (in shares)		19,297,000	(643,000)
Preferred Stock Conversion	0	$ 2		63,204	(63,206)
Unrealized (loss) gain on interest rate swap, net of taxes	(886)							(886)
Common Stock, Ending Balance (in shares) at Dec. 31, 2023		53,814,000
Ending Balance at Dec. 31, 2023	222,185	$ 5	$ 0	214,071	0	$ (365)	6,897	1,577
Preferred Stock, Ending Balance (in shares) at Dec. 31, 2023			0
Treasury Stock, Ending Balance (in shares) at Dec. 31, 2023						(82,000)
Common Stock, Beginning Balance (in shares) at Sep. 30, 2023		34,157,000
Beginning Balance at Sep. 30, 2023	$ 225,967	$ 3	$ 0	151,439	66,481	$ (365)	5,946	2,463
Preferred Stock, Beginning Balance (in shares) at Sep. 30, 2023	676,000		676,000
Treasury Stock, Beginning Balance (in shares) at Sep. 30, 2023	(82,000)					(82,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 18,176
Preferred share repurchase (in shares)	0
Unrealized (loss) gain on interest rate swap, net of taxes	$ (533)
Common Stock, Ending Balance (in shares) at Mar. 31, 2024		53,884,000
Ending Balance at Mar. 31, 2024	$ 232,613	$ 5	$ 0	216,359	0	$ (365)	14,684	1,930
Preferred Stock, Ending Balance (in shares) at Mar. 31, 2024	0		0
Treasury Stock, Ending Balance (in shares) at Mar. 31, 2024	(82,000)					(82,000)
Common Stock, Beginning Balance (in shares) at Dec. 31, 2023		53,814,000
Beginning Balance at Dec. 31, 2023	$ 222,185	$ 5	$ 0	214,071	0	$ (365)	6,897	1,577
Preferred Stock, Beginning Balance (in shares) at Dec. 31, 2023			0
Treasury Stock, Beginning Balance (in shares) at Dec. 31, 2023						(82,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,787						7,787
Issuance of common stock under stock-based compensation plans (in shares)		74,000
Shares withheld for payroll taxes (in shares)		(4,000)
Shares withheld for payroll taxes	(65)			(65)
Stock-based compensation	2,353			2,353
Unrealized (loss) gain on interest rate swap, net of taxes	353							353
Common Stock, Ending Balance (in shares) at Mar. 31, 2024		53,884,000
Ending Balance at Mar. 31, 2024	$ 232,613	$ 5	$ 0	$ 216,359	$ 0	$ (365)	$ 14,684	$ 1,930
Preferred Stock, Ending Balance (in shares) at Mar. 31, 2024	0		0
Treasury Stock, Ending Balance (in shares) at Mar. 31, 2024	(82,000)					(82,000)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income	$ 18,176	$ 6,128
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	14,186	11,994
Amortization of right-of-use assets for operating leases	10,952	10,073
Bad debt expense	3,189	2,071
Stock-based compensation	3,835	3,282
Deferred income taxes	(314)	2,479
Training equipment credits earned, net	962	47
Unrealized loss on interest rate swap	(533)	(664)
Other losses (gains), net	83	(196)
Changes in assets and liabilities:
Receivables	(1,533)	(3,895)
Prepaid expenses	(4,469)	(898)
Other assets	(1,088)	2,709
Notes receivable	(4,409)	(579)
Accounts payable, accrued expenses and other current liabilities	(2,140)	(16,446)
Deferred revenue	(18,139)	(9,554)
Operating lease liability	(10,139)	(10,745)
Other liabilities	(274)	(121)
Net cash provided by (used in) operating activities	8,345	(4,315)
Cash flows from investing activities:
Cash paid for acquisition, net of cash acquired	0	(16,973)
Purchase of property and equipment	(9,759)	(38,641)
Proceeds from maturities of held-to-maturity securities	0	29,000
Net cash used in investing activities	(9,759)	(26,614)
Cash flows from financing activities:
Proceeds from revolving credit facility	20,000	90,000
Payments on revolving credit facility	(39,000)	0
Debt issuance costs related to the revolving credit facility	0	(484)
Payments on term loans and finance leases	(1,246)	(715)
Payment of preferred stock cash dividend	(1,097)	(2,528)
Preferred share repurchase	(11,503)	0
Payment of payroll taxes on stock-based compensation through shares withheld	(2,119)	(748)
Net cash (used in) provided by financing activities	(34,965)	85,525
Change in cash, cash equivalents and restricted cash	(36,379)	54,596
Cash and cash equivalents, beginning of period	151,547	66,452
Restricted cash, beginning of period	5,377	3,544
Cash, cash equivalents and restricted cash, beginning of period	156,924	69,996
Cash and cash equivalents, end of period	116,099	120,579
Restricted cash, end of period	4,446	4,013
Cash, cash equivalents and restricted cash, end of period	120,545	124,592
Supplemental disclosure of cash flow information:
Income taxes paid, net of refunds	6,185	306
Interest paid	5,476	3,496
Supplemental schedule of noncash investing and financing activities:
Training equipment obtained in exchange for services	302	343
Depreciation of training equipment obtained in exchange for services	270	394
Change in accrued capital expenditures during the period	(1,768)	1,964
Conversion of Series A Preferred Stock	$ 63,206	$ 0

XML

Nature of the Business

6 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of the Business

Nature of the Business

Universal Technical Institute, Inc., which together with its subsidiaries is referred to as the “Company,” “we,” “us” or “our,” was founded in 1965 and is a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, whose mission is to serve students, partners, and communities by providing quality education and support services for in-demand careers across a number of highly-skilled fields. We offer the majority of our programs in a blended learning model that combines instructor-facilitated online teaching and demonstrations with hands-on labs. We have two reportable segments as follows:

Universal Technical Institute (“UTI”): UTI operates 16 campuses located in nine states and offers a wide range of degree and non-degree transportation and skilled trades technical training programs under brands such as Universal Technical Institute, Motorcycle Mechanics Institute and Marine Mechanics Institute (“MMI”), NASCAR Technical Institute, and MIAT College of Technology (“MIAT”). UTI also offers manufacturer specific advanced training programs, which include student-paid electives, at our campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Lastly, UTI provides dealer technician training or instructor staffing services to manufacturers. UTI works closely with multiple original equipment manufacturers and industry brand partners to understand their needs for qualified service professionals.

Concorde Career Colleges (“Concorde”): Concorde operates across 17 campuses in eight states and online, offering degree, non-degree, and continuing education programs in the allied health, dental, nursing, patient care and diagnostic fields. The Company has designated campuses that offer degree granting programs “Concorde Career College;” where allowed by state regulation. The remaining campuses are designated as “Concorde Career Institute.” Concorde believes in preparing students for their healthcare careers with practical, hands-on experiences including opportunities to learn while providing care to real patients. Prior to graduation, students will complete a number of hours in a clinical setting or externship, depending upon their program of study. We acquired Concorde on December 1, 2022. See Note 4 on “Acquisitions” for additional information.

“Corporate” includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments. Additional information about our reportable segments is presented in Note 19.

Our primary source of revenues is currently tuition and fees paid by students. To pay for a substantial portion of their tuition, the majority of students rely on funds received from federal financial aid programs under Title IV Programs of the Higher Education Act of 1965, as amended (“HEA”), as well as from various veterans’ benefits programs. For further discussion, see Note 2 on “Summary of Significant Accounting Policies - Concentration of Risk” and Note 19 on “Government Regulation and Financial Aid” included in our 2023 Annual Report on Form 10-K.

XML

Basis of Presentation

6 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, our condensed consolidated financial statements do not include all the information and footnotes required by GAAP for complete financial statements. Normal and recurring adjustments considered necessary for a fair statement of the results for the interim periods have been included. Operating results for the six months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the year ending September 30, 2024. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our 2023 Annual Report on Form 10-K.

The unaudited condensed consolidated financial statements include the accounts of Universal Technical Institute, Inc. and our wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates.

Other than described below, there have been no material changes or developments in our significant accounting policies or evaluation of accounting estimates and underlying assumptions or methodologies from those disclosed in Note 2 of our 2023 Annual Report on Form 10-K.

Segment Recast

During fiscal 2023, in coordination with the integration of Concorde, we began to reassess our operating model to determine the optimal structure to achieve future growth goals and support the business. In furtherance of the foregoing, we executed an internal reorganization of our operations to fully transition our operating and reporting model to support a multi-divisional business. Each of the reportable segments now has dedicated accounting, finance, information technology, and human resources teams. Additionally, certain human resources and information technology costs that benefit the entire organization are now allocated across the UTI, Concorde and Corporate segments each period based upon relative headcount. As a result, additional costs have moved from the Corporate segment into the UTI segment and to a lesser extent the Concorde segment, as resources were redirected to support each segment’s objectives. Due to these changes in allocation methodology, the segment disclosures in Note 19 for the three and six months ended March 31, 2023 have been recast from the prior year presentation for comparability to the current year presentation.

XML

Recent Accounting Pronouncements

6 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Recent Accounting Pronouncements

Recent Accounting Pronouncements

The Financial Accounting Standards Board (“FASB”) and the SEC periodically issue new accounting standards or disclosure requirements in a continuing effort to improve standards of financial accounting and reporting. We have reviewed the recently issued pronouncements and concluded the following new accounting standard updates (“ASU”) or SEC rules apply to us.

Effective in Fiscal 2025

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses and increased interim disclosure requirements, among others. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, and the amendments should be applied retrospectively. This ASU will be effective for our Form 10-K for fiscal 2025 and our Form 10-Q for the first quarter of fiscal 2026. We are currently evaluating the impact this ASU may have on our financial statement disclosures.

Effective in Fiscal 2026

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, among others, in order to enhance the transparency of income tax disclosures, including consistent categories and greater disaggregation of information in the rate reconciliation and disaggregation by jurisdiction of income taxes paid. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied prospectively; however, retrospective application is also permitted. This ASU will be effective for our Form 10-K for fiscal 2026. We are currently evaluating the impact this ASU may have on our financial statement disclosures.

Effective in Fiscal 2027

In March 2024, the SEC issued final rules to enhance public company disclosures related to the risks and impacts of climate-related matters. In April 2024, the SEC voluntarily stayed the new rules as a result of pending legal challenges. The new rules, if adopted, include requirements to disclose Scope 1 and Scope 2 greenhouse gas emissions and other climate-related topics in annual reports and registration statements, when material. Disclosure requirements will begin phasing in for our Form 10-K for fiscal 2027. We are currently evaluating the impact this rule may have on our financial statement disclosures.

XML

Acquisitions

6 Months Ended

Mar. 31, 2024

Business Combination and Asset Acquisition [Abstract]

Acquisitions

Acquisitions

Concorde Career Colleges

On December 1, 2022, we completed the acquisition of Concorde. Concorde operates 17 campuses across eight states with approximately 7,600 students, and offers its programs via in-person, hybrid and online formats. Concorde offers more than 20 programs across the allied health, dental, nursing, patient care, and diagnostic fields. The acquisition expands our portfolio of offerings into the higher-growth healthcare arena and creates the opportunity to bring workforce educational solutions to a broader array of students and employers.

Under the terms of the Stock Purchase Agreement (the “Purchase Agreement”), dated May 3, 2022, by and among the Company, Concorde, Liberty Partners Holdings 28, L.L.C., a Delaware limited liability company, and Liberty Investment IIC, LLC, a Delaware limited liability company (each a “Seller,” and collectively, the “Sellers”); and Liberty Partners L.P., a Delaware limited partnership, in its capacity as a representative of the Sellers, we acquired all of the issued and outstanding shares of capital stock of Concorde for a base purchase price of $50.0 million, less $1.9 million of net adjustments including the post-closing working capital adjustment, for total cash consideration paid of $48.1 million. As a result of the transactions contemplated by the Purchase Agreement, Concorde is now a wholly-owned subsidiary of the Company. We funded the consideration paid for Concorde by the Credit Facility entered into on November 18, 2022. See Note 12 for further details on the Credit Facility.

In connection with the acquisition, we incurred total transaction costs of $5.3 million, of which $3.0 million was incurred during the year ended September 30, 2022 and $2.3 million was incurred during the year ended September 30, 2023. These costs are included in “Selling, general and administrative” expenses in the condensed consolidated statements of operations for the applicable period.

Allocation of the purchase price

Under the acquisition method of accounting, the total purchase price was allocated to the identifiable assets acquired and the liabilities assumed based on our valuation estimates of the fair values as of the acquisition date. As of December 1, 2023, the fair value and purchase price allocation are considered final.

The final allocation of the purchase price at December 1, 2022 is summarized as follows:

Assets acquired:
Cash and cash equivalents	$	30,064
Restricted cash	1,689
Accounts receivable, net	6,800
Prepaid expenses	2,957
Other current assets	827
Property and equipment	23,238
Right-of-use assets for operating leases	71,153
Goodwill	11,600
Intangible assets	5,400
Deferred tax assets	5,112
Other assets	4,997
Total assets acquired	$	163,837

Less: Liabilities assumed
Accounts payable and accrued expenses	$	15,482
Deferred revenue	20,145
Operating lease liability, current portion	10,011
Long-term debt, current portion (1)	807
Other current liabilities	208
Long-term debt (1)	5,468
Operating lease liability	63,582
Total liabilities assumed	115,703
Net assets acquired	$	48,134

(1)    Long-term debt consists of one lease classified as a finance lease under ASC 842.

Since September 30, 2023, we further adjusted the purchase price allocation by approximately $0.1 million for income taxes receivable and approximately $0.6 million for deferred income taxes due to completing and filing the final stub period income tax return for Concorde, which resulted in a $0.7 million adjustment to property and equipment. These adjustments did not have a material impact on the financial statements since the date of acquisition.

The amount allocated to goodwill of $11.6 million represents the acquired assembled workforce. None of the goodwill is expected to be deductible for tax purposes. Factors that contributed to a purchase price resulting in the recognition of goodwill include Concorde’s strategic fit into our growth and diversification strategy, which is focused on offering a broader array of high-quality, in-demand workforce education solutions which both prepare students for a variety of careers in fast-growing fields and help close the country's skills gap by leveraging key industry partnerships.

The purchase price allocation requires subjective estimates that, if incorrectly estimated, could be material to our condensed consolidated financial statements including the amount of depreciation and amortization expense. The fair value of the property and equipment was estimated using the cost and market approaches as of the valuation date. The fair value of the leases were estimated using the income and market approaches to determine if there was any favorable or unfavorable terms in place.

The intangible assets acquired, which primarily consist of the accreditations and regulatory approvals, trademarks and trade names, and curriculum, were valued using different valuation techniques depending upon the nature of the intangible asset acquired, all of which are considered level 3 as defined in Note 6. The accreditations and regulatory approvals were valued using the multi-period excess earnings method (“MPEEM”) under the income approach. The MPEEM is a variation of discounted cash-flow analysis. Rather than focusing on the whole entity, the MPEEM isolates the cash flows that can be associated with a single intangible asset and measures fair value by discounting them to present value. The trademarks and trade names were valued using the relief from royalty method. The value of the trade name encompasses all items necessary to generate revenue utilizing the trade name. The curriculum was valued using the cost approach.

The table below presents the final summary of the intangible assets acquired and the useful lives of these assets:

Intangible Asset	Useful life	Amount
Accreditations and regulatory approvals	Indefinite	$	3,500
Trademarks and trade names	10 years	500
Curriculum	5 years	1,400
Total		$	5,400

See Note 8 and Note 9 and for additional details on goodwill and intangible assets.

Student receivables

When financial assets are acquired in connection with a business combination, we evaluate whether those acquired financial assets have experienced a more-than-insignificant deterioration in credit quality since origination. Financial assets acquired with evidence of such credit deterioration are referred to as purchased credit deteriorated (“PCD”) assets and reflect the acquirer’s assessment at the acquisition date. The student receivables acquired in the Concorde acquisition were reviewed to determine if any had experienced a more-than-insignificant deterioration in credit quality since origination. Student receivables of approximately $2.3 million met the established criteria to indicate a more-than insignificant deterioration in credit quality and were identified as PCD assets. Using our best estimate of projected losses over the term of the contracts, we calculated an allowance for credit losses on these PCD assets of approximately $1.0 million.

Pro forma financial information

The following unaudited pro forma financial information summarizes our results of operations as though the acquisition occurred on October 1, 2022:

	Six Months Ended
	March 31, 2023
Revenue	$	319,845
Net income	5,919

The unaudited pro forma financial information includes adjustments to reflect the additional amortization that would have been charged assuming the fair value adjustments to intangible assets and the finance lease asset had been applied from October 1, 2022, with the related tax effects. The unaudited pro forma financial information also includes adjustments to reflect the additional interest expense on the new Credit Facility issued to fund the acquisition (see Note 12 for further details on the Credit Facility). Lastly, the unaudited pro forma financial information includes adjustments to reflect the reduction in depreciation expense assuming the fair value adjustments to property and equipment assets had been applied from October 1, 2022.

This unaudited pro forma financial information is for informational purposes only. It does not reflect the integration of the business or any synergies or incremental costs that may result from the acquisition. As such, it is not indicative of the results of operations that would have been achieved had the acquisition been consummated on October 1, 2022. In addition, the unaudited pro forma financial information amounts are not indicative of future operating results.

XML

Revenue from Contracts with Customers

6 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

Revenue from Contracts with Customers

Nature of Goods and Services

Revenues across the UTI and Concorde segments consist primarily of student tuition and fees derived from the programs we provide after reductions are made for discounts and scholarships that we sponsor and for refunds for students who withdraw from our programs prior to specified dates. We apply the five-step model outlined in Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts from Customers. Tuition and fee revenue is recognized ratably over the term of the course or program offered.

In addition to revenue from tuition and fees, UTI and Concorde derive supplemental revenues from sales of textbooks and program supplies and other revenues, which includes revenues from dealer technician training and staffing services to manufacturers. All of these revenues are recognized as the transfer of goods or services occurs. Deferred revenue represents the excess of tuition and fee payments received as compared to tuition and fees earned and is reflected as a current liability in our condensed consolidated balance sheets because it is expected to be earned within the next 12 months.

All of our revenues are generated within the United States. The impact of economic factors on the nature, amount, timing and uncertainty of revenue and cash flows is consistent across our various programs for both the UTI and Concorde segments. See Note 19 for disaggregated segment revenue information.

The following table provides information about receivables and deferred revenue resulting from our enrollment agreements with students:

	March 31, 2024		September 30, 2023
Receivables (1)	$	64,559	$	59,863
Deferred revenue	67,599		85,738

(1)     Receivables includes tuition receivables, retail installment contract receivables and notes receivable, both current and long term.

During the six months ended March 31, 2024, the deferred revenue balance included decreases for revenues recognized during the period and increases related to new students who started their training programs during the period.

XML

Fair Value Measurements

6 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Fair Value Measurements

Fair Value Measurements

The accounting framework for determining fair value includes a hierarchy for ranking the quality and reliability of the information used to measure fair value, which enables the reader of the financial statements to assess the inputs used to develop those measurements. The fair value hierarchy consists of three tiers:

Level 1:    Defined as quoted market prices in active markets for identical assets or liabilities.

Level 2:    Defined as inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, model-based valuation techniques for which all significant assumptions are observable in the market or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3:    Defined as unobservable inputs that are not corroborated by market data.

Any transfers of investments between levels occurs at the end of the reporting period. Assets measured or disclosed at fair value on a recurring basis consisted of the following:

			Fair Value Measurements Using
	March 31, 2024		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds(1)	$	24,563	$	24,563	$	—	$	—
Notes receivable(2)	41,072		—		—		41,072
Total assets at fair value on a recurring basis	$	65,635	$	24,563	$	—	$	41,072
Revolving credit facility and term loans(3)	137,155		—		137,155		—
Total liabilities at fair value on a recurring basis	$	137,155	$	—	$	137,155	$	—

			Fair Value Measurements Using
	September 30, 2023		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds(1)	$	29,687	$	29,687	$	—	$	—
Notes receivable(2)	36,663		—		—		36,663
Total assets at fair value on a recurring basis	$	66,350	$	29,687	$	—	$	36,663
Revolving credit facility and term loans(3)	156,991		—		156,991		—
Total liabilities at fair value on a recurring basis	$	156,991	$	—	$	156,991	$	—

(1) Money market funds and other highly liquid investments with maturity dates less than 90 days are reflected as “Cash and cash equivalents” in our condensed consolidated balance sheets as of March 31, 2024 and September 30, 2023.

(2) Notes receivable relate to UTI’s proprietary loan program and are reflected as “Notes receivable, current portion” and “Notes receivable, less current portion” in our condensed consolidated balance sheets as of March 31, 2024 and September 30, 2023.

(3) The Credit Facility and Term Loans bear interest at rates commensurate with market rates, and therefore, the respective carrying values approximate fair value (Level 2).

XML

Property and Equipment, net

6 Months Ended

Mar. 31, 2024

Property, Plant and Equipment [Abstract]

Property and Equipment, net

Property and Equipment, net

Property and equipment, net consisted of the following:

	March 31, 2024		September 30, 2023
Land	$	25,601	$	25,601
Buildings and building improvements	164,325		160,920
Leasehold improvements	89,462		87,525
Training equipment	112,448		110,292
Office and computer equipment	37,472		37,251
Curriculum development	3,570		2,478
Software developed for internal use	13,103		12,573
Vehicles	1,406		1,406
Right-of-use assets for finance leases	5,603		5,603
Construction in progress	7,246		9,061
	460,236		452,710
Less: Accumulated depreciation and amortization	(196,698)		(186,364)
Total	$	263,538	$	266,346

Depreciation expense related to property and equipment was $7.0 million and $13.8 million for the three and six months ended March 31, 2024, and $6.6 million and $11.7 million for the three and six months ended March 31, 2023, respectively.

XML

Goodwill

6 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

Goodwill

Our goodwill balance of $28.5 million as of March 31, 2024 and September 30, 2023, respectively, represents the acquired assembled workforce and the excess of the cost of an acquired business over the estimated fair values of the assets acquired and liabilities assumed.

The goodwill balance by reportable segment as of March 31, 2024 and September 30, 2023 was:

UTI	$	16,859
Concorde	11,600
Total	$	28,459

Goodwill is reviewed at least annually for impairment, which may result from the deterioration in the operating performance of the acquired businesses, adverse market conditions, adverse changes in applicable laws or regulations and a variety of other circumstances. Our goodwill is tested annually for impairment as of August 1 and more frequently if events or circumstances lead to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. There were no indicators of goodwill impairment as of March 31, 2024.

XML

Intangible Assets

6 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Intangible Assets

The following table provides the gross carrying value, accumulated amortization, net book value and remaining useful life for those intangible assets that are subject to amortization as of March 31, 2024:

	Gross Carrying Value		Accumulated Amortization		Net Book Value		Weighted Average Remaining Useful Life (Years)
Accreditations and regulatory approvals	$	16,300	$	—	$	16,300	Indefinite
Trademarks, trade names and other	1,942		(848)		1,094		4.89
Curriculum	1,800		(567)		1,233		3.49
Total	$	20,042	$	(1,415)	$	18,627	4.15

The following table provides the gross carrying value, accumulated amortization, net book value and remaining useful life for those intangible assets that are subject to amortization as of March 31, 2023:

	Gross Carrying Value		Accumulated Amortization		Net Book Value		Weighted Average Remaining Useful Life (Years)
Accreditations and regulatory approvals	$	16,300	$	—	$	16,300	Indefinite
Trademarks, trade names and other	1,942		(513)		1,429		5.51
Curriculum	1,800		(207)		1,593		4.47
Total	$	20,042	$	(720)	$	19,322	4.96

Amortization expense was $0.2 million and $0.3 million for the three and six months ended March 31, 2024, and $0.2 million and $0.3 million for the three and six months ended March 31, 2023, respectively.

Future intangible asset amortization expense is expected to be as follows:

Fiscal Year
Remainder of 2024	$	348
2025	677
2026	660
2027	337
2028	97
Thereafter	208
Total	$	2,327

The remaining weighted average useful lives shown are calculated based on the net book value and remaining amortization period of each respective intangible asset. Amortization is computed using the straight-line method based on estimated useful lives of the related assets. Our indefinite-lived intangible assets are reviewed at least annually for impairment as of August 1, or more frequently if there are indicators of impairment. There were no indicators of impairment for our indefinite-lived intangible assets as of March 31, 2024.

XML

Leases

6 Months Ended

Mar. 31, 2024

Leases [Abstract]

Leases

Leases

As of March 31, 2024, we have facility leases at 29 of our 33 campuses and three non-campus locations under non-cancelable operating or finance leases, some of which contain escalation clauses and requirements to pay other fees associated with the leases. The facility leases have original lease terms ranging from 5 to 20 years and expire at various dates through 2036. In addition, the leases commonly include lease incentives in the form of rent abatements and tenant improvement allowances. We sublease certain portions of unused building space to third parties, which as of March 31, 2024, resulted in minimal income. All of the leases, other than those that may qualify for the short-term scope exception of 12 months or less, are recorded on our condensed consolidated balance sheets.

Some of the facility leases are subject to annual changes in the Consumer Price Index (“CPI”). While lease liabilities are not remeasured as a result of changes to the CPI, changes to the CPI are treated as variable lease payments and recognized in the period in which the obligation for those payments was incurred. Many of our lease agreements include options to extend the lease, which we do not include in our minimum lease terms unless they are reasonably certain to be exercised. There are no early termination with penalties, residual value guarantees, restrictions or covenants imposed by our facility leases. The components of lease expense are included in “Educational services and facilities” and “Selling, general and administrative” on the condensed consolidated statement of operations, with the exception of interest on lease liabilities, which is included in “Interest expense.”

The components of lease expense during the three and six months ended March 31, 2024 and 2023 were as follows:

	Three Months Ended March 31,				Six Months Ended March 31,
Lease Expense	2024		2023		2024		2023
Operating lease expense(1)	$	7,597	$	8,273	$	15,259	$	13,977
Finance lease expense:
Amortization of leased assets	227		127		454		325
Interest on lease liabilities	79		35		161		122
Variable lease expense	2,476		2,307		4,837		4,257
Sublease income	(33)		(25)		(65)		(57)
Total net lease expense	$	10,346	$	10,717	$	20,646	$	18,624

(1)    Excludes the expense for short-term leases not accounted for under ASC 842, which was not significant for the three and six months ended March 31, 2024 and 2023.

Supplemental balance sheet, cash flow and other information related to our leases was as follows (in thousands, except lease term and discount rate):

Leases	Classification	March 31, 2024		September 30, 2023
Assets:
Operating lease assets	Right-of-use assets for operating leases	$	169,626	$	176,657
Finance lease assets	Property and equipment, net(1)	4,391		4,846
Total leased assets		$	174,017	$	181,503
Liabilities:
Current
Operating lease liabilities	Operating lease liability, current portion	$	22,841	$	22,481
Finance lease liabilities	Long-term debt, current portion(1)	887		844
Noncurrent
Operating lease liabilities	Operating lease liability	158,448		165,026
Finance lease liabilities	Long-term debt	4,304		4,757
Total lease liabilities		$	186,480	$	193,108

(1)     The finance lease assets and liabilities as of March 31, 2024 and September 30, 2023 consisted of one facility lease. Finance lease assets are recorded net of accumulated amortization of $1.2 million and $0.8 million as of March 31, 2024 and September 30, 2023, respectively.

Lease Term and Discount Rate	March 31, 2024		September 30, 2023
Weighted-average remaining lease term (in years):
Operating leases	7.57		7.91
Finance lease	4.83		5.33
Weighted average discount rate:
Operating leases	4.86	%	4.76	%
Finance lease	6.02	%	6.02	%

	Six Months Ended March 31,
Supplemental Disclosure of Cash Flow and Other Information	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	10,139	$	10,745
Financing cash flows from finance leases	410		304
Non-cash activity related to lease liabilities:
Lease assets obtained in exchange for new operating lease liabilities (1)	$	3,921	$	149

(1) During the six months ended March 31, 2024, Concorde renewed the campus lease for the San Antonio, Texas campus.

Maturities of lease liabilities were as follows:

	As of March 31, 2024
Years ending September 30,	Operating Leases		Finance Lease
Remainder of 2024	$	14,312	$	585
2025	30,148		1,193
2026	30,509		1,229
2027	28,874		1,266
2028	26,747		1,304
2029 and thereafter	85,892		439
Total lease payments	216,482		6,016
Less: interest	(35,193)		(825)
Present value of lease liabilities	181,289		5,191
Less: current lease liabilities	(22,841)		(887)
Long-term lease liabilities	$	158,448	$	4,304

Leases

Leases

As of March 31, 2024, we have facility leases at 29 of our 33 campuses and three non-campus locations under non-cancelable operating or finance leases, some of which contain escalation clauses and requirements to pay other fees associated with the leases. The facility leases have original lease terms ranging from 5 to 20 years and expire at various dates through 2036. In addition, the leases commonly include lease incentives in the form of rent abatements and tenant improvement allowances. We sublease certain portions of unused building space to third parties, which as of March 31, 2024, resulted in minimal income. All of the leases, other than those that may qualify for the short-term scope exception of 12 months or less, are recorded on our condensed consolidated balance sheets.

Some of the facility leases are subject to annual changes in the Consumer Price Index (“CPI”). While lease liabilities are not remeasured as a result of changes to the CPI, changes to the CPI are treated as variable lease payments and recognized in the period in which the obligation for those payments was incurred. Many of our lease agreements include options to extend the lease, which we do not include in our minimum lease terms unless they are reasonably certain to be exercised. There are no early termination with penalties, residual value guarantees, restrictions or covenants imposed by our facility leases. The components of lease expense are included in “Educational services and facilities” and “Selling, general and administrative” on the condensed consolidated statement of operations, with the exception of interest on lease liabilities, which is included in “Interest expense.”

The components of lease expense during the three and six months ended March 31, 2024 and 2023 were as follows:

	Three Months Ended March 31,				Six Months Ended March 31,
Lease Expense	2024		2023		2024		2023
Operating lease expense(1)	$	7,597	$	8,273	$	15,259	$	13,977
Finance lease expense:
Amortization of leased assets	227		127		454		325
Interest on lease liabilities	79		35		161		122
Variable lease expense	2,476		2,307		4,837		4,257
Sublease income	(33)		(25)		(65)		(57)
Total net lease expense	$	10,346	$	10,717	$	20,646	$	18,624

(1)    Excludes the expense for short-term leases not accounted for under ASC 842, which was not significant for the three and six months ended March 31, 2024 and 2023.

Supplemental balance sheet, cash flow and other information related to our leases was as follows (in thousands, except lease term and discount rate):

Leases	Classification	March 31, 2024		September 30, 2023
Assets:
Operating lease assets	Right-of-use assets for operating leases	$	169,626	$	176,657
Finance lease assets	Property and equipment, net(1)	4,391		4,846
Total leased assets		$	174,017	$	181,503
Liabilities:
Current
Operating lease liabilities	Operating lease liability, current portion	$	22,841	$	22,481
Finance lease liabilities	Long-term debt, current portion(1)	887		844
Noncurrent
Operating lease liabilities	Operating lease liability	158,448		165,026
Finance lease liabilities	Long-term debt	4,304		4,757
Total lease liabilities		$	186,480	$	193,108

(1)     The finance lease assets and liabilities as of March 31, 2024 and September 30, 2023 consisted of one facility lease. Finance lease assets are recorded net of accumulated amortization of $1.2 million and $0.8 million as of March 31, 2024 and September 30, 2023, respectively.

Lease Term and Discount Rate	March 31, 2024		September 30, 2023
Weighted-average remaining lease term (in years):
Operating leases	7.57		7.91
Finance lease	4.83		5.33
Weighted average discount rate:
Operating leases	4.86	%	4.76	%
Finance lease	6.02	%	6.02	%

	Six Months Ended March 31,
Supplemental Disclosure of Cash Flow and Other Information	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	10,139	$	10,745
Financing cash flows from finance leases	410		304
Non-cash activity related to lease liabilities:
Lease assets obtained in exchange for new operating lease liabilities (1)	$	3,921	$	149

(1) During the six months ended March 31, 2024, Concorde renewed the campus lease for the San Antonio, Texas campus.

Maturities of lease liabilities were as follows:

	As of March 31, 2024
Years ending September 30,	Operating Leases		Finance Lease
Remainder of 2024	$	14,312	$	585
2025	30,148		1,193
2026	30,509		1,229
2027	28,874		1,266
2028	26,747		1,304
2029 and thereafter	85,892		439
Total lease payments	216,482		6,016
Less: interest	(35,193)		(825)
Present value of lease liabilities	181,289		5,191
Less: current lease liabilities	(22,841)		(887)
Long-term lease liabilities	$	158,448	$	4,304

XML

Accounts Payable and Accrued Expenses

6 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

Accounts Payable and Accrued Expenses

Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following:

	March 31, 2024		September 30, 2023
Accounts payable	$	17,658	$	14,438
Accrued compensation and benefits	28,971		36,332
Accrued tool sets	4,743		4,096
Other accrued expenses	18,707		15,075
Total accounts payable and accrued expenses	$	70,079	$	69,941

XML

Debt

6 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Debt

Debt

	March 31, 2024					September 30, 2023
	Interest Rate		Maturity Date	Carrying Value of Debt(6)		Carrying Value of Debt(6)
Revolving Credit Facility(1)	7.78	%	Nov 2025	$	71,000	$	90,000
Avondale Term Loan(2)	7.37	%	May 2028	28,825		29,251
Lisle Term Loan(3)	7.33	%	Apr 2029	37,330		37,740
Finance lease(4)	6.02	%	Various	5,191		5,601
Total debt				142,346		162,592
Debt issuance costs presented with debt (5)				(429)		(475)
Total debt, net				141,917		162,117
Less: current portion of long-term debt				(2,600)		(2,517)
Long-term debt				$	139,317	$	159,600

(1)     Interest on the Revolving Credit Facility (as defined below) accrues at a rate equal to one-month Term SOFR plus a margin of 2.0% and a lender specific spread of 0.10-0.15% or a Prime Rate as set by the lender.

(2)    Interest on the Avondale Term Loan (as defined below) accrues at a rate equal to one-month Term SOFR plus 2.0% and a tranche adjustment of 0.046%.

(3)    Interest on the Lisle Term Loan (as defined below) accrues at a rate equal to one-month Term SOFR plus 2.0%.

(4)    The finance lease is related to a facility lease with an annual interest rate of 6.02% that matures in 2029. See Note 10 for additional details on our finance lease.

(5)    The unamortized debt issuance costs as of March 31, 2024 relate to the Avondale Term Loan and the Lisle Term Loan.

(6)    The Credit Facility, Term Loans and finance leases bear interest at rates commensurate with market rates, and therefore, the respective carrying values approximate fair value (Level 2).

Revolving Credit Facility

On November 18, 2022, we entered into a $100.0 million senior secured revolving credit facility with Fifth Third Bank, a national banking association (the “Credit Facility” or “Revolving Credit Facility”), which includes a $20.0 million sub facility that is available for letters of credit. The Credit Facility has a term of three years, unless earlier terminated pursuant to the terms and conditions set forth in the credit agreement.

This agreement provides that borrowings under the Credit Facility will amortize on an interest-only basis during its term with principal able to be borrowed, re-paid and re-borrowed throughout the term of the Credit Facility and with the outstanding principal due and payable at maturity. In executing the Credit Facility, we incurred $0.5 million in debt issuance costs which are included in “Other assets” on the condensed consolidated balance sheets as of March 31, 2024. On November 28, 2022, we drew $90.0 million from the Credit Facility in support of the closing of the Concorde acquisition at an interest rate of 6.54%. In December 2022, a $1.8 million letter of credit was issued on the Credit Facility.

During the three months ended March 31, 2024, we made payments on the Credit Facility of $39.0 million and we received proceeds of $20.0 million at a fixed base interest rate of 8.5%. During the three months ended March 31, 2024, our $1.8 million letter of credit expired, resulting in $29.0 million in availability under the Credit Facility at period end.

In April 2024, we used cash on hand to pay $20.0 million on the Credit Facility, which increased the availability under the Credit Facility to $49.0 million. It is likely that we will borrow from the Credit Facility in future periods based on future working capital or other needs.

Avondale Term Loan

In connection with the Avondale, Arizona building purchase in December 2020, we entered into a credit agreement with Fifth Third Bank, national banking association (the “Avondale Lender”) on May 12, 2021 in the maximum principal amount of $31.2 million with a maturity of seven years (the “Avondale Term Loan”). Originally, the Avondale Term Loan bore interest at the rate of LIBOR plus 2.0%. On April 3, 2023, we executed an amendment for our Avondale Term Loan to convert the stated rate from LIBOR to SOFR. The Avondale Term Loan bears interest at the rate of Term SOFR plus 2.0% and a tranche rate adjustment of 0.046%.

Principal and interest payments are due monthly. The Avondale Term Loan is secured by a first priority lien on our Avondale, Arizona property, including all land and improvements. Additionally, we entered into an interest rate swap agreement with the Avondale Lender. See Note 13 for further discussion on the interest rate swap.

Lisle Term Loan

On April 14, 2022, our consolidated subsidiary, 2611 Corporate West Drive Venture LLC (the “Borrower”), entered into a new Loan Agreement (“Lisle Loan Agreement”) with Valley National Bank (the “Lisle Lender”), to fund the acquisition and retire the prior loan agreement with Western Alliance bank, via a term loan in the original principal amount of $38.0 million with a maturity of seven years (the “Lisle Term Loan” and together with the Avondale Term Loan, the “Term Loans”). The Lisle Term Loan bears interest at a rate of one-month Term SOFR plus 2.0%. The Lisle Term Loan is secured by a mortgage on the Lisle, Illinois campus and is guaranteed by the Company. In connection with the Lisle Term Loan, we entered into an interest rate swap agreement. See Note 13 for further discussion on the interest rate swap.

Debt Covenants for our Credit Facility and Term Loans

We are subject to certain customary affirmative and negative covenants in connection with our Credit Facility and Term Loans, including, without limitation, certain reporting obligations, certain limitations on restricted payments, limitations on

liens, encumbrances and indebtedness and a debt service coverage ratio covenant. Events of default under the Credit Facility, Avondale Term Loan and the Lisle Term Loan include, among others, the failure to make payments when due, breach of covenants, and breach of representations or warranties. For further discussion of our debt covenants, see Note 14 on “Debt” included in our 2023 Annual Report on Form 10-K. As of March 31, 2024, we were in compliance with all Credit Facility and term loan debt covenants.

Debt Maturities

Scheduled principal payments due on our debt for the remainder of 2024 and for each year through the period ended September 30, 2028, and thereafter were as follows at March 31, 2024:

Maturity	Revolving Credit Facility & Term Loans		Finance Lease		Total
Remainder of 2024	$	837	$	434	$	1,271
2025	1,763		932		2,695
2026	72,836		1,027		73,863
2027	1,909		1,128		3,037
2028	26,610		1,237		27,847
Thereafter	33,200		433		33,633
Subtotal	137,155		5,191		142,346
Debt issuance costs presented with debt	(429)		—		(429)
Total	$	136,726	$	5,191	$	141,917

XML

Derivative Financial Instruments

6 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Derivative Financial Instruments

In the normal course of business, our operations are exposed to market risks, including the effect of changes in interest rates. We may enter into derivative financial instruments to offset these underlying market risks.

On March 31, 2023, we entered into a new interest rate swap agreement, effective April 3, 2023, with the Avondale Lender that effectively fixes the interest rate we pay on 50% of the principal amount of the Avondale Term Loan at 1.45% for the entire loan term (the “Avondale Swap”). The Avondale Swap was designated as an effective cash flow hedge for accounting and tax purposes.

On April 14, 2022, in connection with the Lisle Term Loan, we entered into an interest rate swap agreement with the Lisle Lender that effectively fixes the interest rate on 50% of the principal amount of the Lisle Term Loan at 4.69% for the entire loan term, or seven years (the “Lisle Swap”). The Lisle Swap was designated as an effective cash flow hedge for accounting and tax purposes.

Changes in the fair value of derivatives that are designated and qualify as cash flow hedges are recorded in “Accumulated other comprehensive income” on the condensed consolidated balance sheets. For cash flow hedges, we report the effective portion of the gain or loss as a component of “Accumulated other comprehensive income” and reclassify it to “Interest expense” in the condensed consolidated statements of operations over the corresponding period of the underlying hedged item. The ineffective portion of the change in fair value of a derivative financial instrument is recognized in “Interest expense” at the time the ineffectiveness occurs. To the extent the hedged forecasted interest payments on debt related to our interest rate swap is paid off, the remaining balance in “Accumulated other comprehensive income” is recognized in “Interest expense” in the condensed consolidated statements of operations. Of the net amount of the existing gains that are reported in “Accumulated other comprehensive income” as of March 31, 2024, we estimate that $0.9 million will be reclassified to “Interest expense” within the next twelve months. As of March 31, 2024, the notional amount of the Avondale Swap and Lisle Swap was approximately $14.4 million and $18.7 million, respectively.

Fair Value of Derivative Instruments

The following table presents the fair value of our Avondale Swap and Lisle Swap (Level 2) which are designated as cash flow hedges and the related classification on the condensed consolidated balance sheets as of March 31, 2024 and September 30, 2023:

Interest Rate Swaps	March 31, 2024		September 30, 2023
Other current assets	$	833	$	957
Other assets	1,488		2,075
Total fair value of assets designated as hedging instruments	$	2,321	$	3,032

Effect of Cash Flow Hedge Accounting on the Consolidated Statements of Operations and Accumulated Other Comprehensive Income

The table below presents the effect of cash flow hedge accounting for our Avondale Swap and Lisle Swap on the condensed consolidated statement of operations and “Accumulated other comprehensive income” for the three and six months ended March 31, 2024 and 2023:

	Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative, net of taxes		Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income
	Three Months Ended March 31, 2024
Avondale Swap and Lisle Swap	$	(738)	$	(267)
	Six Months Ended March 31, 2024
Avondale Swap and Lisle Swap	$	174	$	(538)
	Three Months Ended March 31, 2023
Avondale Swap and Lisle Swap	$	518	$	(199)
	Six Months Ended March 31, 2023
Avondale Swap and Lisle Swap	$	559	$	(327)

XML

Income Taxes

6 Months Ended

Mar. 31, 2024

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

Our income tax expense for the three months ended March 31, 2024 was $2.8 million, or 26.2% of pre-tax income, compared to $1.8 million, or 33.6% of pre-tax income, for the three months ended March 31, 2023. For the six months ended March 31, 2024, our income tax expense was $5.9 million, or 24.6% of pre-tax income, compared to an income tax expense of $3.3 million, or 34.9% of pre-tax income, for the six months ended March 31, 2023. The effective income tax rate for the three and six months ended March 31, 2024 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, federal research and development tax credits and state and local income and franchise taxes. The effective income tax rate for the three and six months ended March 31, 2023 differed from the federal statutory rate of 21% primarily due to non-deductible executive compensation, transaction costs and state and local income and franchise taxes.

As of each reporting date, management considers new evidence, both positive and negative, that could affect its view of the future realization of deferred tax assets. As of March 31, 2024, we continued to maintain a valuation allowance related to certain federal and state attributes, which are not expected to be utilized prior to expiration.

XML

Restructuring Costs

6 Months Ended

Mar. 31, 2024

Restructuring and Related Activities [Abstract]

Restructuring Costs

Restructuring Costs

On December 5, 2023, UTI announced plans to consolidate the two Houston, Texas campus locations to align the curriculum, student facing systems, and support services to better serve students seeking careers in in-demand fields. As part of the transition, the MIAT Houston campus, acquired in November 2021, will begin operating under the UTI brand and implement a phased teach-out agreement starting in May 2024. Both facilities will remain in use post-consolidation.

The total costs of the restructuring plan are estimated to be approximately $1.4 million and relate to the UTI segment. Approximately $45 thousand of tool related costs were expensed during the three months ended March 31, 2024, and approximately $88 thousand of employee termination and tool related costs were expensed during the six months ended March 31, 2024, all of which are reported in “Selling, general and administrative” on the condensed consolidated statements of operations. Additional estimated costs of $0.5 million are expected to be recorded during the remainder of fiscal 2024 as incurred, and $0.8 million in additional estimated costs are expected to be recorded during fiscal 2025 as incurred.

XML

Commitments and Contingencies

6 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Legal

In the ordinary conduct of our business, we are periodically subject to lawsuits, demands in arbitration, investigations, regulatory proceedings or other claims, including, but not limited to, claims involving current or former students, routine employment matters, business disputes and regulatory demands. When we are aware of a claim or potential claim, we assess the likelihood of any loss or exposure. If it is probable that a loss will result and the amount of the loss can be reasonably estimated, we accrue a liability for the loss. When a loss is not both probable and estimable, we do not accrue a liability.

Where a loss is not probable but is reasonably possible, including if a loss in excess of an accrued liability is reasonably possible, we determine whether it is possible to provide an estimate of the amount of the loss or range of possible losses for the claims. We are not currently a party to any material legal proceedings, but note that legal proceedings could, generally, have a material adverse effect on our business, cash flows, results of operations or financial condition.

XML

Shareholders' Equity

6 Months Ended

Mar. 31, 2024

Equity [Abstract]

Shareholders’ Equity

Shareholders’ Equity

Common Stock

Holders of our common stock are entitled to receive dividends when and as declared by our Board of Directors and have the right to one vote per share on all matters requiring shareholder approval. On June 9, 2016, our Board of Directors voted to eliminate the quarterly cash dividend on our common stock.

Preferred Stock

As of March 31, 2024, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated.

Under the terms of the Certificate of Designations for the Series A Preferred Stock (the “CoD”), we had the right to convert the outstanding shares of Series A Preferred Stock to common stock when our common stock achieved a stated volume weighted average price per share for a period of 20 consecutive trading days. On December 18, 2023, upon satisfying the stock price condition, we entered into a preferred stock repurchase agreement with Coliseum Capital Partners, L.P. and Blackwell Partners LLC – Series A (collectively the “Selling Stockholders”), pursuant to which we repurchased, directly from the Selling Stockholders, 33,300 shares of Series A Preferred Stock for an aggregate purchase price of $11.3 million. Additionally, we incurred approximately $0.3 million in fees related to excise taxes and other professional services related to the repurchase, which are recorded in equity. Following the repurchase of those shares of Series A Preferred Stock, and in accordance with the terms of the CoD, we issued a notice of conversion causing all remaining outstanding shares of Series A Preferred Stock to be converted into Common Stock. In connection with the conversion, each share of Series A Preferred Stock was cancelled and converted into the right to receive 30.03003 shares of our Common Stock, no par value per share, and we made a final dividend payment of $1.1 million to the Series A Preferred Stock holders of record as of December 18, 2023. As a result of the conversion, the aggregate 642,585 remaining shares of Series A Preferred Stock outstanding were

converted into 19,296,843 shares of Common Stock. No shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date. Following the repurchase and subsequent conversion, the Selling Stockholders held less than 25% of our outstanding shares of common stock (a threshold above which we would have been required to seek regulatory approval for the conversion).

As of September 30, 2023, 675,885 shares of Series A Convertible Preferred Stock with a $0.0001 par value each (“Series A Preferred Stock”) were issued and outstanding, respectively. The liquidation preference associated with the Series A Preferred Stock was $100 per share at September 30, 2023.

Share Repurchase Program

On December 10, 2020, our Board of Directors authorized a share repurchase plan that would allow for the repurchase of up to $35.0 million of our common stock in the open market or through privately negotiated transactions. This share repurchase plan replaced the previously authorized plan from fiscal 2012. We have not repurchased any shares under the $35.0 million share repurchase program, including during the six months ended March 31, 2024 or 2023.

XML

Earnings per Share

6 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Earnings per Share

Earnings per Share

We calculate basic earnings per common share (“EPS”) pursuant to the two-class method as a result of the issuance of the Series A Preferred Stock on June 24, 2016. The two-class method is an earnings allocation formula that determines EPS for common stock and participating securities according to dividend and participation rights in undistributed earnings. Under this method, all earnings, distributed and undistributed, are allocated to common shares and participating securities based on their respective rights to receive dividends.

Diluted EPS is calculated using the more dilutive of the two-class method or as-converted method. The two-class method uses net income available to common shareholders and assumes conversion of all potential shares other than the participating securities. The as-converted method uses net income and assumes conversion of all potential shares including the participating securities. Dilutive potential common shares include outstanding stock options, unvested restricted share units and convertible preferred stock. As noted above in Note 17, no shares of the Series A Preferred Stock remain outstanding and all rights of the holders to receive future dividends have been terminated as of the December 18, 2023 conversion date.

The following table summarizes the computation of basic and diluted EPS under the two-class or as-converted method, as well as the anti-dilutive shares excluded:

	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2024		2023		2024		2023
Basic earnings per common share:
Net income	$	7,787	$	3,480	$	18,176	$	6,128
Less: Preferred stock dividend declared	—		(1,251)		(1,097)		(2,528)
Net income available for distribution	7,787		2,229		17,079		3,600
Income allocated to participating securities	—		(833)		(2,855)		(1,348)
Net income available to common shareholders	$	7,787	$	1,396	$	14,224	$	2,252
Weighted average basic shares outstanding	53,757		33,999		45,048		33,901
Basic income per common share	$	0.14	$	0.04	$	0.32	$	0.07

	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2024		2023		2024		2023
Diluted earnings per common share:
Method used:	Two-class		Two-class		Two-class		Two-class
Net income available to common shareholders	$	7,787	$	1,396	$	14,224	$	2,252
Weighted average basic shares outstanding	53,757		33,999		45,048		33,901
Dilutive effect related to employee stock plans	1,013		554		1,002		576
Weighted average diluted shares outstanding	54,770		34,553		46,050		34,477
Diluted income per common share	$	0.14	$	0.04	$	0.31	$	0.07
Anti-dilutive shares excluded:
Outstanding stock-based grants	—		239		17		515
Convertible preferred stock	—		20,297		—		20,297
Total anti-dilutive shares excluded	—		20,536		17		20,812

XML

Segment Information

6 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Segment Information

Segment Information

We operate our business in two reportable segments: (i) the UTI segment; and (ii) the Concorde segment. These segments are organized by key market segments to enhance operational alignment within each segment to more effectively execute our strategic plan. Each reportable segment represents a group of post-secondary education providers that offer a variety of degree and non-degree academic programs. “Corporate” includes corporate related expenses that are not allocated to the UTI or Concorde reportable segments and is included to reconcile segment results to the condensed consolidated financial statements.

As previously discussed in Note 2, the segment disclosures for the three and six months ended March 31, 2023 have been recast from the prior year presentation for comparability to the current year presentation.

Summary information by reportable segment is as follows:

	UTI		Concorde		Corporate		Consolidated
Three Months Ended March 31, 2024
Revenues	$	123,323	$	60,853	$	—	$	184,176
Income (loss) from operations	18,086		3,246		(10,140)		11,192
Depreciation and amortization	5,684		1,217		301		7,202
Net income (loss)	16,616		3,320		(12,149)		7,787
Three Months Ended March 31, 2023
Revenues	$	107,560	$	56,260	$	—	$	163,820
Income (loss) from operations	9,788		6,189		(10,028)		5,949
Depreciation and amortization	5,094		1,649		3		6,746
Net income (loss)	8,821		6,237		(11,578)		3,480

	UTI		Concorde		Corporate		Consolidated
Six Months Ended March 31, 2024
Revenues	$	238,697	$	120,174	$	—	$	358,871
Income (loss) from operations	33,177		10,373		(18,127)		25,423
Depreciation and amortization	11,178		2,371		637		14,186
Net income (loss)	30,213		10,493		(22,530)		18,176
Six Months Ended March 31, 2023
Revenues	$	213,133	$	70,691	$	—	$	283,824
Income (loss) from operations	23,210		5,463		(18,276)		10,397
Depreciation and amortization	9,869		2,106		19		11,994
Net income (loss)	21,553		5,503		(20,928)		6,128
As of March 31, 2024
Total assets	$	446,337	$	134,849	$	120,902	$	702,088
As of September 30, 2023
Total assets	$	442,507	$	130,813	$	167,365	$	740,685

XML

Government Regulation and Financial Aid

6 Months Ended

Mar. 31, 2024

Government Regulation and Financial Aid [Abstract]

Government Regulation And Financial Aid

Government Regulation and Financial Aid

As discussed at length in our 2023 Annual Report on Form 10-K, our institutions participate in a range of government-sponsored student assistance programs. The most significant of these is the federal student aid programs administered by the U.S. Department of Education (“ED”) pursuant to Title IV of the HEA, commonly referred to as the Title IV Programs. Generally, to participate in the Title IV Programs, an institution must be licensed or otherwise legally authorized to operate in the state where it is physically located, be accredited by an accreditor recognized by ED, be certified as an eligible institution by ED, offer at least one eligible program of education, and comply with other statutory and regulatory requirements.

Each of our institutions holds the state or other authorizations required to operate and offer postsecondary education programs, and to recruit in the states in which it engages in recruiting activities. In addition, our institutions are accredited by ED-recognized accreditors: all of the UTI institutions and 14 of the Concorde institutions are accredited by the Accrediting Commission of Career Schools and Colleges, while the remaining two Concorde institutions are accredited by the Council on Occupational Education. ED will certify an institution to participate in the Title IV programs only after the institution has demonstrated compliance with the Higher Education Act and ED’s extensive regulations regarding institutional eligibility. An institution must also demonstrate its compliance to ED on an ongoing basis. As of December 31, 2023, management believes the Company and its institutions are in compliance with the applicable regulations in all material respects. See “Part I, Item 1. Regulatory Environment” and “Part I, Item 1. State and Accreditor Approvals” in our 2023 Annual Report on Form 10-K for a detailed discussion of the regulatory environment in which the Company operates.

Because the Company operates in a highly regulated industry, it, like other industry participants, may be subject from time to time to investigations, claims of non-compliance, or lawsuits by governmental agencies or third parties, which allege statutory violations, regulatory infractions, or common law causes of action. There can be no assurance that regulatory agencies or third parties will not undertake investigations or make claims against the Company, or that such claims, if made, will not have a material adverse effect on the Company’s business, results of operations or financial condition.

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net income (loss)	$ 7,787	$ 10,389	$ 3,480	$ 2,648	$ 18,176	$ 6,128

XML

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Basis of Presentation (Policies)

6 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Segment Recast

Segment Recast

During fiscal 2023, in coordination with the integration of Concorde, we began to reassess our operating model to determine the optimal structure to achieve future growth goals and support the business. In furtherance of the foregoing, we executed an internal reorganization of our operations to fully transition our operating and reporting model to support a multi-divisional business. Each of the reportable segments now has dedicated accounting, finance, information technology, and human resources teams. Additionally, certain human resources and information technology costs that benefit the entire organization are now allocated across the UTI, Concorde and Corporate segments each period based upon relative headcount. As a result, additional costs have moved from the Corporate segment into the UTI segment and to a lesser extent the Concorde segment, as resources were redirected to support each segment’s objectives. Due to these changes in allocation methodology, the segment disclosures in Note 19 for the three and six months ended March 31, 2023 have been recast from the prior year presentation for comparability to the current year presentation.

Recently Accounting Pronouncements

The Financial Accounting Standards Board (“FASB”) and the SEC periodically issue new accounting standards or disclosure requirements in a continuing effort to improve standards of financial accounting and reporting. We have reviewed the recently issued pronouncements and concluded the following new accounting standard updates (“ASU”) or SEC rules apply to us.

Effective in Fiscal 2025

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses and increased interim disclosure requirements, among others. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted, and the amendments should be applied retrospectively. This ASU will be effective for our Form 10-K for fiscal 2025 and our Form 10-Q for the first quarter of fiscal 2026. We are currently evaluating the impact this ASU may have on our financial statement disclosures.

Effective in Fiscal 2026

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, among others, in order to enhance the transparency of income tax disclosures, including consistent categories and greater disaggregation of information in the rate reconciliation and disaggregation by jurisdiction of income taxes paid. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied prospectively; however, retrospective application is also permitted. This ASU will be effective for our Form 10-K for fiscal 2026. We are currently evaluating the impact this ASU may have on our financial statement disclosures.

Effective in Fiscal 2027

In March 2024, the SEC issued final rules to enhance public company disclosures related to the risks and impacts of climate-related matters. In April 2024, the SEC voluntarily stayed the new rules as a result of pending legal challenges. The new rules, if adopted, include requirements to disclose Scope 1 and Scope 2 greenhouse gas emissions and other climate-related topics in annual reports and registration statements, when material. Disclosure requirements will begin phasing in for our Form 10-K for fiscal 2027. We are currently evaluating the impact this rule may have on our financial statement disclosures.

Nature of Goods and Services/Contract Balances

Nature of Goods and Services

Revenues across the UTI and Concorde segments consist primarily of student tuition and fees derived from the programs we provide after reductions are made for discounts and scholarships that we sponsor and for refunds for students who withdraw from our programs prior to specified dates. We apply the five-step model outlined in Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts from Customers. Tuition and fee revenue is recognized ratably over the term of the course or program offered.

In addition to revenue from tuition and fees, UTI and Concorde derive supplemental revenues from sales of textbooks and program supplies and other revenues, which includes revenues from dealer technician training and staffing services to manufacturers. All of these revenues are recognized as the transfer of goods or services occurs. Deferred revenue represents the excess of tuition and fee payments received as compared to tuition and fees earned and is reflected as a current liability in our condensed consolidated balance sheets because it is expected to be earned within the next 12 months.

All of our revenues are generated within the United States. The impact of economic factors on the nature, amount, timing and uncertainty of revenue and cash flows is consistent across our various programs for both the UTI and Concorde segments. See Note 19 for disaggregated segment revenue information.

Fair Value Measurements

Fair Value Measurements

The accounting framework for determining fair value includes a hierarchy for ranking the quality and reliability of the information used to measure fair value, which enables the reader of the financial statements to assess the inputs used to develop those measurements. The fair value hierarchy consists of three tiers:

Level 1:    Defined as quoted market prices in active markets for identical assets or liabilities.

Level 2:    Defined as inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, model-based valuation techniques for which all significant assumptions are observable in the market or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3:    Defined as unobservable inputs that are not corroborated by market data.

Any transfers of investments between levels occurs at the end of the reporting period.

XML

Acquisitions (Tables)

6 Months Ended

Mar. 31, 2024

Business Combination and Asset Acquisition [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The final allocation of the purchase price at December 1, 2022 is summarized as follows:

Assets acquired:
Cash and cash equivalents	$	30,064
Restricted cash	1,689
Accounts receivable, net	6,800
Prepaid expenses	2,957
Other current assets	827
Property and equipment	23,238
Right-of-use assets for operating leases	71,153
Goodwill	11,600
Intangible assets	5,400
Deferred tax assets	5,112
Other assets	4,997
Total assets acquired	$	163,837

Less: Liabilities assumed
Accounts payable and accrued expenses	$	15,482
Deferred revenue	20,145
Operating lease liability, current portion	10,011
Long-term debt, current portion (1)	807
Other current liabilities	208
Long-term debt (1)	5,468
Operating lease liability	63,582
Total liabilities assumed	115,703
Net assets acquired	$	48,134

(1)    Long-term debt consists of one lease classified as a finance lease under ASC 842.

Schedule of Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination

The table below presents the final summary of the intangible assets acquired and the useful lives of these assets:

Intangible Asset	Useful life	Amount
Accreditations and regulatory approvals	Indefinite	$	3,500
Trademarks and trade names	10 years	500
Curriculum	5 years	1,400
Total		$	5,400

Schedule of Business Acquisition, Pro Forma Information

The following unaudited pro forma financial information summarizes our results of operations as though the acquisition occurred on October 1, 2022:

	Six Months Ended
	March 31, 2023
Revenue	$	319,845
Net income	5,919

XML

Revenue from Contracts with Customers (Tables)

6 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Contract with Customer, Asset and Liability

The following table provides information about receivables and deferred revenue resulting from our enrollment agreements with students:

	March 31, 2024		September 30, 2023
Receivables (1)	$	64,559	$	59,863
Deferred revenue	67,599		85,738

(1)     Receivables includes tuition receivables, retail installment contract receivables and notes receivable, both current and long term.

XML

Fair Value Measurements (Tables)

6 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Fair Value of Assets

Assets measured or disclosed at fair value on a recurring basis consisted of the following:

			Fair Value Measurements Using
	March 31, 2024		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds(1)	$	24,563	$	24,563	$	—	$	—
Notes receivable(2)	41,072		—		—		41,072
Total assets at fair value on a recurring basis	$	65,635	$	24,563	$	—	$	41,072
Revolving credit facility and term loans(3)	137,155		—		137,155		—
Total liabilities at fair value on a recurring basis	$	137,155	$	—	$	137,155	$	—

			Fair Value Measurements Using
	September 30, 2023		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Money market funds(1)	$	29,687	$	29,687	$	—	$	—
Notes receivable(2)	36,663		—		—		36,663
Total assets at fair value on a recurring basis	$	66,350	$	29,687	$	—	$	36,663
Revolving credit facility and term loans(3)	156,991		—		156,991		—
Total liabilities at fair value on a recurring basis	$	156,991	$	—	$	156,991	$	—

(1) Money market funds and other highly liquid investments with maturity dates less than 90 days are reflected as “Cash and cash equivalents” in our condensed consolidated balance sheets as of March 31, 2024 and September 30, 2023.

(2) Notes receivable relate to UTI’s proprietary loan program and are reflected as “Notes receivable, current portion” and “Notes receivable, less current portion” in our condensed consolidated balance sheets as of March 31, 2024 and September 30, 2023.

(3) The Credit Facility and Term Loans bear interest at rates commensurate with market rates, and therefore, the respective carrying values approximate fair value (Level 2).

XML

Property and Equipment, net (Tables)

6 Months Ended

Mar. 31, 2024

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment, Net

Property and equipment, net consisted of the following:

	March 31, 2024		September 30, 2023
Land	$	25,601	$	25,601
Buildings and building improvements	164,325		160,920
Leasehold improvements	89,462		87,525
Training equipment	112,448		110,292
Office and computer equipment	37,472		37,251
Curriculum development	3,570		2,478
Software developed for internal use	13,103		12,573
Vehicles	1,406		1,406
Right-of-use assets for finance leases	5,603		5,603
Construction in progress	7,246		9,061
	460,236		452,710
Less: Accumulated depreciation and amortization	(196,698)		(186,364)
Total	$	263,538	$	266,346

XML

Goodwill (Tables)

6 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

The goodwill balance by reportable segment as of March 31, 2024 and September 30, 2023 was:

UTI	$	16,859
Concorde	11,600
Total	$	28,459

XML

Intangible Assets (Tables)

6 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets

The following table provides the gross carrying value, accumulated amortization, net book value and remaining useful life for those intangible assets that are subject to amortization as of March 31, 2024:

	Gross Carrying Value		Accumulated Amortization		Net Book Value		Weighted Average Remaining Useful Life (Years)
Accreditations and regulatory approvals	$	16,300	$	—	$	16,300	Indefinite
Trademarks, trade names and other	1,942		(848)		1,094		4.89
Curriculum	1,800		(567)		1,233		3.49
Total	$	20,042	$	(1,415)	$	18,627	4.15

The following table provides the gross carrying value, accumulated amortization, net book value and remaining useful life for those intangible assets that are subject to amortization as of March 31, 2023:

	Gross Carrying Value		Accumulated Amortization		Net Book Value		Weighted Average Remaining Useful Life (Years)
Accreditations and regulatory approvals	$	16,300	$	—	$	16,300	Indefinite
Trademarks, trade names and other	1,942		(513)		1,429		5.51
Curriculum	1,800		(207)		1,593		4.47
Total	$	20,042	$	(720)	$	19,322	4.96

Schedule of Indefinite-Lived Intangible Assets

The following table provides the gross carrying value, accumulated amortization, net book value and remaining useful life for those intangible assets that are subject to amortization as of March 31, 2024:

	Gross Carrying Value		Accumulated Amortization		Net Book Value		Weighted Average Remaining Useful Life (Years)
Accreditations and regulatory approvals	$	16,300	$	—	$	16,300	Indefinite
Trademarks, trade names and other	1,942		(848)		1,094		4.89
Curriculum	1,800		(567)		1,233		3.49
Total	$	20,042	$	(1,415)	$	18,627	4.15

The following table provides the gross carrying value, accumulated amortization, net book value and remaining useful life for those intangible assets that are subject to amortization as of March 31, 2023:

	Gross Carrying Value		Accumulated Amortization		Net Book Value		Weighted Average Remaining Useful Life (Years)
Accreditations and regulatory approvals	$	16,300	$	—	$	16,300	Indefinite
Trademarks, trade names and other	1,942		(513)		1,429		5.51
Curriculum	1,800		(207)		1,593		4.47
Total	$	20,042	$	(720)	$	19,322	4.96

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense

Future intangible asset amortization expense is expected to be as follows:

Fiscal Year
Remainder of 2024	$	348
2025	677
2026	660
2027	337
2028	97
Thereafter	208
Total	$	2,327

XML

Leases (Tables)

6 Months Ended

Mar. 31, 2024

Leases [Abstract]

Schedule of Lease Expense

The components of lease expense during the three and six months ended March 31, 2024 and 2023 were as follows:

	Three Months Ended March 31,				Six Months Ended March 31,
Lease Expense	2024		2023		2024		2023
Operating lease expense(1)	$	7,597	$	8,273	$	15,259	$	13,977
Finance lease expense:
Amortization of leased assets	227		127		454		325
Interest on lease liabilities	79		35		161		122
Variable lease expense	2,476		2,307		4,837		4,257
Sublease income	(33)		(25)		(65)		(57)
Total net lease expense	$	10,346	$	10,717	$	20,646	$	18,624

(1)    Excludes the expense for short-term leases not accounted for under ASC 842, which was not significant for the three and six months ended March 31, 2024 and 2023.

Schedule of Supplemental Information

Supplemental balance sheet, cash flow and other information related to our leases was as follows (in thousands, except lease term and discount rate):

Leases	Classification	March 31, 2024		September 30, 2023
Assets:
Operating lease assets	Right-of-use assets for operating leases	$	169,626	$	176,657
Finance lease assets	Property and equipment, net(1)	4,391		4,846
Total leased assets		$	174,017	$	181,503
Liabilities:
Current
Operating lease liabilities	Operating lease liability, current portion	$	22,841	$	22,481
Finance lease liabilities	Long-term debt, current portion(1)	887		844
Noncurrent
Operating lease liabilities	Operating lease liability	158,448		165,026
Finance lease liabilities	Long-term debt	4,304		4,757
Total lease liabilities		$	186,480	$	193,108

(1)     The finance lease assets and liabilities as of March 31, 2024 and September 30, 2023 consisted of one facility lease. Finance lease assets are recorded net of accumulated amortization of $1.2 million and $0.8 million as of March 31, 2024 and September 30, 2023, respectively.

Lease Term and Discount Rate	March 31, 2024		September 30, 2023
Weighted-average remaining lease term (in years):
Operating leases	7.57		7.91
Finance lease	4.83		5.33
Weighted average discount rate:
Operating leases	4.86	%	4.76	%
Finance lease	6.02	%	6.02	%

	Six Months Ended March 31,
Supplemental Disclosure of Cash Flow and Other Information	2024		2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	10,139	$	10,745
Financing cash flows from finance leases	410		304
Non-cash activity related to lease liabilities:
Lease assets obtained in exchange for new operating lease liabilities (1)	$	3,921	$	149

(1) During the six months ended March 31, 2024, Concorde renewed the campus lease for the San Antonio, Texas campus.

Schedule Operating Lease Liabilities Maturities

Maturities of lease liabilities were as follows:

	As of March 31, 2024
Years ending September 30,	Operating Leases		Finance Lease
Remainder of 2024	$	14,312	$	585
2025	30,148		1,193
2026	30,509		1,229
2027	28,874		1,266
2028	26,747		1,304
2029 and thereafter	85,892		439
Total lease payments	216,482		6,016
Less: interest	(35,193)		(825)
Present value of lease liabilities	181,289		5,191
Less: current lease liabilities	(22,841)		(887)
Long-term lease liabilities	$	158,448	$	4,304

Schedule of Finance Lease Liabilities Maturities

Maturities of lease liabilities were as follows:

	As of March 31, 2024
Years ending September 30,	Operating Leases		Finance Lease
Remainder of 2024	$	14,312	$	585
2025	30,148		1,193
2026	30,509		1,229
2027	28,874		1,266
2028	26,747		1,304
2029 and thereafter	85,892		439
Total lease payments	216,482		6,016
Less: interest	(35,193)		(825)
Present value of lease liabilities	181,289		5,191
Less: current lease liabilities	(22,841)		(887)
Long-term lease liabilities	$	158,448	$	4,304

XML

Accounts Payable and Accrued Expenses (Tables)

6 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

Schedule of Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses consisted of the following:

	March 31, 2024		September 30, 2023
Accounts payable	$	17,658	$	14,438
Accrued compensation and benefits	28,971		36,332
Accrued tool sets	4,743		4,096
Other accrued expenses	18,707		15,075
Total accounts payable and accrued expenses	$	70,079	$	69,941

XML

Debt (Tables)

6 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Schedule of Debt

	March 31, 2024					September 30, 2023
	Interest Rate		Maturity Date	Carrying Value of Debt(6)		Carrying Value of Debt(6)
Revolving Credit Facility(1)	7.78	%	Nov 2025	$	71,000	$	90,000
Avondale Term Loan(2)	7.37	%	May 2028	28,825		29,251
Lisle Term Loan(3)	7.33	%	Apr 2029	37,330		37,740
Finance lease(4)	6.02	%	Various	5,191		5,601
Total debt				142,346		162,592
Debt issuance costs presented with debt (5)				(429)		(475)
Total debt, net				141,917		162,117
Less: current portion of long-term debt				(2,600)		(2,517)
Long-term debt				$	139,317	$	159,600

(1)     Interest on the Revolving Credit Facility (as defined below) accrues at a rate equal to one-month Term SOFR plus a margin of 2.0% and a lender specific spread of 0.10-0.15% or a Prime Rate as set by the lender.

(2)    Interest on the Avondale Term Loan (as defined below) accrues at a rate equal to one-month Term SOFR plus 2.0% and a tranche adjustment of 0.046%.

(3)    Interest on the Lisle Term Loan (as defined below) accrues at a rate equal to one-month Term SOFR plus 2.0%.

(4)    The finance lease is related to a facility lease with an annual interest rate of 6.02% that matures in 2029. See Note 10 for additional details on our finance lease.

(5)    The unamortized debt issuance costs as of March 31, 2024 relate to the Avondale Term Loan and the Lisle Term Loan.

(6)    The Credit Facility, Term Loans and finance leases bear interest at rates commensurate with market rates, and therefore, the respective carrying values approximate fair value (Level 2).

Schedule of Maturities of Long-term Debt

Scheduled principal payments due on our debt for the remainder of 2024 and for each year through the period ended September 30, 2028, and thereafter were as follows at March 31, 2024:

Maturity	Revolving Credit Facility & Term Loans		Finance Lease		Total
Remainder of 2024	$	837	$	434	$	1,271
2025	1,763		932		2,695
2026	72,836		1,027		73,863
2027	1,909		1,128		3,037
2028	26,610		1,237		27,847
Thereafter	33,200		433		33,633
Subtotal	137,155		5,191		142,346
Debt issuance costs presented with debt	(429)		—		(429)
Total	$	136,726	$	5,191	$	141,917

XML

Derivative Financial Instruments (Tables)

6 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Fair Value of Derivative Instruments

The following table presents the fair value of our Avondale Swap and Lisle Swap (Level 2) which are designated as cash flow hedges and the related classification on the condensed consolidated balance sheets as of March 31, 2024 and September 30, 2023:

Interest Rate Swaps	March 31, 2024		September 30, 2023
Other current assets	$	833	$	957
Other assets	1,488		2,075
Total fair value of assets designated as hedging instruments	$	2,321	$	3,032

Schedule of Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)

The table below presents the effect of cash flow hedge accounting for our Avondale Swap and Lisle Swap on the condensed consolidated statement of operations and “Accumulated other comprehensive income” for the three and six months ended March 31, 2024 and 2023:

	Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative, net of taxes		Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income
	Three Months Ended March 31, 2024
Avondale Swap and Lisle Swap	$	(738)	$	(267)
	Six Months Ended March 31, 2024
Avondale Swap and Lisle Swap	$	174	$	(538)
	Three Months Ended March 31, 2023
Avondale Swap and Lisle Swap	$	518	$	(199)
	Six Months Ended March 31, 2023
Avondale Swap and Lisle Swap	$	559	$	(327)

XML

Earnings per Share (Tables)

6 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Schedule of Calculation of Weighted Average Number of Shares Outstanding Used in Computing Basic and Diluted Net Income Loss Per Share

The following table summarizes the computation of basic and diluted EPS under the two-class or as-converted method, as well as the anti-dilutive shares excluded:

	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2024		2023		2024		2023
Basic earnings per common share:
Net income	$	7,787	$	3,480	$	18,176	$	6,128
Less: Preferred stock dividend declared	—		(1,251)		(1,097)		(2,528)
Net income available for distribution	7,787		2,229		17,079		3,600
Income allocated to participating securities	—		(833)		(2,855)		(1,348)
Net income available to common shareholders	$	7,787	$	1,396	$	14,224	$	2,252
Weighted average basic shares outstanding	53,757		33,999		45,048		33,901
Basic income per common share	$	0.14	$	0.04	$	0.32	$	0.07

	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2024		2023		2024		2023
Diluted earnings per common share:
Method used:	Two-class		Two-class		Two-class		Two-class
Net income available to common shareholders	$	7,787	$	1,396	$	14,224	$	2,252
Weighted average basic shares outstanding	53,757		33,999		45,048		33,901
Dilutive effect related to employee stock plans	1,013		554		1,002		576
Weighted average diluted shares outstanding	54,770		34,553		46,050		34,477
Diluted income per common share	$	0.14	$	0.04	$	0.31	$	0.07
Anti-dilutive shares excluded:
Outstanding stock-based grants	—		239		17		515
Convertible preferred stock	—		20,297		—		20,297
Total anti-dilutive shares excluded	—		20,536		17		20,812

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table summarizes the computation of basic and diluted EPS under the two-class or as-converted method, as well as the anti-dilutive shares excluded:

	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2024		2023		2024		2023
Basic earnings per common share:
Net income	$	7,787	$	3,480	$	18,176	$	6,128
Less: Preferred stock dividend declared	—		(1,251)		(1,097)		(2,528)
Net income available for distribution	7,787		2,229		17,079		3,600
Income allocated to participating securities	—		(833)		(2,855)		(1,348)
Net income available to common shareholders	$	7,787	$	1,396	$	14,224	$	2,252
Weighted average basic shares outstanding	53,757		33,999		45,048		33,901
Basic income per common share	$	0.14	$	0.04	$	0.32	$	0.07

	Three Months Ended				Six Months Ended
	March 31,				March 31,
	2024		2023		2024		2023
Diluted earnings per common share:
Method used:	Two-class		Two-class		Two-class		Two-class
Net income available to common shareholders	$	7,787	$	1,396	$	14,224	$	2,252
Weighted average basic shares outstanding	53,757		33,999		45,048		33,901
Dilutive effect related to employee stock plans	1,013		554		1,002		576
Weighted average diluted shares outstanding	54,770		34,553		46,050		34,477
Diluted income per common share	$	0.14	$	0.04	$	0.31	$	0.07
Anti-dilutive shares excluded:
Outstanding stock-based grants	—		239		17		515
Convertible preferred stock	—		20,297		—		20,297
Total anti-dilutive shares excluded	—		20,536		17		20,812

XML

Segment Information (Tables)

6 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Schedule of Information by Reportable Segment

Summary information by reportable segment is as follows:

	UTI		Concorde		Corporate		Consolidated
Three Months Ended March 31, 2024
Revenues	$	123,323	$	60,853	$	—	$	184,176
Income (loss) from operations	18,086		3,246		(10,140)		11,192
Depreciation and amortization	5,684		1,217		301		7,202
Net income (loss)	16,616		3,320		(12,149)		7,787
Three Months Ended March 31, 2023
Revenues	$	107,560	$	56,260	$	—	$	163,820
Income (loss) from operations	9,788		6,189		(10,028)		5,949
Depreciation and amortization	5,094		1,649		3		6,746
Net income (loss)	8,821		6,237		(11,578)		3,480

	UTI		Concorde		Corporate		Consolidated
Six Months Ended March 31, 2024
Revenues	$	238,697	$	120,174	$	—	$	358,871
Income (loss) from operations	33,177		10,373		(18,127)		25,423
Depreciation and amortization	11,178		2,371		637		14,186
Net income (loss)	30,213		10,493		(22,530)		18,176
Six Months Ended March 31, 2023
Revenues	$	213,133	$	70,691	$	—	$	283,824
Income (loss) from operations	23,210		5,463		(18,276)		10,397
Depreciation and amortization	9,869		2,106		19		11,994
Net income (loss)	21,553		5,503		(20,928)		6,128
As of March 31, 2024
Total assets	$	446,337	$	134,849	$	120,902	$	702,088
As of September 30, 2023
Total assets	$	442,507	$	130,813	$	167,365	$	740,685

XML

Nature of the Business (Details)		6 Months Ended
	Dec. 01, 2022 segment	Mar. 31, 2024 segment state campus
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of reportable segments | segment	2	2
Number of campuses through which undergraduate degree, diploma and certificate programs are offered | campus		16
Number of states | state		9
Concorde
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of campuses through which undergraduate degree, diploma and certificate programs are offered | campus		17
Number of states | state		8

XML

Acquisitions - Narrative (Details)		3 Months Ended		6 Months Ended
	Dec. 01, 2022 USD ($) state student program campus	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Mar. 31, 2024 USD ($) campus state	Sep. 30, 2023 USD ($)
Business Combination Segment Allocation [Line Items]
Number of campuses through which undergraduate degree, diploma and certificate programs are offered | campus				16
Number of states | state				9
Goodwill				$ 28,459,000	$ 28,459,000
Concorde
Business Combination Segment Allocation [Line Items]
Number of campuses through which undergraduate degree, diploma and certificate programs are offered | campus	17
Number of states | state	8
Number of students | student	7,600
Number of programs | program	20
Base purchase price	$ 50,000,000
Working capital	1,900,000
Purchase consideration	48,100,000
Business combination, acquisition related costs	5,300,000	$ 2,300,000	$ 3,000,000
Adjustment to income tax receivable				100,000
Adjustment to deferred income taxes				600,000
Adjustment to property and equipment				$ 700,000
Goodwill	11,600,000
Goodwill expected to be deductible for tax purposes	0
Receivables acquired	2,300,000
Allowance for credit losses on PCD assets	$ 1,000,000

XML

Acquisitions - Preliminary Allocation of Purchase Price - Concorde (Details) $ in Thousands	Mar. 31, 2024 USD ($)	Sep. 30, 2023 USD ($)	Dec. 01, 2022 USD ($) lease
Assets acquired
Goodwill	$ 28,459	$ 28,459
Concorde
Assets acquired
Cash and cash equivalents			$ 30,064
Restricted cash			1,689
Accounts receivable, net			6,800
Prepaid expenses			2,957
Other current assets			827
Property and equipment			23,238
Right-of-use assets for operating leases			71,153
Goodwill			11,600
Intangible assets			5,400
Deferred tax assets			5,112
Other assets			4,997
Total assets acquired			163,837
Less: Liabilities assumed
Accounts payable and accrued expenses			15,482
Deferred revenue			20,145
Operating lease liability, current portion			10,011
Long-term debt, current portion			807
Other current liabilities			208
Long-term debt			5,468
Operating lease liability			63,582
Total liabilities assumed			115,703
Net assets acquired			$ 48,134
Number of finance leases acquired | lease			1

XML

Acquisitions - Schedule of Intangible Assets Acquired (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Mar. 31, 2023	Dec. 01, 2022
Asset Acquisition [Line Items]
Finite-lived intangible assets, net book value	$ 2,327
Net Book Value	18,627	$ 19,322
Concorde
Asset Acquisition [Line Items]
Net Book Value			$ 5,400
Trademarks, trade names and other
Asset Acquisition [Line Items]
Finite-lived intangible assets, net book value	1,094	1,429
Trademarks, trade names and other | Concorde
Asset Acquisition [Line Items]
Weighted Average Remaining Useful Life (Years)			10 years
Finite-lived intangible assets, net book value			$ 500
Curriculum development
Asset Acquisition [Line Items]
Finite-lived intangible assets, net book value	1,233	1,593
Curriculum development | Concorde
Asset Acquisition [Line Items]
Weighted Average Remaining Useful Life (Years)			5 years
Finite-lived intangible assets, net book value			$ 1,400
Accreditations and regulatory approvals
Asset Acquisition [Line Items]
Indefinite-lived intangible assets, gross carrying amount	$ 16,300	$ 16,300
Accreditations and regulatory approvals | Concorde
Asset Acquisition [Line Items]
Indefinite-lived intangible assets, gross carrying amount			$ 3,500

XML

Acquisitions - Pro Forma Financial Information (Details) - Concorde $ in Thousands	6 Months Ended
	Mar. 31, 2023 USD ($)
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]
Revenue	$ 319,845
Net income	$ 5,919

XML

Revenue from Contracts with Customers (Details) - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2024	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue recognition period	12 months
Receivables	$ 64,559	$ 59,863
Deferred revenue	$ 67,599	$ 85,738

XML

Fair Value Measurements - Assets Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total liabilities at fair value on a recurring basis	$ 137,155	$ 156,991
Revolving credit facility and term loans
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total liabilities at fair value on a recurring basis	137,155	156,991
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total liabilities at fair value on a recurring basis	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Revolving credit facility and term loans
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total liabilities at fair value on a recurring basis	0	0
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total liabilities at fair value on a recurring basis	137,155	156,991
Significant Other Observable Inputs (Level 2) | Revolving credit facility and term loans
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total liabilities at fair value on a recurring basis	137,155	156,991
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total liabilities at fair value on a recurring basis	0	0
Significant Unobservable Inputs (Level 3) | Revolving credit facility and term loans
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total liabilities at fair value on a recurring basis	0	0
Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value on a recurring basis	65,635	66,350
Estimate of Fair Value Measurement | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value on a recurring basis	24,563	29,687
Estimate of Fair Value Measurement | Notes receivable
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value on a recurring basis	41,072	36,663
Estimate of Fair Value Measurement | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value on a recurring basis	24,563	29,687
Estimate of Fair Value Measurement | Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value on a recurring basis	24,563	29,687
Estimate of Fair Value Measurement | Quoted Prices in Active Markets for Identical Assets (Level 1) | Notes receivable
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value on a recurring basis	0	0
Estimate of Fair Value Measurement | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value on a recurring basis	0	0
Estimate of Fair Value Measurement | Significant Other Observable Inputs (Level 2) | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value on a recurring basis	0	0
Estimate of Fair Value Measurement | Significant Other Observable Inputs (Level 2) | Notes receivable
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value on a recurring basis	0	0
Estimate of Fair Value Measurement | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value on a recurring basis	41,072	36,663
Estimate of Fair Value Measurement | Significant Unobservable Inputs (Level 3) | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value on a recurring basis	0	0
Estimate of Fair Value Measurement | Significant Unobservable Inputs (Level 3) | Notes receivable
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Total assets at fair value on a recurring basis	$ 41,072	$ 36,663

XML

Property and Equipment, net - Schedule of property and equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Property, Plant and Equipment [Line Items]
Right-of-use assets for finance leases	$ 5,603	$ 5,603
Property and equipment and Right-of-use assets for finance leases, gross	460,236	452,710
Less: Accumulated depreciation and amortization	(196,698)	(186,364)
Property and equipment and Right-of-use assets for finance leases, net	263,538	266,346
Land
Property, Plant and Equipment [Line Items]
Property and equipment, gross	25,601	25,601
Buildings and building improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	164,325	160,920
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	89,462	87,525
Training equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	112,448	110,292
Office and computer equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	37,472	37,251
Curriculum development
Property, Plant and Equipment [Line Items]
Property and equipment, gross	3,570	2,478
Software developed for internal use
Property, Plant and Equipment [Line Items]
Property and equipment, gross	13,103	12,573
Vehicles
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,406	1,406
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 7,246	$ 9,061

XML

Property and Equipment, net - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Deprecation expense	$ 7.0	$ 6.6	$ 13.8	$ 11.7

XML

Goodwill - Narrative (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 28,459	$ 28,459

XML

Goodwill - Goodwill Reportable Segment (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Goodwill [Line Items]
Goodwill	$ 28,459	$ 28,459
UTI
Goodwill [Line Items]
Goodwill	16,859	16,859
Concorde
Goodwill [Line Items]
Goodwill	$ 11,600	$ 11,600

XML

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Accumulated Amortization	$ (1,415)	$ (720)
Total	2,327
Gross Carrying Value	20,042	20,042
Net Book Value	$ 18,627	$ 19,322
Weighted Average Remaining Useful Life (Years)	4 years 1 month 24 days	4 years 11 months 15 days
Trademarks, trade names and other
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross carrying amount	$ 1,942	$ 1,942
Accumulated Amortization	(848)	(513)
Total	$ 1,094	$ 1,429
Weighted Average Remaining Useful Life (Years)	4 years 10 months 20 days	5 years 6 months 3 days
Curriculum
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross carrying amount	$ 1,800	$ 1,800
Accumulated Amortization	(567)	(207)
Total	$ 1,233	$ 1,593
Weighted Average Remaining Useful Life (Years)	3 years 5 months 26 days	4 years 5 months 19 days
Accreditations and regulatory approvals
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, gross carrying amount	$ 16,300	$ 16,300
Indefinite-lived intangible assets, net book value	$ 16,300	$ 16,300

XML

Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 0.2	$ 0.2	$ 0.3	$ 0.3

XML

Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2024	$ 348
2025	677
2026	660
2027	337
2028	97
Thereafter	208
Total	$ 2,327

XML

Leases - Narrative (Details)	6 Months Ended
	Mar. 31, 2024 location campus
Lessee, Lease, Description [Line Items]
Number of lease contracts	29
Number of leasable campuses	33
Number of corporate office locations leased | location	3
Minimum
Lessee, Lease, Description [Line Items]
Lease term	5 years
Maximum
Lessee, Lease, Description [Line Items]
Lease term	20 years

XML

Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Leases [Abstract]
Operating lease expense	$ 7,597	$ 8,273	$ 15,259	$ 13,977
Income and Expenses, Lessee [Abstract]
Amortization of leased assets	227	127	454	325
Interest on lease liabilities	79	35	161	122
Variable lease expense	2,476	2,307	4,837	4,257
Sublease income	(33)	(25)	(65)	(57)
Total net lease expense	$ 10,346	$ 10,717	$ 20,646	$ 18,624

XML

Leases - Supplemental Information (Details) $ in Thousands	6 Months Ended
	Mar. 31, 2024 USD ($) lease	Mar. 31, 2023 USD ($)	Sep. 30, 2023 USD ($) lease
Assets:
Operating lease assets	$ 169,626		$ 176,657
Finance lease assets	$ 4,391		$ 4,846
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Property and equipment, net		Property and equipment, net
Total leased assets	$ 174,017		$ 181,503
Current
Operating lease liabilities	22,841		22,481
Finance lease liabilities	$ 887		$ 844
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]	Long-term debt, current portion		Long-term debt, current portion
Noncurrent
Operating lease liabilities	$ 158,448		$ 165,026
Finance lease liabilities	$ 4,304		$ 4,757
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Long-term debt		Long-term debt
Total lease liabilities	$ 186,480		$ 193,108
Number of facilities leased | lease	1		1
Finance lease, accumulated amortization	$ 1,200		$ 800
Weighted-average remaining lease term (in years):
Operating leases	7 years 6 months 25 days		7 years 10 months 28 days
Finance lease	4 years 9 months 29 days		5 years 3 months 29 days
Weighted average discount rate:
Operating leases	4.86%		4.76%
Finance lease	6.02%		6.02%
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 10,139	$ 10,745
Financing cash flows from finance leases	410	304
Non-cash activity related to lease liabilities:
Lease assets obtained in exchange for new operating lease liabilities	$ 3,921	$ 149

XML

Leases - Schedule of Operating Leases Liabilities Maturities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Operating Leases
Remainder of 2024	$ 14,312
2025	30,148
2026	30,509
2027	28,874
2028	26,747
2029 and thereafter	85,892
Total lease payments	216,482
Less: interest	(35,193)
Present value of lease liabilities	181,289
Less: current lease liabilities	(22,841)	$ (22,481)
Long-term lease liabilities	158,448	165,026
Finance Lease
Remainder of 2024	585
2025	1,193
2026	1,229
2027	1,266
2028	1,304
2029 and thereafter	439
Total lease payments	6,016
Less: interest	(825)
Present value of lease liabilities	5,191
Less: current lease liabilities	(887)	(844)
Long-term lease liabilities	$ 4,304	$ 4,757

XML

Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Payables and Accruals [Abstract]
Accounts payable	$ 17,658	$ 14,438
Accrued compensation and benefits	28,971	36,332
Accrued tool sets	4,743	4,096
Other accrued expenses	18,707	15,075
Total accounts payable and accrued expenses	$ 70,079	$ 69,941

XML

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	6 Months Ended
	Mar. 31, 2024	Sep. 30, 2023
Debt Instrument [Line Items]
Total debt	$ 142,346	$ 162,592
Debt issuance costs presented with debt	(429)	(475)
Total debt, net	141,917	162,117
Less: current portion of long-term debt	(2,600)	(2,517)
Long-term debt	$ 139,317	159,600
Avondale Term Loan
Debt Instrument [Line Items]
Interest Rate	7.37%
Total debt	$ 28,825	29,251
Avondale Term Loan | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Variable interest rate	2.00%
Tranche rate adjustment	0.046%
Lisle Term Loan
Debt Instrument [Line Items]
Interest Rate	7.33%
Total debt	$ 37,330	37,740
Lisle Term Loan | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Variable interest rate	2.00%
Finance Lease
Debt Instrument [Line Items]
Interest Rate	6.02%
Total debt	$ 5,191	5,601
Debt issuance costs presented with debt	0
Total debt, net	$ 5,191
Weighted average interest rate	6.02%
Revolving Credit Facility
Debt Instrument [Line Items]
Interest Rate	7.78%
Total debt	$ 71,000	$ 90,000
Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | Variable Rate Component One
Debt Instrument [Line Items]
Variable interest rate	2.00%
Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | Variable Rate Component Two | Minimum
Debt Instrument [Line Items]
Variable interest rate	10.00%
Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | Variable Rate Component Two | Maximum
Debt Instrument [Line Items]
Variable interest rate	0.15%

XML

Debt - Narrative (Details) - USD ($)					1 Months Ended	3 Months Ended	6 Months Ended
	Nov. 28, 2022	Nov. 18, 2022	Apr. 14, 2022	May 12, 2021	Apr. 30, 2024	Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2023
Avondale Term Loan
Debt Instrument [Line Items]
Interest Rate						7.37%	7.37%
Avondale Term Loan | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Tranche rate adjustment						0.046%	0.046%
Variable interest rate							2.00%
Lisle Term Loan
Debt Instrument [Line Items]
Interest Rate						7.33%	7.33%
Lisle Term Loan | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Variable interest rate							2.00%
Fifth Third Bank, National Association | Secured Debt | Avondale Term Loan
Debt Instrument [Line Items]
Debt maturity term				7 years
Interest Rate								1.45%
Maximum principal amount				$ 31,200,000
Fifth Third Bank, National Association | Secured Debt | Avondale Term Loan | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Variable interest rate				2.00%
Fifth Third Bank, National Association | Secured Debt | Avondale Term Loan | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Tranche rate adjustment				0.046%
Fifth Third Bank, National Association | Secured Debt | Lisle Term Loan
Debt Instrument [Line Items]
Debt maturity term			7 years
Interest Rate			4.69%
Valley National Bank | Secured Debt | Lisle Term Loan
Debt Instrument [Line Items]
Debt maturity term			7 years
Maximum principal amount			$ 38,000,000
Valley National Bank | Secured Debt | Lisle Term Loan | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Variable interest rate			2.00%
Revolving Credit Facility
Debt Instrument [Line Items]
Interest Rate						7.78%	7.78%
Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | Variable Rate Component Two | Maximum
Debt Instrument [Line Items]
Variable interest rate							0.15%
Revolving Credit Facility | Fifth Third Bank | Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 100,000,000
Debt maturity term		3 years
Revolving Credit Facility | Fifth Third Bank | Line of Credit | Concorde
Debt Instrument [Line Items]
Proceeds from lines of credit	$ 90,000,000					$ 20,000,000
Interest Rate	6.54%					8.50%	8.50%
Revolving Credit Facility | Fifth Third Bank | Secured Debt
Debt Instrument [Line Items]
Debt issuance costs		$ 500,000
Letter of Credit | Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity						$ 29,000,000	$ 29,000,000
Letter of Credit | Line of Credit | Subsequent Event
Debt Instrument [Line Items]
Maximum borrowing capacity					$ 49,000,000
Letter of Credit | Fifth Third Bank | Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 20,000,000
Maximum principal amount								$ 1,800,000
Repayments						$ 39,000,000
Letter of Credit | Fifth Third Bank | Line of Credit | Subsequent Event
Debt Instrument [Line Items]
Repayments					$ 20,000,000

XML

Debt - Debt Maturities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Revolving Credit Facility & Term Loans
Remainder of 2024	$ 1,271
2025	2,695
2026	73,863
2027	3,037
2028	27,847
Thereafter	33,633
Total debt, net	142,346	$ 162,592
Debt issuance costs presented with debt	(429)	(475)
Total debt, net	141,917	162,117
Revolving Credit Facility & Term Loans
Revolving Credit Facility & Term Loans
Remainder of 2024	837
2025	1,763
2026	72,836
2027	1,909
2028	26,610
Thereafter	33,200
Total debt, net	137,155
Debt issuance costs presented with debt	(429)
Total debt, net	136,726
Finance Lease
Revolving Credit Facility & Term Loans
Remainder of 2024	434
2025	932
2026	1,027
2027	1,128
2028	1,237
Thereafter	433
Total debt, net	5,191	$ 5,601
Debt issuance costs presented with debt	0
Total debt, net	$ 5,191

XML

Derivative Financial Instruments - Narrative (Details) - USD ($) $ in Millions	Apr. 14, 2022	May 12, 2021	Mar. 31, 2024	Mar. 31, 2023
Interest Rate Swap | Cash Flow Hedging | Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) expected to reclassified to interest expense within the next twelve months			$ 0.9
Avondale Term Loan
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest Rate			7.37%
Lisle Term Loan
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest Rate			7.33%
Lisle Swap | Interest Rate Swap | Cash Flow Hedging | Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, notional amount			$ 18.7
Avondale Swap | Interest Rate Swap | Cash Flow Hedging | Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative, notional amount			$ 14.4
Secured Debt | Fifth Third Bank, National Association | Avondale Term Loan
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Fixed rate on principal amount				50.00%
Interest Rate				1.45%
Debt maturity term		7 years
Secured Debt | Fifth Third Bank, National Association | Lisle Term Loan
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Fixed rate on principal amount	50.00%
Interest Rate	4.69%
Debt maturity term	7 years

XML

Derivative Financial Instruments - Fair Value of Derivative Instruments (Details) - Interest Rate Swap - Hedging Instrument - Cash Flow Hedging - USD ($) $ in Thousands	Mar. 31, 2024	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total fair value of assets designated as hedging instruments	$ 2,321	$ 3,032
Other current assets
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total fair value of assets designated as hedging instruments	833	957
Other assets
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total fair value of assets designated as hedging instruments	$ 1,488	$ 2,075

XML

Derivative Financial Instruments - Accumulated Other Comprehensive Income (Loss) and Statement of Operations (Details) - Interest Rate Swaps - Cash Flow Hedging - Hedging Instrument - Interest Expense - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) on Derivative, net of taxes	$ (738)	$ 518	$ 174	$ 559
Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Income (Loss) into Income	$ (267)	$ (199)	$ (538)	$ (327)

XML

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income tax expense (benefit)	$ (2,767)	$ (1,763)	$ (5,927)	$ (3,288)
Effective income tax rate, percent	26.20%	33.60%	24.60%	34.90%

XML

Restructuring Costs (Details) - Campus Location Consolidation - Facility Consolidation $ in Thousands		3 Months Ended	6 Months Ended
	Dec. 05, 2023 USD ($) plan	Mar. 31, 2024 USD ($)	Mar. 31, 2024 USD ($)	Sep. 30, 2025 USD ($)	Sep. 30, 2024 USD ($)
Restructuring Cost and Reserve [Line Items]
Number of plans consolidated | plan	2
Forecast
Restructuring Cost and Reserve [Line Items]
Expected estimated costs				$ 800	$ 500
UTI
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 1,400
Termination costs		$ 45	$ 88

XML

Shareholders' Equity (Details) $ / shares in Units, $ in Millions		6 Months Ended
	Dec. 18, 2023 USD ($) day $ / shares shares	Mar. 31, 2024 USD ($) vote $ / shares shares	Mar. 31, 2023 USD ($) shares	Sep. 30, 2023 $ / shares shares	Dec. 10, 2020 USD ($)
Stockholders Equity Note [Line Items]
Number of voting rights | vote		1
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001		$ 0.0001
Preferred stock, shares issued (in shares)		0		676,000
Preferred stock, shares outstanding (in shares)		0		676,000
Preferred stock, par value (in dollars per share) | $ / shares		$ 0.0001		$ 0.0001
Preferred stock, liquidation preference (in dollars per share) | $ / shares		$ 100		$ 100
Repurchase of common stock authorized by Board of Directors | $		$ 35.0	$ 35.0		$ 35.0
Stock repurchased (in shares)		0	0
Common Stock
Stockholders Equity Note [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0
Series A Preferred Stock
Stockholders Equity Note [Line Items]
Consecutive trading days | day	20
Excise taxes and other professional service fees | $	$ 0.3
Preferred stock cancelled and converted into the right to receive (in shares)	30.03003
Dividends payable | $	$ 1.1
Preferred stock conversion of stock, shares converted (in shares)	642,585
Preferred stock outstanding shares converted into common stock shares (in shares)	19,296,843
Preferred stock remain outstanding and all rights of the holders receive (in shares)	0
Preferred stock voting cap, percentage	25.00%
Preferred stock, shares issued (in shares)	33,300			675,885
Preferred stock, shares outstanding (in shares)				675,885
Preferred stock, par value (in dollars per share) | $ / shares				$ 0.0001
Preferred stock, liquidation preference (in dollars per share) | $ / shares				$ 100
Series A Preferred Stock | Preferred Stock Including Additional Paid in Capital
Stockholders Equity Note [Line Items]
Purchase price | $	$ 11.3

XML

Earnings per Share - Narrative (Details)	Dec. 18, 2023 shares
Series A Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Preferred stock remain outstanding and all rights of the holders receive (in shares)	0

XML

Earnings per Share - Calculation of earnings per share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended				6 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2024	Mar. 31, 2023
Basic earnings per common share:
Net income	$ 7,787	$ 10,389	$ 3,480	$ 2,648	$ 18,176	$ 6,128
Less: Preferred stock dividend declared	0		(1,251)		(1,097)	(2,528)
Income available for distribution	7,787		2,229		17,079	3,600
Income allocated to participating securities	0		(833)		(2,855)	(1,348)
Net income available to common shareholders	$ 7,787		$ 1,396		$ 14,224	$ 2,252
Weighted average basic shares outstanding (in shares)	53,757		33,999		45,048	33,901
Basic (loss) income per common share (in dollars per share)	$ 0.14		$ 0.04		$ 0.32	$ 0.07
Diluted earnings per common share:
Net income available to common shareholders	$ 7,787		$ 1,396		$ 14,224	$ 2,252
Weighted average basic shares outstanding (in shares)	53,757		33,999		45,048	33,901
Dilutive effect related to employee stock plans (in shares)	1,013		554		1,002	576
Weighted average diluted shares outstanding (in shares)	54,770		34,553		46,050	34,477
Diluted income per common share (in dollars per share)	$ 0.14		$ 0.04		$ 0.31	$ 0.07

XML

Earnings per Share - Schedule of antidilutive securities (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive shares excluded (in shares)	0	20,536	17	20,812
Outstanding stock-based grants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive shares excluded (in shares)	0	239	17	515
Convertible preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive shares excluded (in shares)	0	20,297	0	20,297

XML

Segment Information (Details) $ in Thousands		3 Months Ended				6 Months Ended
	Dec. 01, 2022 segment	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Mar. 31, 2024 USD ($) segment	Mar. 31, 2023 USD ($)	Sep. 30, 2023 USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments | segment	2					2
Revenues		$ 184,176		$ 163,820		$ 358,871	$ 283,824
Income (loss) from operations		11,192		5,949		25,423	10,397
Depreciation and amortization		7,202		6,746		14,186	11,994
Net income (loss)		7,787	$ 10,389	3,480	$ 2,648	18,176	6,128
Total assets		702,088				702,088		$ 740,685
Operating Segments | UTI
Segment Reporting Information [Line Items]
Revenues		123,323		107,560		238,697	213,133
Income (loss) from operations		18,086		9,788		33,177	23,210
Depreciation and amortization		5,684		5,094		11,178	9,869
Net income (loss)		16,616		8,821		30,213	21,553
Total assets		446,337				446,337		442,507
Operating Segments | Concorde
Segment Reporting Information [Line Items]
Revenues		60,853		56,260		120,174	70,691
Income (loss) from operations		3,246		6,189		10,373	5,463
Depreciation and amortization		1,217		1,649		2,371	2,106
Net income (loss)		3,320		6,237		10,493	5,503
Total assets		134,849				134,849		130,813
Corporate
Segment Reporting Information [Line Items]
Revenues		0		0		0	0
Income (loss) from operations		(10,140)		(10,028)		(18,127)	(18,276)
Depreciation and amortization		301		3		637	19
Net income (loss)		(12,149)		$ (11,578)		(22,530)	$ (20,928)
Total assets		$ 120,902				$ 120,902		$ 167,365

XML

Government Regulation and Financial Aid (Details) - Concorde	Mar. 31, 2024 institution
ACCSC
Unusual or Infrequent Item, or Both [Line Items]
Number of accredited institutions	14
COE
Unusual or Infrequent Item, or Both [Line Items]
Number of accredited institutions	2